Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,24966,0.224904205891318,0.00467651372896198,0.215738238982553,0.234070172800083,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,29786,-0.197518001586969,0.00363523026745433,-0.20464305291118,-0.190392950262759,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,24951,0.0787245168967668,0.00174387598237727,0.0753065199713074,0.0821425138222263,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0998207676976448,0.00206455323083361,-0.103867292030079,-0.0957742433652109,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,24951,0.165696325080047,0.00370949419637454,0.158425716455152,0.172966933704941,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,29301,-0.214568255428886,0.00529927936217181,-0.224954842978743,-0.204181667879029,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.241008916082308,0.00564948510461364,-0.252081906887351,-0.229935925277266,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.137719235901852,0.00222505716797813,0.133358123852615,0.142080347951089,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,28797,-0.517932065249943,0.00844705677960943,-0.534488296537978,-0.501375833961909,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.195282334724104,0.00463634263775845,-0.204369566294111,-0.186195103154098,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.389492882971117,0.00849373758668018,0.372845157301224,0.40614060864101,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.316527491206082,0.00565565092020901,-0.327612567009692,-0.305442415402472,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.122169543062112,0.00288977924930689,-0.127833510390754,-0.116505575733471,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.218309116454903,0.00358187154132571,-0.225329584675901,-0.211288648233904,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,29478,0.155508179927851,0.00326680915553301,0.149105233983007,0.161911125872696,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.158684252497908,0.00389231201553473,-0.166313184048356,-0.15105532094746,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,29443,-0.20784541529043,0.002918610469448,-0.213565891810548,-0.202124938770312,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0868486048006338,0.00214879254409843,0.0826369714142009,0.0910602381870667,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.25805760384407,0.00450197330599834,-0.266881471523827,-0.249233736164314,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.404584653521573,0.00974360663968074,-0.423682122535348,-0.385487184507799,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.11260488592112,0.00219880352694259,0.108295231008312,0.116914540833927,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.101933457954962,0.00251906615448511,0.0969960882921714,0.106870827617753,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.108391588688203,0.00194517323287206,0.104579049151774,0.112204128224633,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.166572170320591,0.00275993151129712,-0.171981636082733,-0.161162704558448,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,29347,-0.156165090551537,0.00281438140783258,-0.161681278110889,-0.150648902992185,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,24111,-0.303481157754695,0.00676187919912533,-0.316734440984981,-0.29022787452441,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.130481070168768,0.0033193898935869,-0.136987074360198,-0.123975065977338,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0926436860721354,0.00237780518134563,-0.0973041842275729,-0.087983187916698,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.150123965845046,0.00374514593818424,-0.157464451883887,-0.142783479806205,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.279935548188031,0.00630861060890594,-0.292300424981487,-0.267570671394576,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,29584,-0.0935363095720536,0.00240775577489564,-0.0982555108908491,-0.0888171082532581,1.11253692925363e-308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,29566,-0.090654524919132,0.00235635621568677,-0.0952729831018781,-0.086036066736386,1.11253695506143e-308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,29478,-0.164301491671542,0.00434150453876106,-0.172810840567514,-0.15579214277557,4.55715861713721e-306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.312500245039325,0.00834375254665455,-0.328854000030768,-0.296146490047882,5.24973297061208e-300
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0875063860310784,0.00234540125153725,-0.0921033724840914,-0.0829093995780654,9.47766344151345e-298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.234412432321044,0.00645486948153807,-0.247063976504858,-0.221760888137229,1.98691320399976e-281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,28931,-0.203052867189882,0.00561486184472842,-0.21405799640555,-0.192047737974214,4.00886389788398e-280
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.213321927043832,0.00590215604742275,-0.224890152896781,-0.201753701190884,8.18610154559112e-280
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,24195,-0.204487527448095,0.00571948032096853,-0.215697708877194,-0.193277346018997,7.51319385280561e-273
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,29545,0.0696313473748655,0.00196086193587198,0.0657880579805565,0.0734746367691746,1.66846848200245e-270
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.130232044912099,0.00369360278529162,-0.13747150637127,-0.122992583452927,7.71323671835932e-267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0933715848723434,0.00265069281737294,0.0881762269502924,0.0985669427943944,2.80156583383622e-266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.111708161273944,0.00318769185457565,0.105460285238976,0.117956037308913,1.29657435398266e-263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,29454,-0.134923843219679,0.00385926352066667,-0.142487999720185,-0.127359686719172,2.06618376029935e-262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0736629372108086,0.00211284041305056,-0.0778041044203877,-0.0695217700012295,5.44011951477189e-261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,24381,-0.0707868530376525,0.00203278458347477,-0.074771110821263,-0.0668025952540419,2.49381127669583e-259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0802327990801721,0.00232013213687473,-0.0847802580684465,-0.0756853400918976,6.08895503736921e-257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,29443,0.0654950685136027,0.00190821494069923,0.0617549672298322,0.0692351697973732,3.56648287409772e-253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.129684806405333,0.00381593602848807,-0.13716404102117,-0.122205571789496,2.41914134148721e-248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0627517321961588,0.00185009887639054,-0.0663779259938843,-0.0591255383984333,1.74097747314207e-246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.0763678169134971,0.00227558167014085,-0.0808279569869732,-0.0719076768400211,2.69645128868788e-241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0513231699346732,0.00153414140048183,0.0483162527897288,0.0543300870796175,6.7663697664993e-241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.126909451661639,0.00379670167141143,0.119467916385673,0.134350986937605,2.08100124541871e-240
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0842176457589783,0.00252068228728894,0.079277108475892,0.0891581830420646,2.7095863179256e-240
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.130455791646944,0.00390549109872846,-0.138110554200452,-0.122801029093436,4.53608515139818e-240
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,29400,-0.238103703671315,0.00720360362092371,-0.252222766768326,-0.223984640574305,2.8478003825291e-235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.121175124517043,0.00366154516170737,0.113998496000097,0.12835175303399,4.39855464469772e-235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,27442,-0.0947028845714348,0.00287853847515152,-0.100344819982732,-0.0890609491601378,7.49258044487611e-233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,23787,0.101453844359173,0.00308020855124576,0.0954166355987317,0.107491053119615,1.08286694101022e-232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.195968610622333,0.00596280793660487,-0.207655714178079,-0.184281507066588,1.1270718546789e-232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0762875421073126,0.00232576358017215,-0.08084603872445,-0.0717290454901752,9.18928322029657e-232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.341759497203863,0.0104335624860957,-0.36220927967661,-0.321309714731115,4.08648754341266e-231
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.122441190607356,0.00374566723537651,-0.129782698388694,-0.115099682826018,3.69837447091423e-230
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.0765019617857544,0.00235955102837054,0.0718772417701482,0.0811266818013607,1.24434657426842e-226
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0783418151298012,0.00241754378432369,0.0736034293125267,0.0830802009470756,1.9633274733681e-226
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,29545,-0.0417335959420254,0.00128876590912703,-0.0442595771239144,-0.0392076147601364,4.37211180153487e-226
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.15561347921311,0.00482291630708541,-0.165066395174997,-0.146160563251223,1.80442084587293e-224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.11805908740558,0.00366397156576028,-0.12524047167447,-0.11087770313669,8.06515703109406e-224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.138881508348791,0.00434500884370025,-0.147397725682444,-0.130365291015139,2.05451254260349e-220
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.127173813464341,0.00397966948855781,-0.134973965661915,-0.119373661266768,2.69610357556724e-220
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.1724712687128,0.00540817653475889,-0.183071294720928,-0.161871242704673,9.22869927083569e-219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,29683,-0.0453321638512742,0.00142624733445731,-0.0481276086268105,-0.0425367190757378,4.88148829009515e-218
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.142778051584486,0.0044955003052831,-0.151589232182841,-0.133966870986131,1.31528783594822e-217
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.138381654432791,0.00441438278873699,0.129729464166866,0.147033844698715,2.97176736854647e-212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0676955274807257,0.00216133214875641,-0.0719317384922883,-0.0634593164691631,7.19492712861787e-212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.131383929229049,0.00420063304349983,-0.139617169994308,-0.123150688463789,3.28759713768865e-211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.188866759076172,0.00604667463974734,-0.200718241370076,-0.177015276782267,4.22583408222564e-210
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0694274250660914,0.00222893027544291,-0.0737961284059595,-0.0650587217262233,1.28692251930669e-209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.175749947498714,0.00564361110256999,-0.186811425259751,-0.164688469737677,1.71682242288557e-209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,29544,-0.0663884554623483,0.00217575586052603,-0.0706529369489793,-0.0621239739757172,2.36714970233357e-201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,24966,-0.042144752049122,0.00138483186481999,-0.0448590225041692,-0.0394304815940748,8.96257419412003e-200
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,28774,-0.111127431713152,0.00365888297556376,-0.118298842345257,-0.103956021081047,1.82994771850425e-199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.164509347786526,0.00544063209200986,-0.175172986686866,-0.153845708886187,9.56858518746021e-198
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0809081069922016,0.00267631937268486,-0.0861536929626639,-0.0756625210217392,4.09769956933564e-197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.101219488653888,0.00336406645661228,-0.107813058908848,-0.0946259183989278,6.92942449924676e-196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0762543326042277,0.00254857024428552,-0.0812495302830274,-0.0712591349254281,8.33754327268795e-194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0730689819997677,0.00244356949404535,-0.0778583782080966,-0.0682795857914388,1.3359132534215e-193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,29786,-0.0551120486187578,0.00186480606127333,-0.0587670684988535,-0.0514570287386621,3.19183141198203e-189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0667672146038208,0.00225978217367118,-0.0711963876642163,-0.0623380415434253,4.3917966580899e-189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.171051968709484,0.00584281735160126,-0.182503890718623,-0.159600046700346,1.12198201121558e-185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,24938,0.122982244613999,0.00421135212204117,0.114727994454798,0.1312364947732,2.2911580022723e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.180007747421817,0.00617671087945768,-0.192114100745554,-0.16790139409808,4.32929068192404e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.048386845044343,0.00166396762676111,-0.0516482215927948,-0.0451254684958912,2.5286492725282e-183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.167916874022942,0.00577980317483185,-0.179245288245613,-0.156588459800272,5.63429064895547e-183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,29349,-0.165260127517563,0.00570877161659769,-0.176449319886095,-0.154070935149032,1.05780648793732e-181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.105456817639937,0.00364544211226802,-0.112601884179982,-0.0983117510998913,6.2435925268431e-181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0602987657730039,0.00209472422053853,0.0561931063007484,0.0644044252452594,9.78868793847995e-180
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0848892334773649,0.00295668842465283,-0.0906843427896844,-0.0790941241650453,7.9617380059787e-179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,29786,-0.0577882900424176,0.00201707169732336,-0.0617417505691714,-0.0538348295156638,4.25156740792529e-178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.214783447497018,0.00752326750407049,-0.229529051804996,-0.200037843189039,7.55558821287637e-177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.0983300269420358,0.0034447004987533,-0.105081639919592,-0.0915784139644793,7.99647019354626e-177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.120667034480053,0.00424767588949501,-0.128992479223463,-0.112341589736643,3.65273053152136e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0397223257700542,0.00140986880518542,0.0369589829118908,0.0424856686282177,2.31406141015187e-172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0753585240698843,0.00267643354755409,-0.0806043338230903,-0.0701127143166782,1.12267271209073e-171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0568715345589446,0.00202145693407409,-0.0608335901497298,-0.0529094789681593,1.80865951036361e-171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,29559,-0.0650161299185874,0.00232150903413084,-0.0695662876254838,-0.0604659722116909,2.31825725765963e-170
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0694927311635472,0.00248357068017016,-0.0743605296966807,-0.0646249326304137,4.58273396159728e-170
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,24707,-0.0506350873323612,0.00180782489045768,-0.0541784241176582,-0.0470917505470641,5.75317534601369e-170
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0868072922248266,0.00312409648097999,-0.0929305213275474,-0.0806840631221059,1.00969104459292e-167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0715726628326769,0.00258165248678656,-0.0766327017067785,-0.0665126239585752,5.29489619416271e-167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,24381,-0.0787382019641535,0.00287845303761114,-0.0843799699178713,-0.0730964340104357,2.71064874542021e-162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0524951902961495,0.00193449605974654,0.0487035780190463,0.0562868025732527,3.43001916760577e-160
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.133333855495206,0.00492640855845048,-0.142989616269769,-0.123678094720643,2.30642470936757e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.139198936149818,0.00513997613776,-0.149273289379828,-0.129124582919808,3.35980739497349e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.105970152088545,0.00391725699709601,-0.113647975802853,-0.0982923283742369,3.47458708843479e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.10803438134957,0.00399756268069799,-0.115869604203738,-0.100199158495402,6.55443227519275e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,29786,-0.0583963837183682,0.00216142140980663,-0.0626327696815892,-0.0541599977551472,7.59119078574508e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,24867,-0.0852678223011966,0.00316050729380754,-0.0914624165970593,-0.0790732280053338,4.90729236707811e-158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,29628,0.0531856368632558,0.00198162996292668,0.0493016421359195,0.0570696315905921,8.4704618489564e-157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0652165379145968,0.00243706176683987,-0.0699931789776029,-0.0604398968515906,6.62487567742064e-156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.149051022680671,0.00561829033885358,-0.160062871744824,-0.138039173616518,3.02194598010745e-153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.210245316303266,0.00792473415077057,-0.225777795238777,-0.194712837367756,5.92844973370327e-153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0415405331991846,0.00157251999215422,-0.0446226723838069,-0.0384583940145624,5.16833932835152e-152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,29443,-0.0605847211613264,0.00229814406222921,-0.0650890835232956,-0.0560803587993571,2.12313779162361e-151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.07281259789503,0.00276889432043672,-0.078239630763086,-0.0673855650269741,1.10564510898297e-150
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0895040053636083,0.00341058632520837,-0.0961887545610167,-0.0828192561661999,4.59911637681174e-150
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.1074752115813,0.0040953766376951,-0.115502149791183,-0.099448273371418,1.06101479786454e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0612333027370934,0.00233832525486293,-0.0658164202366248,-0.0566501852375621,1.85606171216006e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0526447539586107,0.00201437124640161,-0.0565929216015578,-0.0486965863156635,1.48779227941389e-148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,29750,0.10036357160291,0.00384948305510247,0.0928185848149091,0.107908558390911,3.52065226624398e-148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.134692484755242,0.00518071376090112,-0.144846683726608,-0.124538285783876,4.67882502012851e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0434790163677331,0.00167602875964098,-0.0467640327366294,-0.0401939999988367,1.00968482736162e-146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0917573726913989,0.00353745443384052,-0.0986907833817263,-0.0848239620010715,2.35776349295839e-146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0998187671190593,0.00385899176541489,-0.107382390979272,-0.0922551432588461,1.50020560346248e-145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.109605175521145,0.00424556047823501,-0.117926474058485,-0.101283876983804,2.63315540378866e-145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.10326410356384,0.00400711187511452,-0.111118042839064,-0.0954101642886151,7.98008026227258e-145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,29820,-0.0921097136975679,0.00359203173250642,-0.0991500958932805,-0.0850693315018553,1.83452408039768e-143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.167878531692313,0.00654962136539843,-0.180715789568494,-0.155041273816132,2.7002609131018e-143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,24240,-0.117569079577073,0.00458282259014336,-0.126551411853754,-0.108586747300392,3.09628370657836e-143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.132385285885512,0.00518514021661135,-0.14254816071007,-0.122222411060954,3.21826748225879e-142
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.0913503944107806,0.00358323417717776,-0.098373533398049,-0.0843272554235122,7.73939110520772e-142
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.114371963432448,0.00449641216154781,0.105558995595815,0.123184931269082,3.41352160565388e-141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0688330466018995,0.00271079168290984,-0.0741461983004028,-0.0635198949033962,9.69908806370388e-141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.117990079585196,0.00465580926550898,-0.127115465745594,-0.108864693424799,3.41720031876278e-140
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0884509177209691,0.00349880225446683,0.0815932653022141,0.0953085701397241,3.01292971373584e-139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0591883420233045,0.00234945829665432,-0.063793280284747,-0.0545834037618621,2.61523083813497e-138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.085154983639051,0.00338140389261512,-0.0917825352685767,-0.0785274320095254,3.57924353660273e-138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.0793820651715484,0.00317393262301399,-0.0856029731126558,-0.073161157230441,1.20459009292275e-136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.107998766852429,0.00433780678698076,-0.116500868154912,-0.099496665549947,1.96739166528738e-135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0503779797117207,0.00204123752292801,-0.0543788052566596,-0.0463771541667818,3.84311344590507e-133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.135169067153855,0.00548337140555077,-0.145916475108735,-0.124421659198976,7.78107137446827e-133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.116318958267623,0.00471630791754787,-0.125562921786017,-0.107074994749229,1.04034712546493e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0915829816017609,0.00372403257464676,-0.0988820854480686,-0.0842838777554533,3.21401161685782e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0921919975237585,0.00374961449101431,-0.0995412419261466,-0.0848427531213705,6.61961629852343e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.119743302200274,0.0048752424556017,-0.129298777413253,-0.110187826987294,1.35310546252501e-131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.104601521257496,0.0042638876994234,-0.112958741148366,-0.096244301366626,1.39362700293643e-131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0604094643082408,0.00247615305666246,-0.0652627242992992,-0.0555562043171824,3.57555031182557e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0763923072555164,0.00313289506001984,-0.0825327815731553,-0.0702518329378775,5.21633864486424e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0689086077601016,0.00282862332144257,-0.0744527094701291,-0.0633645060500742,8.61664588927671e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0662505750620575,0.00272406689564533,0.0609114039465927,0.0715897461775224,2.22569293122279e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,29786,-0.0787463289130046,0.00323862347610845,-0.0850940309261772,-0.0723986268998321,2.50397263713936e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0764837726977945,0.00314591675108196,-0.0826497695299151,-0.0703177758656739,2.66042424639378e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,29581,0.0747467108960331,0.00308406209941719,0.0687019491811754,0.0807914726108908,1.65215239440909e-128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,29478,-0.109807311030494,0.00453685353945145,-0.118699543967819,-0.10091507809317,3.66203762557721e-128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0671496402078166,0.00279676295806299,0.0616679848100131,0.07263129560562,3.60532970363063e-126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.219248141840981,0.00914033567737651,-0.237163199768639,-0.201333083913323,6.02065638872438e-126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,29478,-0.114769436164683,0.00479997159002459,-0.124177380481131,-0.105361491848235,3.72196529754011e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0629357633285384,0.00263845001178351,-0.0681071253516341,-0.0577644013054428,1.39120053029213e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,24381,0.0387320022358026,0.00162589965003801,0.0355452389217281,0.0419187655498771,5.18768731529657e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0456702769442373,0.0019264999778573,0.041894336987637,0.0494462169008376,4.42825654524571e-123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0932535188799624,0.003936916309187,-0.100969874845969,-0.0855371629139559,7.48627537906808e-123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,24938,0.064161778037704,0.00271296230288136,0.0588443719240565,0.0694791841513514,2.62267326080712e-122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0703911980832734,0.00300992515905161,-0.0762906513950145,-0.0644917447715322,7.16579706470671e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,29581,-0.0575131052898669,0.00246041188449481,-0.0623355125834768,-0.0526906979962571,9.29286179019075e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,29545,-0.0550159843390341,0.0023609816331758,-0.0596435083400586,-0.0503884603380095,5.00749471419071e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0461949468936156,0.00198417305406768,-0.0500839260795883,-0.042305967707643,8.07502734993522e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.0980389513388524,0.00422039127824029,-0.106310918244203,-0.0897669844335015,2.56479144318264e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,29530,-0.0470490816677337,0.00202777736926373,-0.0510235253114906,-0.0430746380239767,4.92492865458648e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,29480,0.0868868943890315,0.0037529479897408,0.0795311163291395,0.0942426724489235,1.56974548024647e-117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.112585158206723,0.00486343208558549,-0.12211748509447,-0.103052831318975,1.63948330058908e-117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,24557,-0.0394866701525442,0.0017106119519274,-0.0428394695783219,-0.0361338707267665,1.19002078178626e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0564463809547889,0.00245157540294222,0.0516412931650221,0.0612514687445556,2.82871077029406e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.043309166876311,0.00188383760361975,-0.0470014885794058,-0.0396168451732163,6.18063560116221e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0523347731734008,0.00228079770238991,-0.056805136670085,-0.0478644096767166,2.62746839618331e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.0365085037602204,0.00159427567227329,-0.0396332840778761,-0.0333837234425648,7.1604692767619e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0447419415040771,0.00195510986360296,-0.0485739568367389,-0.0409099261714152,1.0709557171518e-114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0816392595927057,0.00359204218645964,-0.0886796622781666,-0.0745988569072448,2.26441530301021e-113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,29433,0.287278982104864,0.0126900027791912,0.26240657665765,0.312151387552079,1.66994603727914e-112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,24966,-0.0322974465928201,0.00142765747130193,-0.0350956552365719,-0.0294992379490683,3.48674826579424e-112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,29433,-0.0481689484380335,0.00213354111928581,-0.0523506890318337,-0.0439872078442333,6.52591458050828e-112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.06455982788571,0.00287244618338374,-0.0701898224051421,-0.0589298333662779,6.19548985995771e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0466741416365158,0.00207834095386963,-0.0507476899061003,-0.0426005933669314,9.16167268600708e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.073840396734828,0.0032958421776074,-0.0803002474029385,-0.0673805460667175,2.94509590852079e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0425471673349561,0.00190091267669625,-0.0462729561812807,-0.0388213784886314,4.75387432800962e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0437903334027834,0.00195693597970037,-0.0476259279229961,-0.0399547388825707,8.19794220198528e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0976359312273051,0.00436730100892325,0.0890760212498155,0.106195841204795,1.35224681233591e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0569430639778583,0.00255253393813414,-0.0619460304966012,-0.0519400974591154,2.4873155596589e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0412268633705322,0.00184893371815373,-0.0448507734581135,-0.0376029532829509,3.16446621371769e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.054773828209897,0.00246000654835764,-0.0595954410446779,-0.049952215375116,6.21021773229491e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0486193364283709,0.00218617679026766,-0.0529042429372955,-0.0443344299194463,1.11957366586009e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0606549221474743,0.00273997902218196,-0.066025281030951,-0.0552845632639977,1.03320456826973e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0586513541468651,0.00265115631725501,-0.0638476205286849,-0.0534550877650453,1.45949507958551e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.059761132748535,0.00270544708566287,-0.0650638090364342,-0.0544584564606357,2.99445598449993e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.107105644962579,0.0048527014292884,-0.116616939763985,-0.097594350161174,4.61346823455522e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.116044719064641,0.00526339112689528,-0.126360965673356,-0.105728472455927,7.52181248375667e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0901606844867288,0.0040866379978459,-0.0981704949625067,-0.0821508740109508,7.77796017014557e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,29594,-0.0841943689750495,0.00383200526093662,-0.0917050992864853,-0.0766836386636137,3.82885165661713e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0260960441288409,0.0011886259549347,0.0237663372571689,0.0284257510005129,5.43411085209933e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,29527,0.0610422027334634,0.00278670198634989,0.0555802668402176,0.0665041386267092,1.62208832590147e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,29434,-0.138870959305068,0.00636628355076543,-0.151348875064568,-0.126393043545567,1.1681541813865e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,29487,-0.0493308017290059,0.00226159733590163,-0.0537635325073731,-0.0448980709506387,1.19292340110837e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0584943518098976,0.00268657836685904,0.0532286582108539,0.0637600454089413,3.9362648503691e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.171185317788647,0.00788391921418785,-0.186637799448456,-0.155732836128839,1.04737144722425e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,24867,-0.0683724080337228,0.00315245215271627,-0.0745512142530467,-0.0621936018143989,2.38800092534661e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0875724397046244,0.00405306323584373,-0.0955164436468781,-0.0796284357623707,1.36682338835573e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0540053474598617,0.00250322295828104,0.0490990304616308,0.0589116644580925,1.95052880083948e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.0983676525319497,0.00456420964637083,-0.107313503438837,-0.0894218016250629,3.13911556510229e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,24229,-0.129289851720414,0.00599737944619093,-0.141044715434948,-0.11753498800588,4.08963037246361e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,29478,-0.117263547610344,0.00544850052137574,-0.12794260863224,-0.106584486588447,5.89570419766863e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0619768484872778,0.00288009072442027,0.0563318706674141,0.0676218263071416,6.3112630935611e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,24240,-0.0929248688004236,0.0043218325545534,-0.101395660607348,-0.0844540769934989,1.3500586224341e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0689373160236023,0.00320646612065417,-0.0752219896200844,-0.0626526424271201,1.40372594951789e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.126980868934587,0.00591130908431253,-0.13856703473984,-0.115394703129335,1.47246100920712e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0766355703619149,0.00357568383940779,-0.0836439106871542,-0.0696272300366756,3.87016110238448e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0422906690291224,0.00197498113283316,-0.0461616320494754,-0.0384197060087694,8.24884024437503e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0425946467570105,0.00199166943813534,-0.0464983188557558,-0.0386909746582653,1.04562903909147e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.106457971539475,0.00497442881503444,-0.116207852016942,-0.0967080910620073,1.06670486218784e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0648053963604756,0.00304414393743382,-0.0707719184778459,-0.0588388742431053,8.14367149156709e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0780716342542567,0.00367246751716193,-0.0852696705878941,-0.0708735979206193,1.54042353617481e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.030765584132026,0.00144844722245636,-0.0336045406880405,-0.0279266275760115,2.26681140164458e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.153341103393781,0.00723417026004939,-0.167520077103478,-0.139162129684085,5.9311785557122e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0514178548984247,0.00243020081496331,-0.0561810484957527,-0.0466546613010966,1.2669107480522e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0454031041988949,0.00214980590239768,-0.0496167237675944,-0.0411894846301954,2.82080548804132e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.100626171232589,0.00477245546780153,-0.10998018394948,-0.0912721585156978,5.74623583685692e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.187177467616848,0.00888446916873636,-0.204591027187571,-0.169763908046125,8.31630866537519e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0869919831857262,0.00413091952317904,-0.0950885854511572,-0.0788953809202953,9.88340139208891e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,24922,-0.0529712101829378,0.00252151197310374,-0.0579133736502212,-0.0480290467156545,3.88288397306637e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,24938,-0.169946452750833,0.00809251212342237,-0.185807776512741,-0.154085128988926,4.50651678142646e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0853335696157437,0.00406892333161224,-0.0933086593457037,-0.0773584798857837,5.97433964358118e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0583374371837181,0.00278639895669874,-0.0637987791388476,-0.0528760952285885,1.27902934198632e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0660485383943697,0.00315568889164792,-0.0722336886219996,-0.0598633881667398,1.45266370187284e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,29169,-0.046074906037206,0.00220145956291023,-0.0503897667805101,-0.041760045293902,1.48968711417403e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.0537920958280697,0.00257108085980246,-0.0588314143132825,-0.0487527773428568,1.71427094868685e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,24381,-0.0957882038238211,0.00457707999470591,-0.104759280613445,-0.0868171270341976,2.10924919138744e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,28774,-0.0771250236153287,0.0036898940949476,-0.0843572160414259,-0.0698928311892314,2.69116903374672e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.128113543178318,0.00612683221877008,-0.140122134327107,-0.116104952029528,3.06485998225501e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0888768709890981,0.00426223414189545,-0.0972308499072131,-0.080522892070983,7.23390714261183e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.101032392755062,0.00484732233700425,-0.11053314453559,-0.0915316409745337,8.75178944654865e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.10801768095718,0.00519304386020362,-0.11819604692318,-0.0978393149911813,2.09623034472642e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,29786,-0.061466920614248,0.00295810897638161,-0.0672648142079559,-0.05566902702054,3.17455353653968e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,29349,-0.0679811958374336,0.00327545263190809,-0.0744010829959734,-0.0615613086788937,5.35600485204647e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0689516201037389,0.00332309126063481,-0.0754648789745831,-0.0624383612328947,5.97181857333055e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0646197585417758,0.00312739604621602,-0.0707494547923592,-0.0584900622911924,3.53681155925213e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0458187360286378,0.00221847371400171,0.0414705275491945,0.0501669445080812,4.22581362577457e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.134877728509822,0.00653522406974826,-0.147686767686528,-0.122068689333115,5.69562592178822e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.080242903684225,0.00388933411592459,-0.0878659985514372,-0.0726198088170128,6.62085064373612e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,24240,-0.0892619978271358,0.00433017410973206,-0.0977491390822107,-0.080774856572061,1.30916199462601e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.130478576645576,0.00633844014859521,-0.142901919336823,-0.118055233954329,1.71678243252686e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0548962328823054,0.00266716919138375,-0.0601238844974176,-0.0496685812671933,1.78742221757709e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0856420635605269,0.00415812991528297,-0.0937919981944816,-0.0774921289265723,1.78924570596032e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.167635896193594,0.00814514889800079,-0.183600388033675,-0.151671404353512,1.85763333747653e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,29434,0.0640913199107024,0.00312041829893515,0.0579753000447895,0.0702073397766153,4.31840684101918e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,24381,-0.067615981715824,0.00329128481877401,-0.074066899960621,-0.0611650634710269,5.35551707144465e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0695670458312079,0.00339408700455771,-0.076219456360141,-0.0629146353022748,1.35095597488164e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0300383047479065,0.00146756950005975,-0.0329147409680236,-0.0271618685277893,1.80316571109922e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0389139245633974,0.00190354893840381,-0.0426448804826689,-0.0351829686441259,3.00507914580146e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0466277909518554,0.00229010871141897,-0.0511164040262366,-0.0421391778774742,2.12542342311251e-91
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,29349,-0.101127377323957,0.00499812033966686,-0.110923693189704,-0.0913310614582099,2.07577728959757e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,29453,-0.046087527590147,0.00228507039762948,-0.0505662655695008,-0.0416087896107932,7.43196030769742e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.132528554254601,0.00657588736122908,-0.14541729348261,-0.119639815026592,1.00997759905887e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.099087210918045,0.00491619904437148,-0.108722961045013,-0.0894514607910769,1.25608912913143e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.0876779038382043,0.00435654912805915,-0.0962167401292002,-0.0791390675472083,1.7359999586244e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.10868363493905,0.00543590059501626,-0.119338000105282,-0.0980292697728182,3.19043718823334e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.131088254633628,0.00655807778747981,-0.143942087097089,-0.118234422170168,3.39008961833109e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.139207722481675,0.00697484342299537,-0.152878415590746,-0.125537029372604,4.85836469873565e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.156598565782818,0.0078422437915246,-0.171969363614206,-0.14122776795143,5.08409198798829e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.0395115523804896,0.00198162723296207,-0.0433955417570952,-0.0356275630038839,9.49153113242049e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0758749308534643,0.0038104610184009,-0.08334343444953,-0.0684064272573985,1.20481779822051e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.149322426222797,0.00750876033688324,-0.164039596483088,-0.134605255962506,2.01597839108992e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0278616342557333,0.00140495332444644,-0.0306153427716483,-0.0251079257398183,6.18640744950226e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,24528,-0.0400337573466321,0.00201828349407108,-0.0439895929950114,-0.0360779216982528,7.06120886769607e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,24938,0.0570609434649983,0.00288903091448429,0.0513984428726091,0.0627234440573875,3.59768031879822e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.088427794280956,0.00448288510889574,-0.0972142490943916,-0.0796413394675203,6.19391629656055e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.119613919375572,0.00607736904968066,-0.131525562712946,-0.107702276038198,1.43914251165393e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.112496067078014,0.0057194495413809,-0.12370618817912,-0.101285945976907,1.84720590255826e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0913388742349196,0.00464745993044851,-0.100447895698599,-0.0822298527712406,1.88527184948848e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,23693,-0.0331010150858822,0.00168406782761074,-0.0364017880279993,-0.0298002421437652,2.49113233593829e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,29478,-0.0497319814325929,0.00253774904008537,-0.0547059695511602,-0.0447579933140255,5.72069883841405e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,24845,-0.183361543418813,0.00935836955386002,-0.201703947744379,-0.165019139093247,7.71674708237419e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.124728288259153,0.00639879457013545,-0.137269925616619,-0.112186650901688,4.36810360236923e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.0935595270161372,0.00480091441322731,-0.102969319266063,-0.0841497347662117,4.64864205177121e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,29786,-0.0483428305275461,0.00248428331427586,-0.0532120258235268,-0.0434736352315654,8.04651945796222e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0502280502770434,0.00258825364992143,-0.0553010274308894,-0.0451550731231974,2.27209235806455e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0415285767078858,0.00214050318408407,-0.0457239629486906,-0.037333190467081,2.49696948126174e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.049771982813801,0.00256920137210983,-0.0548076175031362,-0.0447363481244657,4.45355848149644e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.113546974817378,0.00586811129675495,-0.125048472959017,-0.102045476675738,8.29763329048717e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0501070969735713,0.00259268402563401,-0.0551887576638139,-0.0450254362833286,1.06503727950911e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,28477,-0.0556598395106316,0.00288000339373227,-0.0613046461623468,-0.0500150328589163,1.09434187860892e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0600563935399442,0.00311275900700307,-0.0661574011936702,-0.0539553858862182,1.94555811510285e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,29435,-0.0466120266150132,0.0024177735950128,-0.0513508628612383,-0.0418731903687881,2.60320495624699e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,24845,0.026395426975201,0.00137319506897097,0.0237039646400179,0.0290868893103841,9.53486987438317e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.147555156452735,0.00768003904665556,-0.16260803298418,-0.13250227992129,1.13564300692044e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.129480516883491,0.00674501342384848,-0.142700743194234,-0.116260290572748,1.25055510745555e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.076843291039601,0.00401386441860851,-0.0847104653000737,-0.0689761167791283,3.35973615752583e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0383268867321345,0.00200636772130199,-0.0422593674658864,-0.0343944059983826,7.61445377237952e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,29725,-0.0756273730218904,0.0039774846113152,-0.0834232428600682,-0.0678315031837126,3.92144677829497e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0432881715250466,0.00228013233998604,-0.0477572309114192,-0.038819112138674,7.00944109678439e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0694298273104948,0.00365752643007821,-0.076598579113448,-0.0622610755075415,7.29699937965789e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0361704401691904,0.00190477765154542,0.0324370759721614,0.0399038043662194,7.65588833502887e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.115682966291077,0.00610174026001023,-0.127642377200697,-0.103723555381457,1.13350031447701e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0812320008085194,0.00428344388407142,-0.0896275508212994,-0.0728364507957394,1.23625072616376e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.110658652891838,0.00584469889421097,-0.122114262724491,-0.0992030430591842,2.20996458390341e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0388525331729556,0.00205737126112827,-0.042884980844767,-0.0348200855011441,4.49040861207748e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0534256923404263,0.00283101011230585,-0.0589744721605458,-0.0478769125203068,5.64453463679853e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.105081567012485,0.00557156288513944,-0.116001830267358,-0.0941613037576118,7.08575831853376e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.037284848700091,0.00197634417692561,0.0334112141133168,0.0411584832868652,7.75100471264265e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0861398303378076,0.00458607447809245,-0.0951285363148688,-0.0771511243607464,3.06365360151996e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.153734900092794,0.00818810388822791,-0.16978358371372,-0.137686216471867,3.44290613234878e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,29468,0.051980247455102,0.0027703374307155,0.0465503860908996,0.0574101088193043,4.31857466326427e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.101603326577753,0.00542144403802518,-0.112229356892282,-0.0909772962632236,6.44470864962489e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,24951,-0.0371431445254693,0.00198223050224368,-0.0410283163098669,-0.0332579727410717,8.30233108819072e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.106848853499743,0.00571895027151844,-0.118057996031919,-0.0956397109675672,2.30450358631898e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,24922,-0.0354973439484582,0.00190102009241359,-0.0392233433295888,-0.0317713445673275,2.78081087367283e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,28916,-0.0717061659728979,0.00384464832151677,-0.0792416766830707,-0.064170655262725,3.52799726257584e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.112955921260179,0.00606156496347201,-0.124836588588584,-0.101075253931774,4.6804061001511e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0982990308263435,0.00527887787662008,-0.108645631464519,-0.0879524301881682,5.9965838138537e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0954260421111219,0.00512571498217504,-0.105472443476185,-0.0853796407460588,6.611762048024e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0624000662405505,0.00335222745438528,-0.0689704320511456,-0.0558297004299554,6.78449810655653e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0571076615561986,0.00306886559977368,-0.063122638131755,-0.0510926849806422,7.54670107587471e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0218834267863857,0.00117668960553241,0.0195771151595422,0.0241897384132292,9.1723296237103e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,29694,-0.0492862442669186,0.00265544789819782,-0.0544909221473863,-0.0440815663864508,1.82166756098048e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0750729167512936,0.00404590924139797,-0.0830028988644336,-0.0671429346381536,2.51793646121908e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0769775527635454,0.00415152737447595,-0.0851145464175182,-0.0688405591095725,2.56494013867459e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0686668183263563,0.00370736544963753,-0.0759332546076459,-0.0614003820450668,3.82850658973634e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0447995340687551,0.00242176727034293,0.040052870218883,0.0495461979186273,5.699183406693e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0316701690234432,0.00171232684107488,-0.03502632963195,-0.0283140084149364,6.01346571963877e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,29694,-0.031819511275396,0.00172181633288769,-0.0351942712878558,-0.0284447512629361,7.9473164569232e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0831997479788878,0.00450014268402002,-0.092020027639567,-0.0743794683182085,8.28498528161445e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0929259424694161,0.00503328626838274,-0.102791183555446,-0.0830607013833859,1.13204485033585e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0720118164531758,0.00390619744035401,-0.0796679634362697,-0.0643556694700819,1.80311052657536e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0657868874863066,0.00356910049031557,-0.0727823244473252,-0.0587914505252881,1.92027733315856e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0754117038084827,0.00409586731622256,-0.0834396037482789,-0.0673838038686865,2.80779193252927e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0373180318636019,0.00203785414953825,-0.0413122259966969,-0.033323837730507,1.72500110718038e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0649957222856054,0.00354952116269837,-0.0719527837644942,-0.0580386608067166,1.78809446952026e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.12777872320236,0.00698665340615027,-0.141472563878414,-0.114084882526305,2.61738667634231e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0587166920484282,0.00321542793436681,-0.0650189307997872,-0.0524144532970693,5.31994391142211e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0322541015388354,0.00176825318074737,0.0287883253045706,0.0357198777731003,6.20460410010446e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0974965033996492,0.00534985785257171,-0.10798222479069,-0.0870107820086086,1.03927608031848e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,29820,0.0356448454970009,0.00195743621662277,0.0318082705124202,0.0394814204815815,1.08067064130379e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0699996486232599,0.00384449247840142,-0.0775348538809266,-0.0624644433655931,1.1331743538409e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.058657819902617,0.00322732333666561,-0.0649833736424816,-0.0523322661627524,2.41082302208423e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.158150414200993,0.00870049548529575,-0.175203385352173,-0.141097443049813,2.41141688535001e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,29349,-0.0680743387115672,0.00375028731069251,-0.0754249018405245,-0.0607237755826099,3.132164185161e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,29192,0.0368260238962082,0.00203295071111051,0.0328414405024316,0.0408106072899848,6.14525681555731e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.1244219893205,0.00687322240077085,-0.137893505226011,-0.110950473414989,7.52604116798002e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.11269819870189,0.00623358338123858,-0.124916022129117,-0.100480375274662,1.14930763461618e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.090307335707637,0.00499242568983241,-0.100092490059709,-0.0805221813555655,1.17364035333316e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.0939033266307896,0.00520617742080972,-0.104107434375577,-0.0836992188860025,2.44057688522607e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0958996845745954,0.0053341004302703,-0.106354521417925,-0.0854448477312656,7.09409761859567e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.136675496150172,0.00760821061475449,-0.151587588955091,-0.121763403345253,8.99304657008545e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.128246420758116,0.00713721546137244,-0.142235363062406,-0.114257478453826,9.78535553050482e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,29478,0.0400505284634621,0.00223026222588478,0.035679214500728,0.0444218424261963,1.00741976482673e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0642481465941127,0.00358157683162878,-0.0712680371841051,-0.0572282560041202,1.4206221197356e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0548082083854063,0.00305828387655993,-0.0608024447834637,-0.0488139719873488,1.9304685220544e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.105060804472241,0.00586604687475552,-0.116558256346762,-0.0935633525977206,2.34221615711554e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0406895552723554,0.0022719651213183,0.0362365036345716,0.0451426069101393,2.38487934496935e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.180175729857745,0.0100614920123779,-0.199896254202005,-0.160455205513484,2.90230995906934e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0789365448009568,0.00441317827701216,-0.0875863742239007,-0.070286715378013,3.57918049470465e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0395241511457729,0.00221330513018329,-0.0438622292009321,-0.0351860730906136,6.00506099753292e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.0659288555668777,0.00369459703856794,0.0586874453712845,0.0731702657624708,7.51147738544644e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,29169,-0.0656248576788656,0.00367833551164368,-0.0728343952816872,-0.0584153200760439,8.10093804545613e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0390430300898734,0.00219002080265691,-0.043335470863081,-0.0347505893166659,1.01983963017754e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0867739438277099,0.00486826785865358,-0.0963157488306709,-0.0772321388247489,1.07841636261126e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0536663780360709,0.00301116555551771,-0.0595682625248856,-0.0477644935472562,1.10306396992433e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0406624953261981,0.00228505057931169,0.0361837961907472,0.0451411944616491,1.79028262718785e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0461118976454146,0.00259721105104808,-0.0512024313054688,-0.0410213639853603,3.74364703000279e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,29218,0.0433315219086834,0.00244070091618261,0.0385477481129655,0.0481152957044013,3.77302770848488e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0768347404407312,0.00434042574308061,-0.0853419748971692,-0.0683275059842932,9.29645533199616e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.124279489017859,0.00703426164008478,-0.138066641832426,-0.110492336203293,1.98148164787872e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0922228605772565,0.00522244325615404,-0.102458849359318,-0.0819868717951946,2.36379327758544e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0303352470947839,0.00171889474790433,0.0269662133888914,0.0337042808006764,2.38924493752727e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0380563120978728,0.00215671527850083,-0.0422834740437344,-0.0338291501520112,2.92386160876501e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.105303684610092,0.00597853927691958,-0.117021621592854,-0.0935857476273295,5.18882890910293e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0507140172356687,0.00287993940920161,-0.0563586984777039,-0.0450693359936336,5.48330906517201e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0660328808244181,0.00376420932875296,0.0586550305400623,0.0734107311087739,1.52219107681105e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0440751685663571,0.00251296812411683,-0.0490005860896261,-0.0391497510430881,1.59354141714434e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.137673354389302,0.00784776906976565,-0.153054981766043,-0.122291727012561,1.75025628584355e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,29566,-0.0716296521913619,0.00408573286036139,-0.0796376885976702,-0.0636216157850536,1.82608017069229e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0388526351544362,0.00221557159529654,-0.0431951554812174,-0.0345101148276549,1.96407237277273e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0333768156105048,0.00190431080852061,-0.0371092647952052,-0.0296443664258044,1.98085447153857e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,28795,-0.0625358665119742,0.00357093923197399,-0.0695349074066432,-0.0555368256173051,2.60534791186012e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0497018747630119,0.0028395678876315,-0.0552674278227697,-0.0441363217032542,3.05533992580306e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0400691907453341,0.00229253964236198,-0.0445625684443636,-0.0355758130463046,4.66039088071979e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0742325743136935,0.00425269702569787,-0.0825678604840614,-0.0658972881433257,6.84263394224643e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.114463625538352,0.00657151339180379,-0.127343791786287,-0.101583459290416,1.31332839051235e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.042814247328418,0.00246027221443481,0.0379921137881258,0.0476363808687103,1.72834086608689e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.058145644439862,0.00334246315776622,-0.0646968722290838,-0.0515944166506402,1.92149137583815e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.0833455525722085,0.00479434036983117,-0.0927424596970776,-0.0739486454473394,2.35430130457094e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,24229,-0.116541386357376,0.00670025613843777,-0.129673888388714,-0.103408884326038,2.37076981597655e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.10319327916885,0.00593693565790967,-0.114829673058353,-0.0915568852793468,2.46255350266517e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.107987639547514,0.00621691562184227,-0.120172794166325,-0.0958024849287033,3.47862814228142e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,29434,-0.118364731652225,0.00682171211737848,-0.131735287402287,-0.104994175902163,4.17400159315085e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,28931,-0.0590367052607393,0.00340441475347843,-0.065709358177557,-0.0523640523439216,5.02122090470138e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,29434,-0.0488693876442437,0.00281979953150179,-0.0543961947259872,-0.0433425805625002,5.9284910137797e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0637571970840785,0.00367932305319678,-0.0709686702683442,-0.0565457238998128,7.10695371211225e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.048560891330662,0.00280497347299377,-0.0540586393377298,-0.0430631433235942,9.56986563242541e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0625780371983962,0.00361527625073161,-0.0696639786498301,-0.0554920957469622,1.01256991245707e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,29434,-0.0942705441515576,0.00545040766585962,-0.104953343176642,-0.0835877451264727,1.07756379386885e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0699073113723955,0.0040440499308514,-0.0778336492368642,-0.0619809735079268,1.27055151035645e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0841377861941631,0.00487652637929449,-0.0936957778975803,-0.0745797944907459,2.22066689863509e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0753401894459326,0.00436779569526325,-0.0839010690086486,-0.0667793098832166,2.45511790800586e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0792326662576929,0.00459843634914073,-0.0882456015020087,-0.0702197310133771,3.37973557601728e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.0858974101137976,0.00498367928170558,-0.0956654215059405,-0.0761293987216546,3.47825460216121e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.120831728373341,0.00702606559030644,-0.134602816930342,-0.10706063981634,6.6607092935583e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0709727651915599,0.00415023746712499,-0.0791072306271249,-0.0628382997559949,3.00420868765156e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.13834721986592,0.00811778201415073,-0.154258072613656,-0.122436367118185,9.4143774205796e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,24938,-0.091758634250805,0.00538936121192938,-0.102321782226187,-0.0811954862754234,1.22545780188819e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0815596636283057,0.0047929591961458,-0.0909538636527515,-0.0721654636038599,1.2692428013339e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.0918299064179138,0.00540406202952358,-0.10242186799578,-0.0812379448400476,2.14420123412152e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0240801356563783,0.00141987682581892,0.0212971770777732,0.0268630942349833,3.325207215957e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0826279292174142,0.00487230475399217,-0.0921776465352388,-0.0730782118995895,3.91194415357266e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0310645656932309,0.00183390804343794,0.0274701059280925,0.0346590254583693,4.67814848685719e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,29163,-0.0754258235951302,0.00445622948946407,-0.0841600333944798,-0.0666916137957806,5.85936169739661e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0640601070853276,0.00379701244339769,-0.0715022514743871,-0.0566179626962681,1.46730134955163e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0740857934849011,0.00439727899082701,-0.082704460306922,-0.0654671266628801,2.14989547605044e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0955696239770579,0.00567331535791074,-0.106689322078563,-0.0844499258755529,2.28185482927275e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0511062648609404,0.00303532128790906,0.0451570351366386,0.0570554945852421,2.58549517842688e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0491938465320958,0.00293031334673687,-0.0549372606917001,-0.0434504323724916,5.85904894688937e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0643057100309008,0.00383588902126443,-0.071824052512579,-0.0567873675492225,8.7693819908387e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,24905,0.0416159612602386,0.00248163634730188,0.0367519540195269,0.0464799685009503,9.01423215466258e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,24938,-0.0339599448722255,0.00202673614677642,-0.0379323477199073,-0.0299875420245437,1.1288451751454e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,24445,-0.155097424328929,0.00926849109388815,-0.17326366687295,-0.136931181784909,1.65672558863143e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,29511,0.0444261194949058,0.00266114597381227,0.0392102733862337,0.0496419656035778,2.78428293460845e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,29335,-0.0550583538360687,0.00330042294113989,-0.0615271828007029,-0.0485895248714346,3.41919991089334e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0500575640337541,0.00300256455566611,-0.0559425905628597,-0.0441725375046486,4.08742052935072e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0922710847814474,0.00554508504858701,-0.103139451476678,-0.0814027180862168,7.69890299778862e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,24919,-0.0672213973390513,0.00404037922845103,-0.0751405406268153,-0.0593022540512873,8.05853023140898e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0733861555616692,0.00441333219869809,-0.0820362866711174,-0.0647360244522209,8.45656776001632e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0279736573010796,0.00168292403533375,-0.0312721884103338,-0.0246751261918255,9.23425822713999e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.073096284372749,0.00439827376649895,-0.0817169009550869,-0.064475667790411,9.80856242508512e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0521965710189023,0.00314164035499779,0.0460389559231067,0.058354186114698,1.0439495458433e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.112308747536847,0.00676359197428986,-0.125565387806455,-0.0990521072672385,1.21697643336273e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.0919259140412645,0.00553833289207568,-0.102781046509733,-0.0810707815727962,1.37008698037078e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,29349,-0.121858997634445,0.00735195899789591,-0.136268837270321,-0.107449157998569,2.01045199111065e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0828514418396532,0.00499960775759911,-0.0926506730445475,-0.073052210634759,2.15879590384514e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0606345105089764,0.00366115739667304,-0.0678103790064555,-0.0534586420114972,2.54211583876317e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.101859620976751,0.00616115812429807,-0.113935490900375,-0.0897837510531265,4.03888034425275e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0598091258692775,0.0036181058306349,-0.0669006132973219,-0.0527176384412331,4.17641171744471e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0529435583360479,0.00320418932053843,-0.0592237694043032,-0.0466633472677926,5.29600626789637e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.108420067247838,0.00657145180676239,-0.121300112789092,-0.0955400217065835,7.04749493196172e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,29443,0.0339515673230825,0.00205850403341703,0.0299168994175851,0.0379862352285799,7.68956109830376e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0615756054927806,0.00373457843860636,-0.0688953792324491,-0.0542558317531122,8.37872836179832e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0330852896991198,0.00200707399913895,-0.0370191547374321,-0.0291514246608074,8.92744710822716e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.034251510476524,0.00207801333821851,-0.0383244166194323,-0.0301786043336157,1.03975881827665e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0460375584667226,0.00279862938064369,-0.0515228720527842,-0.040552244880661,1.56215458890464e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.11665555050628,0.00709854481968505,-0.130568698352863,-0.102742402659698,2.02566370304325e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.11311987971179,0.00688308660521002,-0.126610729458001,-0.0996290299655781,2.03828853310031e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0695864960315538,0.00423522397749172,-0.0778875350274376,-0.06128545703567,2.41638169529693e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.0283038756978352,0.00172441445154806,0.0249240233728011,0.0316837280228694,2.8390933986318e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,24922,0.0325798159718356,0.00198463674985663,0.0286899279421166,0.0364697040015546,3.04577688837096e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0759997717982717,0.00463443056668534,-0.0850832557089749,-0.0669162878875684,3.65145861067821e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.100136780090661,0.00610719767018503,-0.112106887524223,-0.0881666726570981,3.79882123143215e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0954529067976292,0.00582770625638027,-0.106875211060135,-0.0840306025351238,4.97127493440352e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0741162744178836,0.00452652839614657,-0.0829882700743308,-0.0652442787614363,5.5017613304692e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,29293,-0.0834296459121758,0.00510397006801561,-0.0934334272454865,-0.0734258645788652,8.54812832933183e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0503574393661257,0.00308114387962342,-0.0563964813701876,-0.0443183973620638,8.84539991953377e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0466536304479032,0.00285813974697358,-0.0522555843519714,-0.041051676543835,1.23617018503974e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0330814498326381,0.00203080497131318,-0.0370618275764119,-0.0291010720888642,2.11227421031856e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0978967915501056,0.00601505158894585,-0.10968629266444,-0.0861072904357718,2.68513986050541e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0873934305516044,0.00536757409057287,-0.0979138757691272,-0.0768729853340815,2.7479500205321e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0396091279770547,0.00243594589024035,-0.0443835819219258,-0.0348346740321836,3.42064454936613e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0779160379759829,0.00479180309045253,-0.0873079720332699,-0.0685241039186959,3.46955636460805e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.120968582468808,0.00744828857349463,-0.135567228072857,-0.106369936864758,4.66713198396174e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.100775376359532,0.00621479859818904,-0.112956381611982,-0.0885943711070814,7.19375442418549e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0490699276573375,0.00302679373042079,-0.0550024433689622,-0.0431374119457127,7.46300624419542e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0532651183570661,0.0032903321512579,0.0468160673406007,0.0597141693735316,1.08749195205247e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,29786,-0.043739119562843,0.00270399867958568,-0.049038956974831,-0.0384392821508551,1.33087464703764e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,29594,-0.0659802977354119,0.00408005464087514,-0.0739772048315272,-0.0579833906392966,1.43137365701523e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.0703165820402087,0.00435083561863622,-0.0788442198527357,-0.0617889442276817,1.68377915121631e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0926996076783677,0.00573608346344068,-0.103942331266711,-0.081456884090024,1.8954905527341e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.121442803088427,0.00754407012364374,-0.136229180530769,-0.106656425646085,5.19839803616601e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0730757613112183,0.00454309493022266,-0.0819802273744548,-0.0641712952479819,6.37904449589029e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0995424077232123,0.00619345458234355,-0.111681578704606,-0.0874032367418189,7.0401653564271e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.13191654000281,0.00821238626132147,-0.148012817075,-0.11582026293062,9.06229724621309e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0229468405969574,0.00143011083541162,-0.0257498578343641,-0.0201438233595506,1.08133659875086e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0469990112008697,0.00292906939483995,-0.052739987214756,-0.0412580351869834,1.19453535766149e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,29478,-0.124731240090989,0.00777779814097727,-0.139975724447304,-0.109486755734673,1.2400262786155e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0487223582589711,0.00303898615274629,0.0427659453995884,0.0546787711183539,1.3278691088719e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0532628493705212,0.00332758621926627,0.0467407803807594,0.0597849183602831,2.01446945738657e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0368576145302783,0.00230414133214323,-0.041373731541279,-0.0323414975192775,2.66860963537378e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0830300446023731,0.00519739475162121,-0.0932169383155507,-0.0728431508891955,3.66555143250088e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0751905613448476,0.00471036553480312,-0.0844228777930617,-0.0659582448966334,4.03499275610429e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,29434,-0.0934858731930833,0.00585719885381042,-0.104965982946552,-0.0820057634396149,4.16107244012899e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0468067267541875,0.00293357085677443,-0.0525565256334654,-0.0410569278749096,4.49470683531512e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0800508297365795,0.00502222505377576,-0.08989439084198,-0.070207268631179,6.58612497906013e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0584605325889964,0.00367281538119835,-0.0656592507361452,-0.0512618144418476,8.3297151637296e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0469209223385761,0.00294837547082262,-0.0526997382613884,-0.0411421064157637,8.73286921962792e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,29694,0.0427055679157507,0.00268531618013924,0.0374423482026778,0.0479687876288236,1.03044453636494e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0594919074668626,0.00374097348968188,-0.0668242155066391,-0.0521595994270861,1.04907093262494e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0657001724202462,0.00413152483349522,-0.0737979610938968,-0.0576023837465955,1.05953262414791e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,29725,0.0526352428011687,0.00331431064764445,0.0461391939317856,0.0591312916705518,1.46236136491414e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0914244370845415,0.00575444303319338,-0.102703145429601,-0.0801457287394825,1.49206480586811e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0874851880449381,0.00551105731724279,-0.0982868603867339,-0.0766835157031422,1.63738656826239e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0319895571573034,0.0020173718713652,-0.0359436060251792,-0.0280355082894276,2.15146042383985e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,23389,-0.0278843834403074,0.00176227154072512,-0.0313384356601286,-0.0244303312204861,4.22585438953514e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.122785417332713,0.00777482077853021,-0.138024066058632,-0.107546768606793,6.53954630162551e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,24381,-0.0351158350476379,0.00222982282847081,-0.0394862877914407,-0.0307453823038352,1.32795822207511e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0847044505372058,0.00538214557694581,-0.0952534558680196,-0.074155445206392,1.53712255593279e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0370121525255342,0.00235456719289192,-0.0416271042236024,-0.032397200827466,1.87213453940543e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0966243769544928,0.00614572506135157,-0.108669998074742,-0.0845787558342438,1.974723498415e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,29030,-0.0479205074702371,0.00305609404336105,-0.0539104517952248,-0.0419305631452494,3.47645947930512e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0193170796306815,0.00123161417371257,-0.0217310434111581,-0.0169031158502048,3.55157536113341e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0333780915839762,0.00212818360950009,-0.0375493314585964,-0.029206851709356,3.58427843567003e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0996877021233097,0.00636647832541901,-0.112165999641131,-0.0872094046054884,5.35290150305887e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0495170035751878,0.003163756407032,-0.0557179661329706,-0.0433160410174051,5.4449691429481e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0351673998214612,0.00224634931325953,0.0307645551674726,0.0395702444754499,5.45180649876252e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.154405410270158,0.00986777895545684,-0.173746257022853,-0.135064563517463,5.7728722625237e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,29725,-0.0449381098547914,0.00288018017394801,-0.0505832629957295,-0.0392929567138533,1.15348688855995e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,24805,-0.117102329986202,0.00750654163127515,-0.131815151583502,-0.102389508388903,1.32328022573857e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,29433,-0.0416912754255492,0.00267410708876141,-0.0469325253195216,-0.0364500255315769,1.39250283073428e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,29434,-0.0323439010321267,0.00208530230912087,-0.0364310935580036,-0.0282567085062498,4.83033694168979e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,29478,-0.0635896127122926,0.0041004024761657,-0.0716264015655774,-0.0555528238590079,4.99937740322809e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0819044993705497,0.00528229198913003,0.0715512070718549,0.0922577916692446,5.69960111715858e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0289556660337547,0.00186855629333246,0.0252932956988231,0.0326180363686863,5.974017834559e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,24922,-0.0516693356229255,0.00333417723060495,-0.0582043229949112,-0.0451343482509398,6.50388362587467e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,29581,-0.0526998811654178,0.00340651574607274,-0.0593766520277204,-0.0460231103031152,8.94523113751189e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0340054124935305,0.00219875730278164,-0.0383149768069825,-0.0296958481800785,9.58713293971934e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0584565184575719,0.00377865693798415,-0.0658626860560208,-0.0510503508591229,9.97254306781399e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0702654617299281,0.00454642398979722,-0.0791764527499306,-0.0613544707099255,1.23929160965305e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.111350336904933,0.00721397185956751,-0.125489721749686,-0.097210952060181,1.53148891722385e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,24381,-0.128897118751055,0.00835651390519808,-0.145275886005243,-0.112518351496866,1.99678437375927e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0946011374084746,0.00613745840650337,-0.106630555885221,-0.082571718931728,2.14112676067327e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.104730727244216,0.00679573740391746,-0.118050372555894,-0.0914110819325378,2.23257021268108e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.069957661902455,0.00454175716525098,0.0610558178585631,0.0788595059463469,2.51874739853267e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0405181461648751,0.00263235042285974,-0.0456775529936802,-0.03535873933607,3.29994095106203e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0627661482977089,0.00408767982165286,-0.0707780007481485,-0.0547542958472693,5.32758989110053e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0242137026889924,0.00157745910923252,-0.0273055225430882,-0.0211218828348967,6.28560969379233e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0407394601651771,0.00265585084357755,0.0355339925117651,0.0459449278185891,7.27819996532204e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0506933544669468,0.00330686684156332,-0.0571748134764109,-0.0442118954574827,7.74949191340406e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,28424,-0.100909195492376,0.00659288144592166,-0.113831243126383,-0.08798714785837,1.13555169974551e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,29163,-0.0876573490041232,0.00575616815762942,-0.0989394385930769,-0.0763752594151695,3.63853008491157e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0471658272917428,0.00309735174938736,-0.0532366367205421,-0.0410950178629436,3.66293088361652e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0444132208915292,0.00291976265813355,-0.050135955701471,-0.0386904860815874,4.69068783410788e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0758396409402029,0.00498554323318689,-0.0856113056772492,-0.0660679762031566,4.69086364506338e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0652713224509512,0.0042901994690765,-0.0736801134103411,-0.0568625314915612,4.90512320741004e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0631247580121537,0.00415260982474104,-0.0712638732686462,-0.0549856427556613,5.49031132889851e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0289990885407396,0.0019112934302859,0.0252529534173792,0.0327452236640999,8.46331724892899e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0407201421459743,0.00268411219257349,-0.0459810020434184,-0.0354592822485303,9.40236507332795e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.0691012314640074,0.00455677925247034,-0.0780325187988493,-0.0601699441291655,9.53304520391392e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0445713498386035,0.00294023016839265,-0.050334200968653,-0.0388084987085539,1.12127553042354e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0695832149178179,0.00459079159513607,-0.0785811664442846,-0.0605852633913512,1.15615832303672e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0355889764037923,0.002349105993246,-0.0401932241505545,-0.0309847286570302,1.18871416186095e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0811757563813216,0.00536831578333657,-0.0916976553166613,-0.0706538574459819,1.98898690866877e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0604085174589121,0.00399792723133578,-0.0682444548323302,-0.052572580085494,2.17127915439671e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0369754287918578,0.00244945013198583,0.0321745065331656,0.04177635105055,2.69199094773275e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,24966,-0.0225090058583653,0.00149185014163524,-0.0254330321359703,-0.0195849795807602,3.27019758320708e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0299539738892028,0.00199002158039385,-0.0338544161867747,-0.0260535315916309,5.18205215609576e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.102773548186302,0.00682924080353858,-0.116158860161237,-0.089388236211366,5.41407036809349e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0417868216136785,0.00277971489414008,-0.047235062806193,-0.0363385804211639,6.98588762096502e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,24381,-0.0759750120049936,0.00505256566188694,-0.085878040702292,-0.0660719833076952,7.11812036168449e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,29443,-0.048337570354532,0.00321737792735142,-0.0546436310921407,-0.0420315096169232,7.90605919155965e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0829768845352275,0.00552203043835196,-0.0938000641943974,-0.0721537048760577,8.24250501983898e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0411584349845443,0.00274452321021588,-0.0465377004765675,-0.0357791694925212,1.19396505079228e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0844118148489656,0.00563191199391919,-0.0954503623570472,-0.073373267340884,1.47549921497688e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,24845,-0.0408758905199872,0.00272920723883486,-0.0462251367081036,-0.0355266443318709,1.71992733888199e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,29566,-0.043138477388087,0.00288254187960006,-0.0487882594721032,-0.0374886953040709,1.89124370482401e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0906879291019718,0.0060623215769062,-0.102570079392708,-0.0788057788112357,2.07960784145754e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0324871459606709,0.00217446266671135,0.0282251991339167,0.0367490927874252,2.74911732271546e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,29694,-0.0242210807138394,0.00162291654002778,-0.0274019971322938,-0.0210401642953849,3.4780800984814e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,24888,-0.0478203314498862,0.00320453938090723,-0.0541012286364644,-0.0415394342633081,3.86813991979055e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0654291416321776,0.00438787669194063,-0.0740293799483812,-0.0568289033159739,4.25315182540034e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0326188746784832,0.00218895662623371,-0.0369092296659013,-0.0283285196910651,5.28464072073132e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0716949424900828,0.00482194821233496,-0.0811459609862594,-0.0622439239939063,8.09047115564072e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0304147571713475,0.00205369438879758,0.0263895161693042,0.0344399981733908,1.90916823745219e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0244320479625472,0.00164912418119465,-0.0276643313576888,-0.0211997645674057,1.91927944005004e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0514429825658816,0.0034740062820102,-0.0582520348786216,-0.0446339302531416,2.11672080324235e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.133061833865114,0.00899041575094473,-0.150683048736966,-0.115440618993262,2.18815938726781e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0287491922864137,0.00194292888607419,-0.0325573329031191,-0.0249410516697083,2.30677447224347e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0293385941262314,0.00198382887021321,-0.0332268987118493,-0.0254502895406135,2.59411088451252e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,24381,-0.0557543938323724,0.00377272640016982,-0.0631489375767052,-0.0483598500880396,3.30480244959709e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0633797221796256,0.00429283277195026,-0.0717936744126482,-0.0549657699466031,3.77200668234243e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0590806985112053,0.00400394693099468,-0.0669284344959549,-0.0512329625264557,4.22049434689975e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0687900605783257,0.00466701821221974,-0.0779374162742764,-0.059642704882375,5.34905810915956e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,29694,-0.0641595226183388,0.00435441810651059,-0.0726941821070995,-0.055624863129578,5.77951209947247e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0328256366654034,0.00222724976749986,-0.0371910462097031,-0.0284602271211037,5.97256465009383e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0557382857189677,0.00378402660786774,0.0483215935675469,0.0631549778703884,6.19283979854776e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,28774,-0.0369243132796761,0.00250780525869628,-0.0418396115867208,-0.0320090149726314,6.83866874250589e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0957488536389798,0.0065105443872113,-0.108509520637914,-0.0829881866400456,9.36113774286482e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0799462214371945,0.00543792755456391,-0.0906045594441397,-0.0692878834302492,9.39664585632301e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0455469356182965,0.00310619318236762,-0.051635074255737,-0.0394587969808559,1.79300149895322e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.0569653056581056,0.00388965759589574,-0.0645890345460613,-0.04934157677015,2.13947245285004e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.0205062085777958,0.00140077361074204,-0.0232517248548502,-0.0177606923007414,2.3389991504428e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.109111112669082,0.00745356863112043,-0.123720107186078,-0.0945021181520855,2.52912620512141e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0384415299292243,0.00262743079636915,-0.0435912942901078,-0.0332917655683408,2.63991330753527e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0451832329690823,0.00309258149273363,-0.0512446926948402,-0.0391217732433243,3.86551068825583e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.115356302681532,0.0079056813618936,-0.130851438150844,-0.099861167212221,5.05066210012055e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0241406077263414,0.00165511716043786,-0.0273846373607996,-0.0208965780918832,5.12777728126558e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0820495246468913,0.00562405602458298,-0.0930726744550739,-0.0710263748387087,5.21130440626583e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0407732327692042,0.00279589263905623,-0.0462531823417544,-0.035293283196654,5.27792960770436e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0766797182018718,0.00525726657062009,-0.0869839606802872,-0.0663754757234565,5.4822930873089e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0462491369788754,0.0031724893540469,-0.0524672161128074,-0.0400310578449435,6.15039963462554e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0265838374126321,0.00182491155958077,-0.0301606640694104,-0.0230070107558538,7.14687633759382e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0600678513023103,0.0041251786855728,-0.068153201526033,-0.0519825010785877,7.24730422754379e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,28916,0.0245363721499522,0.00168687131125994,0.0212301043798827,0.0278426399200216,9.20393111116494e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0861599248890081,0.00592206252791221,-0.097767167443716,-0.0745526823343002,9.311034018237e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0610282613860339,0.00419594640277055,-0.0692523163354642,-0.0528042064366036,9.34936261148262e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0491601912672802,0.00338224416203362,-0.0557893898248661,-0.0425309927096943,1.07262581981218e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0479601780427148,0.00330201327387851,-0.0544321240595167,-0.0414882320259129,1.24124931974549e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0407687970105804,0.00280650565147439,-0.0462695480874702,-0.0352680459336906,1.30149049624787e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0286881060305836,0.00197773614621375,0.0248117431840046,0.0325644688771625,1.63002738826231e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0423373349832818,0.00291951668905301,-0.0480595876938257,-0.0366150822727379,1.7437976647793e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0661067274317115,0.00455786444706876,-0.0750401417479663,-0.0571733131154567,1.78988086946634e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0579073494473064,0.00399397505787142,-0.0657355405607343,-0.0500791583338784,1.79316571437523e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0255122172318022,0.00176151702056991,-0.0289647905921192,-0.0220596438714852,2.41289595858519e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.11592289184941,0.00801473399156661,-0.13163177047288,-0.100214013225939,2.99466041052632e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.031213039031475,0.00216105932093946,-0.0354487153005164,-0.0269773627624337,4.00267130618286e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0601277508896486,0.00416610823273929,-0.0682933230258177,-0.0519621787534796,4.70525681435154e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.075636689154421,0.0052434879597751,-0.0859139255555802,-0.0653594527532619,5.25777817432486e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,29639,-0.059893931888017,0.00415474431506557,-0.0680372307455455,-0.0517506330304884,5.93775736048285e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0604517461630605,0.00419316043382101,-0.0686703406133497,-0.0522331517127713,6.33545105913697e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0504681582282848,0.00350262352919664,-0.0573333003455102,-0.0436030161110594,6.63797073253208e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.10923542297055,0.00758488479844878,-0.12410179717551,-0.0943690487655904,7.27389937418926e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0342756499440667,0.00238097921790534,0.0296089306769723,0.0389423692111612,8.49720103663064e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0274388681191006,0.00190759797378978,0.0236999760904726,0.0311777601477286,1.0038097221949e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0604958612100987,0.00421801497137692,-0.0687631705539975,-0.0522285518662,1.70964225953731e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,29566,-0.0428887720785937,0.00299221303799845,-0.0487535096330707,-0.0370240345241167,1.93582208986372e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0856512191965224,0.00597670889716383,-0.0973655686349635,-0.0739368697580813,2.15292645765375e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0859082124901725,0.00600129230718959,-0.0976707454122641,-0.0741456795680809,2.70015388472178e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0296838967956042,0.00208077198478359,-0.03376220988578,-0.0256055837054283,5.13104970305582e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0449426907034157,0.00315267645791176,0.0387634448459087,0.0511219365609227,5.90284455531644e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0341181524606935,0.00239333795855117,-0.0388090948594538,-0.0294272100619332,5.90449370241901e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,29478,-0.124614751444492,0.00874496399655149,-0.141754880877733,-0.107474622011251,6.3824425144849e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0571248499907459,0.00402073567732726,-0.0650054919183073,-0.0492442080631844,1.17375340997396e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0793595264052402,0.00558685680719573,-0.0903097657473438,-0.0684092870631366,1.29295593083877e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0340278586242779,0.0023967701896331,-0.0387255281959588,-0.0293301890525971,1.45894229896062e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0666121894718747,0.00469345514053716,-0.0758113615473276,-0.0574130173964219,1.54688628600796e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,29349,-0.0311470182519282,0.0021969337676123,-0.0354530084364483,-0.0268410280674081,1.78502674868643e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,29443,0.0263055152235513,0.00185706992643804,0.0226656581677328,0.0299453722793699,2.12583118934319e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0217111738541308,0.00153371524106532,-0.0247172557266188,-0.0187050919816428,2.57851203948616e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.0525600831020217,0.00371417354208558,-0.0598398632445095,-0.045280302959534,2.59355438426041e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.099663226107882,0.00704927113248802,-0.113479797527559,-0.0858466546882055,3.13559760143175e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0481277330700011,0.00340766003907831,-0.0548067467465946,-0.0414487193934076,4.07833351232674e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,29474,0.0220757167394521,0.00156364597027013,0.0190109706377226,0.0251404628411815,4.12342222055067e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0392774492923566,0.00278291903233669,-0.0447319705957365,-0.0338229279889767,4.37841602710407e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0516177417072811,0.00365917998880931,-0.0587897344853473,-0.0444457489292149,5.21867578099184e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0543145733763584,0.00385894882122028,-0.0618781130659502,-0.0467510336867667,8.17710564742465e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.124660487703303,0.00888075469912295,-0.142066766913584,-0.107254208493022,1.38148807772068e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0553693135823132,0.00394873299732884,-0.0631088302570778,-0.0476297969075487,1.70646423160519e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0562205812102344,0.00401074047478341,-0.0640816325408099,-0.0483595298796589,1.70674790382105e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0862720214702625,0.00615529342265206,-0.0983363965786605,-0.0742076463618644,1.72991153715e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0485506893964881,0.0034687452808136,-0.0553494301468827,-0.0417519486460934,2.40957380825536e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.0477357863196281,0.00341556461419707,-0.0544302929634543,-0.0410412796758018,3.2461894167671e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0711604629125238,0.00509844258897192,-0.0811534103869087,-0.0611675154381388,4.17225092809518e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0321369566327624,0.0023054662883414,-0.0366556705579116,-0.0276182427076133,5.0334105346435e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,24845,-0.0620242853047079,0.00445224160441431,-0.0707506788493599,-0.0532978917600558,6.00838907879176e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,28797,-0.047101766415402,0.0033881396200487,-0.0537425200706974,-0.0404610127601065,8.54155265997469e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.0801653388579738,0.00577297848577821,-0.0914803766900991,-0.0688503010258485,1.11692155139672e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0533339107665233,0.00384500081507681,-0.0608701123640739,-0.0457977091689728,1.3898719331197e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0690142222452526,0.00498151299122947,-0.0787779877080624,-0.0592504567824428,1.76269846753806e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0622219961576146,0.00449192660421627,-0.0710261723018785,-0.0534178200133507,1.81716016357728e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,29454,-0.026260900867883,0.00189749700338088,-0.0299799949945095,-0.0225418067412565,2.00699216088567e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0213336645200178,0.00154442872110634,0.0183065842266494,0.0243607448133862,2.90865922119989e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0549058302767686,0.003988133808226,-0.0627225725408916,-0.0470890880126457,5.76577263968366e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.102079938557095,0.00741445433944341,-0.116612269062404,-0.0875476080517856,5.7884751375877e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0572612301912197,0.00416327176786856,-0.0654212428562421,-0.0491012175261973,6.59889615906778e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0639687891514307,0.00465265752959076,-0.0730879979094285,-0.0548495803934328,7.02517963657007e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.03143576392198,0.00229100743727874,-0.0359261384990463,-0.0269453893449136,1.01998163733805e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.074502280866725,0.00543403278076489,-0.0851529851170242,-0.0638515766164258,1.25958678714124e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0527743898029464,0.00385450630908876,-0.0603292221687603,-0.0452195574371324,1.6409785719632e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0806828635548268,0.00589500920477248,0.0691286455134728,0.0922370815961809,1.64560120409081e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0713316186273368,0.00521990702596449,-0.0815626363982273,-0.0611006008564464,2.32828859339265e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0814906043599814,0.00597055888827939,-0.093192899781009,-0.0697883089389538,2.76484793152716e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0407973651463385,0.00298953836732566,-0.0466568603462968,-0.0349378699463802,3.0206101957436e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.100829384646813,0.00739540240681442,-0.115324373364169,-0.0863343959294564,3.56623220498857e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0218230287563638,0.00160181301921421,-0.0249625822740236,-0.0186834752387039,3.85907815326649e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0513564043324609,0.00378389707352382,-0.0587728425965676,-0.0439399660683542,7.78376644011113e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,29455,-0.0495687617526553,0.00365492934378683,-0.0567324232664775,-0.0424051002388331,8.96333286513061e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0515819188434753,0.00380300814496678,-0.0590358148076102,-0.0441280228793405,9.28937894394892e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0536453060252573,0.00396643621555066,-0.0614195210077366,-0.045871091042778,1.48746723277925e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.105818444821413,0.00782639399347478,-0.121158177048624,-0.0904787125942024,1.65654483946728e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0656591943754426,0.00485806512608791,-0.0751810020225749,-0.0561373867283103,1.7876763347553e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.0390463101610678,0.00289024918066486,-0.0447111985551709,-0.0333814217669646,1.92270944185735e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0646457342837677,0.00479045380134983,-0.0740350237344134,-0.0552564448331221,2.23167340661816e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0619162321756263,0.0045895898375156,-0.0709118282571569,-0.0529206360940957,2.36530351817367e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.0291239900283467,0.0021588455346175,0.0248926527804964,0.0333553272761969,2.37065970124639e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0610131713712328,0.00452691029054133,-0.0698859155406938,-0.0521404272017718,2.79268534724975e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0996819621756077,0.00740184170164205,-0.114189571910826,-0.0851743524403892,3.22770325212979e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0365148730243676,0.00271163639697818,-0.0418296803624449,-0.0312000656862904,3.30184856166288e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0281401892833265,0.00209304364074577,0.0240378237474648,0.0322425548191883,4.37828805294462e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.100677528562089,0.00748938420087599,-0.115356721595806,-0.0859983355283723,4.48736765466975e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0314990140139228,0.00234638330709712,-0.0360979252958332,-0.0269001027320125,5.72126789913572e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0373428300417309,0.00278369474402044,-0.042798871740011,-0.0318867883434509,6.5377673813045e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0420738444075308,0.00313562006380209,-0.048219659732583,-0.0359280290824787,6.59280081683625e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0741714077798314,0.00553018040268409,-0.0850105613690922,-0.0633322541905706,7.18595588568414e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0479024384204767,0.00357310130455216,-0.0549057169773989,-0.0408991598635545,7.75781040687406e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0576076929681462,0.00430264547951155,-0.0660408781079888,-0.0491745078283035,9.28777348839937e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0551606048418886,0.00411998379381028,-0.0632357730777568,-0.0470854366060205,9.33292936900926e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0430750012869733,0.00321815195812934,-0.0493825791249068,-0.0367674234490398,9.74506469884529e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0627757771375814,0.00469240741518315,-0.0719728956713404,-0.0535786586038224,1.06654519137378e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,24688,-0.0905817750086657,0.00677050946498542,-0.103851973560037,-0.0773115764572943,1.11403770405493e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,24951,-0.0702897487431511,0.00525597052011098,-0.0805914509625687,-0.0599880465237336,1.19573889212039e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0650257006975286,0.00487205543674949,-0.0745749293535576,-0.0554764720414996,1.62133623691358e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,29725,-0.105883309761676,0.00793973396420372,-0.121445188331515,-0.0903214311918369,1.87174015087169e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0590050506586172,0.00442453742842988,-0.0676771440183397,-0.0503329572988946,1.98846785707771e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0636973534454541,0.00478363806305587,-0.0730732840490436,-0.0543214228418646,2.45295901309306e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0296107871324519,0.00222376467184512,-0.0339693658892684,-0.0252522083756355,2.4546237239257e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.0866407829185748,0.00650686685313569,-0.0993942419507208,-0.0738873238864289,2.61517556649116e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,24867,-0.0508228080523174,0.00382069045053852,-0.0583113613353729,-0.0433342547692619,3.09432679873114e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0789209338978057,0.00593409133631195,-0.0905517529169771,-0.0672901148786343,3.19602042681811e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,23907,-0.0681730965791734,0.00513110315441625,-0.0782300587618292,-0.0581161343965175,3.86226770367038e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,24966,-0.0207015693349257,0.00155973939807364,-0.02375865855515,-0.0176444801147013,4.57346972307281e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,29786,-0.0473062982376609,0.00356768867650474,-0.0542989680436102,-0.0403136284317116,5.15325748471403e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0320051839213554,0.00241457663350377,-0.0367377541230228,-0.027272613719688,5.4922486031192e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0532316614953116,0.00401730062973679,-0.0611055707295957,-0.0453577522610275,6.117344929823e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.0890354379752603,0.00672204511584707,-0.102210646402321,-0.0758602295482,6.28188112045762e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0377449499135564,0.00285111211062654,-0.0433331296503844,-0.0321567701767283,6.82445105685114e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,29079,-0.0361959928000916,0.00273434311315921,-0.0415553053018837,-0.0308366802982996,6.94953498268684e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0801377457226855,0.00605843515433395,-0.0920122786251801,-0.068263212820191,7.92336929368428e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0384174349088584,0.00290888598120936,-0.0441188514320287,-0.0327160183856881,1.0977349081002e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0527752486396173,0.00399860898389591,-0.0606125222480533,-0.0449379750311813,1.16067025554143e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,29443,-0.03552528375681,0.00269209743637302,-0.0408017947321012,-0.0302487727815189,1.19718425364657e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.0298919069608756,0.00226644828190614,-0.0343341455934116,-0.0254496683283396,1.38188580472029e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0395985481866815,0.00300893037813218,-0.0454960517278206,-0.0337010446455425,2.0115791601173e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.0323965803663077,0.0024626255488123,-0.0372233264419799,-0.0275698342906356,2.05414674566113e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0391216271361003,0.00297495544577985,-0.0449525398098288,-0.0332907144623718,2.19898747934083e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,29433,-0.0365923807081721,0.00278326232692421,-0.0420475748689436,-0.0311371865474007,2.27779057065513e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0735898353455057,0.00560121639083271,-0.0845682194715378,-0.0626114512194736,2.58193083761864e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,24805,-0.0640396565543879,0.00487401129734214,-0.0735927186971785,-0.0544865944115973,2.66343995861186e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.094561111030578,0.00720785183610407,-0.108688500629342,-0.080433721431814,3.44928066088208e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,29218,0.0242879347345965,0.00185204622319597,0.0206579241371324,0.0279179453320606,3.52831227382216e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.10577199914414,0.00807048877319743,-0.121590157139607,-0.0899538411486729,3.91557816127618e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0727625920458793,0.00555262587714795,-0.0836457387650893,-0.0618794453266693,4.23344706169123e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0554997501004532,0.00423831365338607,-0.0638068448610899,-0.0471926553398165,4.56253245997804e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0561322100131409,0.0042944842989009,-0.0645493992389866,-0.0477150207872951,6.49750523745196e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0537727295058771,0.00411941084843784,-0.0618467747688153,-0.045698684242939,7.82549979263602e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0311978278006786,0.00239162408498289,-0.035885411007245,-0.0265102445941121,9.21504308981945e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0631402258844254,0.00484303767778015,-0.0726325797328745,-0.0536478720359763,9.58393257033774e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0619384162815125,0.00475131905348295,-0.0712510016263391,-0.0526258309366859,1.02249748440453e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,28774,-0.0670948041652396,0.00514861139567399,-0.0771860825007607,-0.0570035258297186,1.04102171291043e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0426066318533908,0.00327024697766171,-0.0490163159296077,-0.0361969477771738,1.13573623156078e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0356222617654654,0.00274009541059008,-0.0409928487702219,-0.0302516747607088,1.55080453721839e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.037119200389244,0.00285601434349975,-0.0427169885025036,-0.0315214122759845,1.70363116570811e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0394931274511524,0.00304266524571248,-0.0454567513327489,-0.0335295035695559,2.03174863567565e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,29227,-0.0675984269469141,0.00520904639701762,-0.0778081578850686,-0.0573886960087596,2.10687266268509e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0610197755167531,0.00470232028174908,-0.0702363232689813,-0.0518032277645249,2.11512235232363e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0251711683929571,0.00193976185449909,-0.0289731016277753,-0.0213692351581389,2.12014648232924e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.0910745101046365,0.00702107059906798,-0.10483580847881,-0.0773132117304633,2.37954516049024e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0620229007108406,0.00478405523585305,-0.0713996489731126,-0.0526461524485686,2.47811652247557e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0695168350724842,0.00536286135687994,-0.0800280433319688,-0.0590056268129995,2.5379659725708e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0725634222310522,0.00559687881719502,-0.0835333047127544,-0.06159353974935,2.59291728573935e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0457699416397526,0.00353677082024141,-0.0527020124474258,-0.0388378708320794,3.34236738180985e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0835198289528407,0.00646159963066291,-0.09618456422894,-0.0708550936767414,4.10425523943683e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0661089104271877,0.00511680559785797,-0.0761378493989893,-0.0560799714553861,4.4175341297559e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0708958718986165,0.00548751226031892,-0.0816513959288416,-0.0601403478683914,4.63436204543429e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0348904759663748,0.00270372052145406,-0.0401897681884248,-0.0295911837443248,5.37609732606025e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0666312873332081,0.00516379208396332,-0.0767523198177762,-0.05651025484864,5.43341015896647e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,24726,-0.0323018590297459,0.00250395448451126,-0.037209609819388,-0.0273941082401039,5.9428107949064e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0355293714423569,0.00275473435694457,-0.0409286507819682,-0.0301300921027455,6.15059141096264e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0523235503891081,0.00405823015321764,-0.0602776814894146,-0.0443694192888015,6.21073714937095e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0657226424989235,0.00509808759552218,-0.0757148941861469,-0.0557303908117,6.35178971137354e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0618096741250146,0.00479511802303555,-0.0712081054501643,-0.0524112427998649,6.76949060587103e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0673276791998397,0.00522326376875285,-0.0775652761865953,-0.0570900822130841,6.83467418080074e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0224844703540068,0.00174532101351535,0.0190636411675167,0.0259052995404969,7.12201480604228e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0265660049691569,0.00206363911111358,0.0225212723113743,0.0306107376269395,8.44267934896272e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.045299830155232,0.00352323206404333,-0.052205365000757,-0.0383942953097071,1.03814934962865e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,28931,-0.0485070018776629,0.00377532754803097,-0.0559066438718036,-0.0411073598835222,1.11320519196598e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0334017252162679,0.00260032154057814,-0.038498355435801,-0.0283050949967347,1.20651338843212e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,24867,-0.0508976381979043,0.00396374495331396,-0.0586665783063996,-0.0431286980894089,1.27610887581504e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0411430057971079,0.00320715958312607,-0.047429038580035,-0.0348569730141808,1.43957247562649e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,24381,0.0480154257198618,0.00374773609402954,0.0406698629755639,0.0553609884641597,1.85948580532618e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0727505458219221,0.00568094234432007,-0.0838851928167894,-0.0616158988270548,1.91091211249983e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.089946161264313,0.00702460714869495,-0.103714391275755,-0.0761779312528709,2.04797894368327e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.0238015821385746,0.00186087078585893,-0.0274488888788581,-0.0201542753982911,2.32657411327003e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,29434,-0.031292453258875,0.00244699671919981,-0.0360885668285066,-0.0264963396892433,2.40289743648781e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,29478,-0.0496854735699173,0.00389162421552349,-0.0573130570323433,-0.0420578901074912,3.13465479979619e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00815769780860943,0.000639941260056284,0.00690341293889912,0.00941198267831975,4.02207137038817e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,24240,-0.067691694130068,0.00532730521371115,-0.0781332123489419,-0.0572501759111942,7.13139981376779e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0578562468688264,0.0045545016529597,-0.0667830701086274,-0.0489294236290254,7.14042289292461e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0606566395232435,0.00478501780646494,-0.0700352744239148,-0.0512780046225722,1.0388443659467e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.046908808047643,0.00370190148660635,-0.0541645349613914,-0.0396530811338946,1.11176132910972e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0554614758711555,0.0043817243519522,-0.0640496556009818,-0.0468732961413292,1.31995371814535e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0733111143625293,0.00579436330370009,-0.0846680664377815,-0.0619541622872771,1.42187921633792e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0768690629329122,0.0060761027803428,-0.0887782243823841,-0.0649599014834403,1.43139899141094e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.071611630913159,0.00566410444574536,-0.0827132756268199,-0.0605099861994981,1.51832395166789e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0665769895960918,0.0052657879281931,-0.0768979339353503,-0.0562560452568333,1.59151171444102e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0363682397372658,0.00287838786523976,-0.0420098799531357,-0.0307265995213959,1.70573954655741e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0283749485822714,0.00224587839639317,-0.032776870239202,-0.0239730269253407,1.76856274343903e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,24816,-0.0771039968213656,0.00610388716053089,-0.0890676156560062,-0.0651403779867251,1.82310199140028e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0587111610295552,0.00464894395916176,-0.0678230911895123,-0.0495992308695982,1.89203011623181e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0295395743715454,0.00234123100194886,0.0249507616077256,0.0341283871353651,2.2122968128609e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0212023775250417,0.00168176224697571,-0.0244986315291141,-0.0179061235209693,2.4869815978095e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,29349,-0.049501881191396,0.00393377771251295,-0.0572120855079213,-0.0417916768748706,3.21625856819982e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0450817004876763,0.00358409437715331,-0.0521065254668968,-0.0380568755084558,3.62833597505695e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0610563079493531,0.00485617355760965,-0.070574408122268,-0.0515382077764382,3.85268417392205e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0872039072240611,0.00694007437064635,-0.100806452990528,-0.0736013614575943,4.06499638394127e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0419319241786185,0.00333761806367064,-0.048473655583413,-0.035390192773824,4.14326098285452e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0650391849739018,0.00517904609431625,-0.0751901153187617,-0.054888254629042,4.63908686533091e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.0973386431155165,0.00775289376937808,-0.112534314903498,-0.0821429713275355,4.7943224753883e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,28774,-0.0609845929291239,0.00486390511265554,-0.0705178469499288,-0.0514513389083191,5.7306147216507e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,24922,-0.0283275943112032,0.0022596709987923,-0.032756549468836,-0.0238986391535703,6.07838827554286e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0340573403081384,0.00272309403521256,-0.039394604617155,-0.0287200759991218,8.47789399882119e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0412587052739444,0.00330039902610188,-0.0477274873651041,-0.0347899231827847,9.09218752558007e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0344133516121735,0.00275327035931357,-0.0398097615164281,-0.0290169417079189,9.34827446072833e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,24793,-0.0566934218869892,0.00453481250563655,-0.0655816543980368,-0.0478051893759415,9.35469080731275e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0224972792204026,0.00180091002254139,0.0189674955762215,0.0260270628645837,1.01231576017706e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,24229,-0.041430407380858,0.00331718963851714,-0.0479320990723516,-0.0349287156893644,1.09596545109167e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0649558740944527,0.00520443747522281,-0.0751565715458894,-0.054755176643016,1.16917007914994e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0687335030291193,0.00551351341653434,-0.0795399893255267,-0.057927016732712,1.45612488041907e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0355102071244444,0.00285311563662125,-0.0411023137722221,-0.0299181004766668,1.8119022337009e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0285394249257678,0.00229528715987656,-0.0330381877591259,-0.0240406620924098,2.18018678848331e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,28750,0.10718829007701,0.00863098895806132,0.0902715517192101,0.12410502843481,2.53988823629404e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0899753144310514,0.00726503237076291,-0.104214777877747,-0.0757358509843561,3.86942982131162e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0578000206629304,0.00466650045216651,-0.0669463615491768,-0.0486536797766841,3.94585632197392e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,29381,-0.0365715240147451,0.00295350382002365,-0.0423603915019914,-0.0307826565274987,3.98229419935836e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0411547927975296,0.00332471323022977,-0.0476712307287799,-0.0346383548662792,4.18240817992416e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0618701511882179,0.0050017454434759,-0.0716735722574307,-0.0520667301190052,4.85707409978921e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.100963289616631,0.00818179722211419,-0.116999612171975,-0.084926967061287,6.73276857364973e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0694899400378157,0.00563401484913724,-0.0805326091421247,-0.0584472709335067,7.25794035534337e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,24922,-0.0265300290272154,0.0021509402424668,-0.0307458719024503,-0.0223141861519805,7.49736595388456e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,24381,-0.0482049503699819,0.00390865774000664,-0.0558659195403949,-0.0405439811995689,7.65710543315153e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0285838595951872,0.0023199431924556,-0.0331309482524001,-0.0240367709379742,8.49967235754134e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0354330105557919,0.00287581343543752,-0.0410696048892494,-0.0297964162223343,8.88366409887103e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,29491,-0.0939395770460707,0.00762764877405481,-0.108889768643218,-0.0789893854489232,9.08399478921367e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.0147666460327991,0.00119972911812101,-0.0171181151043163,-0.0124151769612819,1.03049435515022e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0524713359117782,0.0042758519808941,-0.0608520057943307,-0.0440906660292258,1.56220895917575e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0224154493500751,0.00182679880326399,-0.0259959750044725,-0.0188349236956776,1.64432280249547e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0233496757839874,0.00190491859303491,-0.0270833162263358,-0.019616035341639,1.85547051564351e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0335800141691686,0.00273977049554978,-0.0389499643404462,-0.0282100639978911,1.95091459149341e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0618353897036619,0.00506131157537961,-0.0717555603914059,-0.0519152190159178,3.0436872720015e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,24822,-0.0857211574612797,0.0070166009637409,-0.0994736953502119,-0.0719686195723475,3.16726856006043e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0457244475616165,0.00374420262374791,-0.0530630847041624,-0.0383858104190706,3.24818630058149e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0314545329611248,0.00257735065254305,0.0264029256821404,0.0365061402401092,3.56375707994266e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0335389634634744,0.0027531275863673,-0.0389350935327543,-0.0281428333941945,4.67536590562157e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0432799592159405,0.0035567816143492,-0.050251251180065,-0.0363086672518161,5.52614659094167e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0308054581118948,0.00253215442276118,-0.0357684807805067,-0.0258424354432829,5.71183958784934e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0519173773540653,0.00427095073006387,-0.0602884407849904,-0.0435463139231401,6.6631644639099e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0662752807361528,0.00545641692494221,-0.0769698579090395,-0.055580703563266,7.23462109351795e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,29443,0.0210370283130424,0.00173290326116742,0.0176405379211542,0.0244335187049305,7.83377534895948e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.032161848437412,0.00264979422523898,-0.0373554451188804,-0.0269682517559436,8.0534778272551e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,29362,-0.0368001814233906,0.00303741498377722,-0.0427535147915939,-0.0308468480551873,1.05080513092509e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,29786,-0.0490458755312779,0.00405250637168836,-0.0569887880197871,-0.0411029630427687,1.22739657995518e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.0217563460134427,0.00179996302295144,-0.0252842735384275,-0.0182284184884578,1.48402703212569e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0400428369662847,0.00331309570681883,-0.0465365045516496,-0.0335491693809198,1.50679280665599e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0467776310306659,0.00387341147133813,-0.0543695175144887,-0.0391857445468432,1.75021670407569e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.0455352107923275,0.00377412370265201,-0.0529324932495254,-0.0381379283351296,1.93983704331681e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0597713015892436,0.00496274524052631,-0.0694982822606751,-0.050044320917812,2.5843750964917e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0655221452367148,0.00544807247077567,-0.0762003672794351,-0.0548439231939945,3.08978485332883e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0758508539971944,0.00631318958261466,-0.0882247055791191,-0.0634770024152697,3.56076806803691e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0289677528582479,0.00241225205285015,-0.0336957668818342,-0.0242397388346616,3.84370477136801e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.021905734013673,0.00182502983772275,-0.0254827924956096,-0.0183286755317364,4.09445856395566e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,29566,-0.0606951872187619,0.00505790111045767,-0.0706086733952589,-0.0507817010422648,4.23832312399886e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0365701919700303,0.00304989326467507,-0.0425479827687934,-0.0305924011712672,4.73970802711838e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0494090116556415,0.00412189661274553,-0.0574879290166227,-0.0413300942946602,4.96538741580268e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.126952419214739,0.0105891331924236,-0.147707120271889,-0.106197718157589,5.01202495405552e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0839572054131582,0.00701208844788299,-0.0977008987710088,-0.0702135120553075,5.85710441953617e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0926501748082573,0.00774586314152327,-0.107832066565643,-0.0774682830508717,6.97820172850935e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0583169589676871,0.00487751457499067,-0.0678768875346688,-0.0487570304007054,7.40853510349994e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0385541553120581,0.00322450599965799,-0.0448741870713877,-0.0322341235527284,7.42033060979329e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0575693158825173,0.00481532337950878,-0.0670073497063546,-0.0481312820586801,7.48381769656161e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,24845,-0.019050020096339,0.00160026004956572,-0.0221865297934878,-0.0159135103991902,1.37829403073439e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0413655878774371,0.00347754770268039,-0.0481815813746907,-0.0345495943801836,1.53919917452147e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.112418356195711,0.00945126278867643,-0.130942831261517,-0.0938938811299052,1.55736846620219e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.0543098151395907,0.00456719033234532,-0.0632615081909875,-0.0453581220881939,1.60837094511918e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0657141885674112,0.00552773922165188,-0.0765485574418488,-0.0548798196929735,1.62064817432433e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0682755418735057,0.0057472293806087,-0.0795401114594988,-0.0570109722875127,1.78954633261033e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0493336490899899,0.00415558742036795,-0.057478600433911,-0.0411886977460687,1.96973557744085e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.032818101040236,0.00276652168838792,-0.0382404835494763,-0.0273957185309956,2.19140262670719e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0926916887751184,0.00781348228738438,0.0773772634918451,0.108006114058392,2.25690065246919e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0401873439051494,0.00339134871975181,-0.046834387395863,-0.0335403004144359,2.55992576346053e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0301430323046973,0.00254366665579655,0.0251574456593361,0.0351286189500585,2.63588783577625e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0726209028729708,0.00613087588209099,-0.0846374196018691,-0.0606043861440724,2.80254420294975e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0234473290469392,0.00198153598397333,-0.0273311395755269,-0.0195635185183514,3.12528671020676e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0381509237565927,0.00322425480286581,-0.0444704631702097,-0.0318313843429757,3.13216038166321e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0384759416934154,0.00325421370158345,0.0320976828383119,0.044854200548519,3.49204576971176e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,24966,-0.0354671672007559,0.00300102614453777,-0.0413491784440499,-0.0295851559574619,3.82325117770825e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0586240300622033,0.00496417352487064,-0.0683538101709498,-0.0488942499534569,4.1172366523439e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0685905109097546,0.00581086084981999,-0.0799797981754018,-0.0572012236441075,4.41092547555061e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0796346761858595,0.00674927756740369,-0.0928632602179707,-0.0664060921537482,4.81031247009715e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0445293134120966,0.00377912436519828,-0.0519363971678852,-0.0371222296563079,5.6570439501226e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0882964018824117,0.00750782582474431,-0.103011740498911,-0.0735810632659129,7.34351697597556e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0322858263400461,0.00274560278697552,-0.0376672078025181,-0.0269044448775741,7.46068926091195e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,24229,-0.0357891911724359,0.00304394392698243,-0.0417553212693214,-0.0298230610755503,7.88714453094591e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0727901473797181,0.00619789543779417,-0.0849380224377946,-0.0606422723216415,9.20223590324965e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,29434,-0.0276830154398245,0.00236228081159543,-0.0323130858305516,-0.0230529450490975,1.2012341836022e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0369542564872423,0.00315281803414706,-0.0431337798341706,-0.0307747331403141,1.21112540036611e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0297452516558626,0.00254377826976474,-0.0347310570646015,-0.0247594462471237,1.66825988380501e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.0660837901087273,0.00565403596858427,-0.0771657006071525,-0.0550018796103021,1.73173869805399e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,24195,-0.0354276963287614,0.00303326547490822,-0.0413728966595815,-0.0294824959979412,1.9656469686082e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,29434,-0.0405469991932796,0.00347869704477289,-0.0473652454010344,-0.0337287529855247,2.51211797523891e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.0262617470434614,0.00225399433874265,0.0218439181395258,0.030679575947397,2.64893930391047e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0809013588362801,0.00694552490164707,-0.0945145876435084,-0.0672881300290519,2.76196518532583e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0313493770015892,0.00269157795150934,-0.0366248697865475,-0.0260738842166309,2.87272187512618e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0475439721188465,0.00408322422102033,-0.0555470915920463,-0.0395408526456467,2.89223612329982e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0577566184481223,0.00496007525025358,-0.0674783659386193,-0.0480348709576253,2.97185567869667e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0372896697254288,0.00320389753351683,-0.0435693088911218,-0.0310100305597358,3.16738628710891e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0761102657139644,0.00653979634209475,-0.0889282665444701,-0.0632922648834587,3.18118484253857e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,29065,0.0230767375775998,0.00198332504263779,0.0191894204940297,0.0269640546611699,3.19497173642698e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0757721341139972,0.00652068472029372,-0.0885526761657729,-0.0629915920622215,3.93214709077242e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0497770028869746,0.00428596742168885,-0.0581774990334847,-0.0413765067404644,4.23246965083677e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0349244399548082,0.00300819489808859,-0.0408205019550618,-0.0290283779545546,4.30258204712961e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0557895623794284,0.00480821834411764,-0.0652136703338989,-0.0463654544249578,4.81423484041103e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.055727679507372,0.00480453672531932,-0.0651445714889979,-0.0463107875257462,5.04265699530799e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0398032528109549,0.00343517842515204,-0.0465362025242529,-0.0330703030976569,5.76239657877575e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0697514153905289,0.00602368453651577,-0.0815578370820998,-0.057944993698958,6.10828977864548e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.0271508155487083,0.00234452413473072,-0.0317460828527805,-0.0225555482446361,6.21481340696537e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.049840562007547,0.00430550249165443,-0.0582793468911897,-0.0414017771239043,6.38416987956528e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0535464315256748,0.00462739453954473,-0.0626161248231824,-0.0444767382281671,6.91993382918371e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0395436220761495,0.0034174606194787,-0.0462418448903277,-0.0328453992619712,6.92820947906256e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0519505302402063,0.00449191364817654,-0.0607546809906324,-0.0431463794897803,7.40674348989458e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.045511282991724,0.00393654786043441,-0.0532269167981754,-0.0377956491852726,7.57426017694037e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.078342424655536,0.00679283496718009,-0.091656381191209,-0.0650284681198631,1.04662747255333e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,29478,0.0309824067034707,0.00268687262525252,0.0257161363579757,0.0362486770489656,1.07124540373157e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.10776676884633,0.00934865591077985,-0.126090134431459,-0.0894434032612017,1.11508595031308e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0649548622505174,0.00563913332984518,-0.0760075635770139,-0.0539021609240208,1.23784005888014e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0198164548265579,0.00172267979314604,0.0164400024319916,0.0231929072211241,1.476001374198e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0362056869024893,0.00315005441591379,-0.0423797935576803,-0.0300315802472983,1.70310603630323e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0326280719197477,0.002845991388653,-0.0382062150415076,-0.0270499287979878,2.38242942422736e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0462826699731849,0.00403748486406642,-0.0541961403067551,-0.0383691996396147,2.41423333138343e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.031903991987045,0.00278358869093582,-0.0373598258212793,-0.0264481581528108,2.45558552919215e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0222666624105118,0.00194470028597389,-0.0260782749710206,-0.018455049850003,2.8018439485475e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.0400453940748941,0.00349763489873387,0.0331900296733758,0.0469007584764125,2.82255906605825e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.055126205859716,0.00481865860011506,-0.0645707767159415,-0.0456816350034905,3.15286791637209e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0173782675193426,0.0015191710615598,0.0144006922386854,0.0203558427999998,3.1805865708672e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0624815594846153,0.00546224437453675,-0.0731875584587073,-0.0517755605105232,3.18460640846826e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0940196996677237,0.00823864308714047,-0.110167440118519,-0.0778719592169284,4.32705007940412e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0536232230537794,0.00470745980864387,-0.0628498442787214,-0.0443966018288374,5.36899325362952e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0315240216844564,0.00276833776265964,-0.0369499636992693,-0.0260980796696435,5.61138068566203e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0475702457587715,0.00417778738741796,-0.0557587090381108,-0.0393817824794323,5.82126919488705e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0290097039520512,0.00255086182504117,-0.0340093931291319,-0.0240100147749706,6.61944313451809e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0518946186194211,0.00456419438920888,-0.0608404396222705,-0.0429487976165717,6.80699671109136e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0176826883719282,0.00155606569038501,0.0146327996187736,0.0207325771250828,7.50808805785641e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.034648188645588,0.00305176283606992,-0.040629643804285,-0.0286667334868909,8.21084864808356e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0245953724011932,0.00216707428475964,0.0203479068030643,0.0288428379993221,8.58019702688396e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0447978050057292,0.00394813979979908,-0.0525361590133354,-0.037059450998123,9.17146438025198e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0328643741144236,0.00289749210830358,-0.0385434586466986,-0.0271852895821486,9.58027652824784e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0381514552894579,0.00336476967365873,-0.044746403849829,-0.0315565067290868,9.73820345716555e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0257489824044181,0.0022716178612342,-0.0302013534124371,-0.0212966113963991,1.01921562618643e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0876745815033665,0.00773544900015469,-0.10283606154367,-0.0725131014630634,1.0517687199408e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.0191705404322021,0.00169799381884654,-0.0224986083171413,-0.0158424725472629,1.69106208618073e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0779588176527085,0.0069104223453987,-0.0915032454496899,-0.064414389855727,1.86526870832624e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0703650372574976,0.00623971151046841,-0.0825948718180157,-0.0581352026969795,2.01140920462482e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0463641373130193,0.00411184000273285,-0.0544233437183756,-0.0383049309076629,2.04712735788437e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,29478,-0.0345717438076723,0.00306703409499588,-0.0405831306338642,-0.0285603569814804,2.07170327604302e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0748660668534911,0.00665380435265611,-0.0879075233846971,-0.0618246103222851,2.60834997592801e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0366893825222325,0.00326370643280741,-0.043086247130535,-0.03029251791393,2.93043648448275e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0742612398503496,0.00660618988804869,-0.087209372030925,-0.0613131076697742,2.94602548753683e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.024314531884505,0.00216537180532797,-0.0285586606229478,-0.0200704031460622,3.37606359874633e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,29349,-0.0479693224658019,0.00427275890668741,-0.0563439299229092,-0.0395947150086946,3.45539736821804e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0386977743590958,0.00345152332688981,-0.0454627600797999,-0.0319327886383918,4.21305037128069e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0488378741162383,0.00435715939082928,-0.0573779065222637,-0.040297841710213,4.23651304768302e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0538064377299439,0.00481118875632096,-0.063236367692333,-0.0443765077675549,5.76868202313372e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0463224407500925,0.00414351750147503,-0.0544437350529835,-0.0382011464472014,5.87640406996492e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0573593208293573,0.00513627158235755,-0.0674264131307781,-0.0472922285279365,6.7198390004215e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0343818182506033,0.00308085038947489,0.0283433514872325,0.0404202850139741,7.53802882275303e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0612251907051543,0.00549597323380432,-0.0719972982434108,-0.0504530831668979,9.14287786536878e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.0350239536208098,0.00314617087982737,-0.0411904485452714,-0.0288574586963481,1.00051502469462e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0431450428828395,0.00387729404580258,-0.0507445392126126,-0.0355455465530665,1.04921204394978e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0827157757779908,0.00743609946902686,-0.0972905307372835,-0.0681410208186982,1.09972887135482e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0649398192058088,0.00584541504250779,-0.076396832689124,-0.0534828057224935,1.3224620224308e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0706026497927772,0.00635835801440014,-0.0830650315010014,-0.0581402680845529,1.36915069693704e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0541588471707056,0.00487985559471211,-0.0637233641363413,-0.0445943302050699,1.49692215543681e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0304400186800746,0.0027439631064515,0.0250618509914297,0.0358181863687195,1.54026390020899e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,24890,-0.0374399186200657,0.00337497793147299,-0.0440548753657528,-0.0308249618743786,1.57597504939695e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0277169157371903,0.00249916404081537,-0.0326152772571884,-0.0228185542171922,1.59332816286938e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,29478,-0.0542929258462081,0.00489766391004907,-0.0638923471099042,-0.0446935045825119,1.68028414138457e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,29594,0.0381113012555194,0.00343931208333228,0.0313702495721881,0.0448523529388507,1.76352239924293e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0833849592824226,0.00753223504027658,-0.0981481399613647,-0.0686217786034805,2.04084655568694e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,28870,-0.0398320270375596,0.00359933136257581,-0.0468867165082082,-0.032777337566911,2.08038767134869e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0710884788175134,0.00642714498623246,-0.0836856829905291,-0.0584912746444978,2.2681070534777e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0294458723322739,0.00266726430831485,-0.034673710376571,-0.0242180342879768,2.79318731446186e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0943755358547495,0.00855491470287651,-0.111143168672388,-0.0776079030371116,3.12403067413434e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0267449250238026,0.00242659981667163,0.0219887893831262,0.031501060664479,3.4187937322043e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0738224640971213,0.00669929998963967,-0.086953092076815,-0.0606918361174275,3.57993117451727e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,29820,0.0241078048080746,0.00218820626763227,0.0198189205235154,0.0283966890926339,3.58043443288181e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0407280546882193,0.00369693478618831,-0.0479740468691484,-0.0334820625072902,3.60232419969219e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,24761,-0.0226089124979915,0.0020530694244687,-0.0266329285699501,-0.0185848964260328,3.87753666282423e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0457992272274706,0.00415899258398293,-0.0539508526920771,-0.037647601762864,3.89319303522278e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.0196268705197047,0.00178410084788139,-0.0231237081815522,-0.0161300328578571,4.28554956533468e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0510348523433407,0.00463917003842603,-0.0601276256186557,-0.0419420790680257,4.39608266259057e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0718891289058912,0.00654886832586971,-0.0847249108245959,-0.0590533469871866,5.69759719960253e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.058672561649174,0.00534575478694349,-0.0691502410315832,-0.0481948822667647,5.82618827787398e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0405602603062892,0.00369764872311865,-0.0478076518036017,-0.0333128688089766,6.08000966770003e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0228778502433886,0.00208565463026507,0.0187899671680691,0.0269657333187082,6.08875553683937e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0272955161305813,0.00248986456433083,-0.0321756506766697,-0.0224153815844929,6.53666621088053e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0280625574116294,0.0025658602101303,0.023033471399774,0.0330916434234848,8.68231104306823e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0697254525157867,0.00637644720512606,-0.0822232890378337,-0.0572276159937396,9.12133154888223e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.0210593347038677,0.00192745420364742,-0.0248371449430167,-0.0172815244647188,9.79059552099622e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0623301175867543,0.00570596660316443,-0.0735138121289566,-0.051146423044552,1.00514233178536e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0270690554957736,0.00247884546384146,-0.0319275926049029,-0.0222105183866444,1.04560018615947e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.0205385392084749,0.00188168556198941,0.0168504355069757,0.0242266429099741,1.12919382330986e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0363511326524406,0.00333780104052252,-0.0428932226918647,-0.0298090426130164,1.47293017061184e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0290230832984155,0.00266837955811289,-0.0342531072323168,-0.0237930593645142,1.68031550477824e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0659920336139627,0.00607662434472181,-0.0779022173296175,-0.054081849898308,2.02265111622444e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0556196210664611,0.00512250030225376,-0.0656597216588784,-0.0455795204740437,2.10772205050189e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0484243338201928,0.0044610400474128,-0.0571679723131219,-0.0396806953272637,2.13523497061895e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0265666747446414,0.00244807590410959,-0.0313649035166962,-0.0217684459725866,2.19728844281744e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0355765718293343,0.00327931748334478,-0.04200403409669,-0.0291491095619785,2.33698195698389e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0378878547879031,0.00349605485035507,0.0310355872812071,0.044740122294599,2.58297243237949e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0375295398710682,0.00346246653602747,-0.0443159742816821,-0.0307431054604544,2.59110784863301e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,24805,-0.06073179,0.005603282,-0.07171422,-0.04974936,2.601007e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.06573528,0.006078717,-0.07764957,-0.053821,3.32489e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.03999808,0.003699752,-0.0472496,-0.03274657,3.443346e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.06189319,0.005725872,-0.0731159,-0.05067049,3.502421e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.07067499,0.006545559,-0.08350429,-0.0578457,3.981495e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.05274072,0.004893208,-0.06233141,-0.04315003,4.894586e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,24951,-0.0180128,0.001671861,-0.02128965,-0.01473595,5.231775e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.03804841,0.003533097,-0.04497328,-0.03112354,5.542818e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,24938,-0.06510192,0.006050445,-0.07696079,-0.05324305,6.103154e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,28774,-0.02368956,0.002202734,-0.02800692,-0.0193722,6.342569e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.04035653,0.003756276,-0.04771883,-0.03299423,7.112374e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,29694,-0.02799736,0.002607575,-0.03310821,-0.02288652,7.648583e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,29331,-0.02214094,0.002064236,-0.02618684,-0.01809504,8.6203e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.04329533,0.004042097,-0.05121784,-0.03537282,1.011834e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.07751052,0.007239794,-0.09170052,-0.06332053,1.089058e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.07395056,0.006911822,-0.08749773,-0.06040339,1.151352e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,29383,-0.03642964,0.003409392,-0.04311205,-0.02974723,1.337897e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,29786,-0.02677573,0.002506255,-0.03168799,-0.02186347,1.357898e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.04105139,0.003846252,-0.04859004,-0.03351274,1.553022e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,24801,-0.02478403,0.002324042,-0.02933915,-0.0202289,1.708761e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.05912699,0.005549665,-0.07000433,-0.04824965,1.863474e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,23779,-0.03592892,0.003372242,-0.04253851,-0.02931932,1.910081e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.03318537,0.003117609,-0.03929588,-0.02707486,2.10968e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.04668258,0.004402689,-0.05531185,-0.03805331,3.209806e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0588126,0.005547684,-0.06968606,-0.04793914,3.277139e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.04973155,0.004705346,-0.05895403,-0.04050907,4.613702e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,29694,0.022864,0.002164536,0.0186215,0.02710649,4.919823e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,24229,-0.03792795,0.003591149,-0.0449666,-0.0308893,5.119582e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.01339953,0.00127162,0.01090715,0.0158919,6.463143e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,24845,-0.1038846,0.009863102,-0.1232163,-0.08455291,6.927785e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.08238241,0.007834691,-0.0977384,-0.06702641,8.361206e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.05245072,0.004989988,-0.06223109,-0.04267034,8.711736e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,29478,-0.01839274,0.001754065,-0.02183071,-0.01495477,1.114352e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.02982827,0.002845377,0.02425133,0.03540521,1.149003e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,24381,-0.05869992,0.005598815,-0.0696736,-0.04772625,1.156177e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.04115707,0.003929242,-0.04885838,-0.03345576,1.282024e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.06403035,0.006116366,-0.07601843,-0.05204227,1.337376e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,29443,0.02385666,0.002278913,0.01938999,0.02832333,1.33787e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.02647356,0.002530367,-0.03143308,-0.02151404,1.458498e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.02075552,0.001984323,-0.0246448,-0.01686625,1.465862e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.03638506,0.003478715,-0.04320334,-0.02956678,1.475482e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,29786,-0.03533511,0.003379163,-0.04195827,-0.02871195,1.510846e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0199699,0.001911913,0.01622255,0.02371725,1.71191e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.02464024,0.002359857,-0.02926556,-0.02001492,1.776298e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.01978569,0.00189643,0.01606868,0.02350269,1.975636e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.06742414,0.00646445,-0.08009446,-0.05475382,2.004247e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.04954315,0.004750203,-0.05885355,-0.04023276,2.05368e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.04255603,0.004080729,-0.05055426,-0.0345578,2.079433e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.09582282,0.009206321,-0.1138672,-0.07777843,2.512418e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.05139639,0.004941582,-0.06108189,-0.04171089,2.720679e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.01114067,0.001071264,0.009040991,0.01324034,2.806816e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.02161853,0.002080672,0.01754042,0.02569665,3.035714e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.062283,0.006000846,-0.07404465,-0.05052134,3.478771e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.07031655,0.006776237,-0.08359798,-0.05703513,3.492653e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,29218,0.02524271,0.002433149,0.02047374,0.03001169,3.582274e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.09104207,0.008791425,-0.1082733,-0.07381088,4.364443e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.02854623,0.002757805,-0.03395153,-0.02314093,4.57968e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.03648889,0.003526413,-0.04340066,-0.02957712,4.760273e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,29114,-0.02963581,0.002870648,-0.03526228,-0.02400934,6.077737e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.06857341,0.006650204,-0.08160781,-0.05553901,6.906464e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,29349,0.03357298,0.003256284,0.02719067,0.0399553,6.987479e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.04881153,0.004737176,0.03952667,0.0580964,7.457739e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.06356538,0.00617262,-0.07566372,-0.05146705,8.092283e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.09105918,0.008849451,-0.1084041,-0.07371425,8.622046e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0424765,0.004130073,-0.05057145,-0.03438156,9.096293e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.05004519,0.004867619,-0.05958572,-0.04050465,9.427497e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.08605823,0.008376324,-0.1024758,-0.06964064,1.016638e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.02400425,0.002340101,0.01941765,0.02859084,1.22543e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.02249956,0.002195126,-0.02680201,-0.01819712,1.328753e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.04508149,0.004400642,-0.05370675,-0.03645623,1.380609e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.02532871,0.002472581,-0.03017497,-0.02048245,1.411283e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.04958839,0.004848056,-0.05909058,-0.0400862,1.627833e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.05328696,0.005217093,-0.06351246,-0.04306146,1.885998e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.04409551,0.004320434,-0.05256356,-0.03562746,2.045661e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.05043172,0.004942672,-0.06011936,-0.04074408,2.10308e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.06062193,0.005944401,-0.07227295,-0.0489709,2.257616e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.02193009,0.002151714,-0.02614745,-0.01771273,2.40619e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,24805,-0.06229859,0.006114096,-0.07428222,-0.05031497,2.471113e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,29478,-0.02512661,0.002468387,-0.02996465,-0.02028857,2.689562e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0453522,0.004457536,-0.05408897,-0.03661543,2.881547e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,24732,-0.03420836,0.003366889,-0.04080746,-0.02760926,3.329169e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.02928647,0.002888127,0.02362574,0.0349472,4.008267e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.02936305,0.002895411,-0.03503805,-0.02368804,4.037917e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.06452668,0.006369357,-0.07701062,-0.05204274,4.494256e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,28774,-0.07676108,0.007582553,-0.09162289,-0.06189928,4.774503e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.03516048,0.003472939,-0.04196744,-0.02835352,4.821207e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.08353441,0.008265159,0.0673347,0.09973412,5.643521e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.02620577,0.002595765,-0.03129347,-0.02111807,6.444221e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.07988896,0.007917376,-0.09540702,-0.06437091,6.664722e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,24951,-0.05028552,0.004984328,-0.06005481,-0.04051624,6.887033e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.03611195,0.003581916,-0.0431325,-0.02909139,7.408805e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.04593442,0.004558991,-0.05487004,-0.0369988,7.737033e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.03690551,0.003663308,-0.04408559,-0.02972543,7.967179e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.03842677,0.003825189,-0.04592414,-0.0309294,1.04768e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,24845,-0.02032113,0.002023278,-0.02428675,-0.0163555,1.087226e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.06686582,0.006658066,-0.07991563,-0.05381601,1.099308e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.07471945,0.007448966,-0.08931942,-0.06011947,1.240114e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.01479613,0.001475672,0.01190382,0.01768845,1.26902e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,29390,-0.02040835,0.002035422,-0.02439778,-0.01641892,1.271193e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0314161,0.003133467,-0.0375577,-0.02527451,1.303175e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,24922,-0.03991593,0.003984498,-0.04772555,-0.03210631,1.410808e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.04050632,0.004049758,-0.04844385,-0.0325688,1.656348e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.02492383,0.00249294,-0.02980999,-0.02003767,1.699788e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.02932199,0.002934961,-0.03507451,-0.02356946,1.825497e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,24805,-0.07425277,0.007432751,-0.08882097,-0.05968458,1.868199e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.02162948,0.002165362,0.01738537,0.02587359,1.888805e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.04615625,0.004621694,-0.05521477,-0.03709773,1.899957e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.04246246,0.004251634,-0.05079566,-0.03412926,1.917478e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.02580215,0.002585157,-0.03086906,-0.02073524,2.044888e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,29218,-0.0487327,0.004885691,-0.05830865,-0.03915674,2.146776e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.06295514,0.006320607,-0.07534353,-0.05056675,2.473308e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.02843118,0.002855995,0.02283343,0.03402893,2.612909e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.06386972,0.006418295,-0.07644958,-0.05128986,2.712835e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.07194532,0.007233364,-0.08612271,-0.05776793,2.849877e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.03919925,0.003947655,-0.04693666,-0.03146185,3.36199e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.04340812,0.004372911,-0.05197902,-0.03483721,3.525501e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.02079041,0.002096807,-0.02490015,-0.01668067,3.945577e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.02346942,0.00236702,0.01883006,0.02810877,3.947317e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,29498,-0.06643544,0.006701963,-0.07957129,-0.05329959,3.979389e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,29544,-0.02123536,0.002145428,-0.0254404,-0.01703032,4.615057e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0366378,0.003707992,-0.04390547,-0.02937014,5.563236e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.06166134,0.006247049,-0.07390555,-0.04941712,6.066635e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.03434738,0.003479362,-0.04116692,-0.02752783,6.084877e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,24111,-0.04208337,0.004269681,-0.05045195,-0.0337148,7.110481e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.06438122,0.006543305,-0.0772061,-0.05155634,8.417176e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.01801712,0.001834072,0.01442234,0.0216119,9.656347e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.03488085,0.003552674,-0.0418441,-0.02791761,1.036683e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,29163,-0.02468421,0.00251785,-0.0296192,-0.01974922,1.176727e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.03142809,0.00320647,-0.03771277,-0.02514341,1.221664e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.06933654,0.007079669,-0.08321269,-0.05546038,1.299198e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.06421122,0.006556721,-0.07706239,-0.05136005,1.326588e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,29760,-0.01445193,0.001479739,-0.01735222,-0.01155164,1.694053e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.04737563,0.004851666,-0.0568849,-0.03786637,1.749574e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0248302,0.002542774,-0.02981403,-0.01984636,1.750623e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.01893502,0.001941592,-0.02274054,-0.0151295,1.949205e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,29443,-0.06302243,0.006477382,-0.0757181,-0.05032676,2.436283e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,28534,-0.05362966,0.005512139,-0.06443346,-0.04282587,2.448065e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.05575963,0.005738026,-0.06700616,-0.0445131,2.78855e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.01787598,0.001843946,-0.02149012,-0.01426185,3.484858e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.08133724,0.00839989,-0.09780102,-0.06487345,3.841323e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.01941043,0.002006536,-0.02334324,-0.01547762,4.281365e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,29443,-0.05102193,0.005278643,-0.06136807,-0.04067579,4.547065e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,29443,0.03180332,0.003291234,0.02535251,0.03825414,4.667588e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.07373412,0.007652992,-0.08873399,-0.05873426,6.24345e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.05774252,0.00599686,-0.06949637,-0.04598868,6.509942e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.02259371,0.002347978,-0.02719575,-0.01799167,6.913536e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.02744133,0.002853293,0.02184887,0.03303378,7.262947e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.02000318,0.002080809,-0.02408157,-0.0159248,7.575774e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.02198069,0.002289711,-0.02646852,-0.01749286,8.760989e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.04052604,0.004221923,-0.04880101,-0.03225107,8.812486e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,24966,0.0161027,0.001678181,0.01281346,0.01939193,9.121592e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,29566,-0.04326581,0.004510257,-0.05210591,-0.03442571,9.22584e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.03674007,0.003829591,-0.04424607,-0.02923408,9.26807e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.04476523,0.004666932,-0.05391242,-0.03561805,9.423788e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0197559,0.002059962,-0.02379342,-0.01571837,9.565714e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.02000686,0.002089661,-0.02410259,-0.01591112,1.103338e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.03804238,0.003983916,-0.04585085,-0.0302339,1.430413e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,24845,-0.05794049,0.006068997,-0.06983573,-0.04604526,1.454385e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.03509433,0.003677346,-0.04230193,-0.02788673,1.485112e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0360911,0.003783371,-0.0435065,-0.02867569,1.545887e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0183481,0.001924302,-0.02211973,-0.01457647,1.610151e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.02078222,0.002183821,-0.02506251,-0.01650193,1.949674e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,29443,-0.02886287,0.003034547,-0.03481058,-0.02291516,2.018844e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,29478,-0.02471035,0.00259936,-0.0298051,-0.01961561,2.1199e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.01925755,0.002026753,-0.02322998,-0.01528511,2.251346e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.02623013,0.002763181,-0.03164597,-0.0208143,2.418578e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.02056993,0.002171432,-0.02482593,-0.01631392,2.958816e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,28931,-0.030096,0.003180206,-0.0363292,-0.0238628,3.195125e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.05866386,0.006201904,-0.07081959,-0.04650812,3.380404e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,24229,-0.03921937,0.00415494,-0.04736305,-0.03107569,4.083325e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.02283435,0.002423298,-0.02758402,-0.01808469,4.697884e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.03507777,0.003724754,-0.04237829,-0.02777725,4.954398e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.06302131,0.006693388,-0.07614035,-0.04990227,5.048631e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0326005,0.00346544,-0.03939276,-0.02580823,5.514819e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.02868175,0.003050456,-0.03466064,-0.02270285,5.78535e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.03855426,0.004103915,-0.04659793,-0.03051059,6.159542e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.04501557,0.004792287,-0.05440846,-0.03562269,6.296725e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.01821248,0.001939504,-0.0220139,-0.01441105,6.400495e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.05613071,0.005977671,-0.06784694,-0.04441447,6.504798e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.02747584,0.002926134,-0.03321107,-0.02174062,6.520356e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.05177244,0.005516409,-0.0625846,-0.04096028,6.803369e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.06642934,0.007087494,-0.08032082,-0.05253785,7.647555e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,24867,-0.05180932,0.005531152,-0.06265037,-0.04096826,8.089455e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.05359571,0.005725843,-0.06481837,-0.04237306,8.601397e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.04869605,0.005207909,-0.05890355,-0.03848854,9.327266e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.02920122,0.003125527,-0.03532726,-0.02307519,1.002115e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.07488567,0.008015233,0.05917581,0.09059553,1.018336e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.06571774,0.00705172,-0.07953911,-0.05189637,1.264387e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.05870398,0.006299577,-0.07105115,-0.04635681,1.274877e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,29434,-0.04553919,0.004888009,-0.05511969,-0.03595869,1.283492e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.06099298,0.006546213,-0.07382356,-0.0481624,1.292046e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.03787962,0.00406588,-0.04584874,-0.02991049,1.301297e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,24636,-0.06665942,0.007180174,-0.08073256,-0.05258628,1.766001e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.03508884,0.003780771,-0.04249916,-0.02767853,1.791778e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.05721326,0.006167723,-0.069302,-0.04512452,1.894397e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.04893924,0.005277042,-0.05928224,-0.03859623,1.911766e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.03995983,0.004310668,-0.04840874,-0.03151092,1.985275e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.03436368,0.003708006,-0.04163137,-0.02709599,2.060951e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.02263434,0.002443316,-0.02742324,-0.01784544,2.103367e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.01985194,0.002144127,-0.02405443,-0.01564945,2.205589e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,29623,-0.03941352,0.004259511,-0.04776216,-0.03106488,2.323872e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,29349,-0.01976847,0.00213652,-0.02395605,-0.01558089,2.334211e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,24421,-0.01483201,0.001603126,-0.01797414,-0.01168988,2.380323e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.04457894,0.004818733,-0.05402366,-0.03513423,2.399487e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,24445,-0.0363257,0.003928449,-0.04402546,-0.02862594,2.496025e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.04083104,0.004418366,-0.04949104,-0.03217105,2.600149e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.03656064,0.003957423,-0.04431719,-0.02880409,2.700462e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.04002808,0.004338865,0.0315239,0.04853225,3.040447e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0373622,0.00405268,-0.04530545,-0.02941895,3.228622e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.01804921,0.001958263,-0.02188741,-0.01421102,3.25266e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.05837967,0.006337426,-0.07080102,-0.04595831,3.450973e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.03388008,0.003687312,-0.04110721,-0.02665295,4.305888e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.04455282,0.004860377,-0.05407916,-0.03502648,5.193492e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.02863564,0.003124389,-0.03475945,-0.02251184,5.258047e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,29443,-0.03028886,0.00330742,-0.0367714,-0.02380631,5.627415e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.04125096,0.004511435,-0.05009337,-0.03240855,6.41228e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.04569152,0.004999584,-0.05549071,-0.03589234,6.694054e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.04521037,0.004948399,-0.05490924,-0.03551151,6.951882e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.02370292,0.002595469,-0.02879004,-0.0186158,7.208981e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.03420203,0.003749314,-0.04155069,-0.02685338,7.81674e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.03529297,0.003869864,-0.0428779,-0.02770803,8.068435e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.04130409,0.004539497,0.03240667,0.0502015,9.822011e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.07320067,0.008049856,-0.08897839,-0.05742295,1.018217e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.02781092,0.003058497,-0.03380557,-0.02181626,1.033561e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.04643933,0.005112408,-0.05645965,-0.03641901,1.126279e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.05257218,0.005790712,-0.06392197,-0.04122238,1.18035e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.03491928,0.003847071,-0.04245954,-0.02737902,1.186787e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.08097464,0.008931885,-0.09848114,-0.06346815,1.331305e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0319139,0.003525954,-0.03882477,-0.02500303,1.515901e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0586207,0.006477956,-0.07131749,-0.0459239,1.541943e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0778888,0.008607607,-0.09475971,-0.06101789,1.550293e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.01860731,0.002058008,-0.02264101,-0.01457362,1.638135e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.04295928,0.004752524,-0.05227422,-0.03364433,1.671503e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.02424579,0.00268285,-0.02950417,-0.0189874,1.719637e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.03785154,0.004188723,-0.04606143,-0.02964164,1.731931e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.01791519,0.001984225,-0.02180427,-0.01402611,1.837442e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.01875287,0.002078857,-0.02282743,-0.0146783,1.978764e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.01751252,0.001949159,-0.02133287,-0.01369217,2.744906e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.04538056,0.005052235,0.03547818,0.05528294,2.80642e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.01786359,0.00198907,-0.02176216,-0.01396501,2.871698e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.03776469,0.004207082,-0.04601057,-0.02951881,2.960102e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.03647487,0.00406576,-0.04444376,-0.02850598,3.102525e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,24229,0.01964318,0.002189989,0.0153508,0.02393556,3.188284e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.03182036,0.003551402,-0.0387811,-0.02485961,3.436159e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.04261957,0.004759167,-0.05194753,-0.0332916,3.587796e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,24951,-0.04612098,0.005151845,-0.05621859,-0.03602336,3.717737e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.01970607,0.002201867,-0.02402173,-0.01539041,3.81391e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,29640,-0.04488308,0.005018339,-0.05471903,-0.03504714,3.973237e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.04063972,0.004551739,-0.04956113,-0.03171831,4.61471e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,29218,0.02714466,0.003041525,0.02118328,0.03310605,4.724902e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.05357614,0.006004138,-0.06534425,-0.04180803,4.834395e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.03122243,0.003503134,-0.03808857,-0.02435628,5.265793e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,24951,-0.0587922,0.006609122,-0.07174608,-0.04583832,6.195009e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,29757,0.02949564,0.003324175,0.02298025,0.03601102,7.505392e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0638653,0.007199846,-0.077977,-0.0497536,7.770433e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,29014,-0.03521615,0.0039719,-0.04300108,-0.02743123,7.983601e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.04542509,0.005123678,-0.0554675,-0.03538268,8.100704e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.05174466,0.005841439,-0.06319388,-0.04029544,8.686479e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.02915976,0.003293067,-0.03561417,-0.02270534,8.924139e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.03325346,0.003756485,-0.04061618,-0.02589075,9.056342e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.02159553,0.002441257,-0.02638039,-0.01681067,9.671506e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.04695448,0.005313529,-0.057369,-0.03653996,1.050707e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.06878661,0.00779341,-0.0840617,-0.05351153,1.152397e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.05372003,0.006087491,-0.06565152,-0.04178855,1.158514e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.02161009,0.002456487,-0.0264248,-0.01679537,1.494173e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.03286162,0.003736511,-0.04018518,-0.02553806,1.509843e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.01865969,0.002122505,0.01449958,0.0228198,1.5555e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.04970649,0.005658639,0.03861556,0.06079743,1.658755e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.04339908,0.004945624,-0.0530925,-0.03370565,1.812975e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.02301163,0.00262385,-0.02815438,-0.01786888,1.87982e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.07435845,0.008498122,-0.09101477,-0.05770213,2.270119e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.01648829,0.001886216,-0.02018528,-0.01279131,2.421685e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,29795,-0.02132487,0.002440581,-0.02610841,-0.01654133,2.50308e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.05590998,0.006400196,-0.06845437,-0.0433656,2.571973e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.01777618,0.002038626,-0.02177189,-0.01378048,2.965288e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0435807,0.005010371,-0.05340103,-0.03376037,3.586563e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,29581,0.04044207,0.004651302,0.03132552,0.04955862,3.651286e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.04264496,0.004911924,-0.05227233,-0.03301759,4.126005e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.05908489,0.006824521,-0.07246095,-0.04570883,5.100043e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.06924586,0.008004398,-0.08493448,-0.05355724,5.365931e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.02546552,0.002947161,-0.03124196,-0.01968909,5.91862e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,24966,0.01900447,0.002199492,0.01469347,0.02331548,5.931904e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,24177,-0.02721705,0.003159761,-0.03341018,-0.02102392,7.502998e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,29443,-0.04034622,0.004691067,-0.04954071,-0.03115173,8.313477e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.02670767,0.003105432,-0.03279432,-0.02062103,8.33433e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,24240,-0.03209847,0.00374091,-0.03943066,-0.02476629,1.001302e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.06393519,0.007467008,-0.07857053,-0.04929985,1.159013e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.05154546,0.006021209,-0.06334703,-0.03974389,1.175853e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0219136,0.002562374,-0.02693585,-0.01689134,1.267153e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.03493815,0.004085764,-0.04294625,-0.02693005,1.275847e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.03722771,0.004357652,-0.0457687,-0.02868671,1.368637e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,28654,-0.04344139,0.005085853,-0.05340966,-0.03347311,1.388208e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.06137742,0.007190352,-0.07547051,-0.04728433,1.46923e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.01587778,0.001860852,-0.01952505,-0.01223051,1.499114e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.02091207,0.002450995,-0.02571602,-0.01610812,1.505282e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),24484,0.1102476,0.01292577,0.08491314,0.1355821,1.556386e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.02403844,0.002820363,-0.02956636,-0.01851053,1.624753e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.03125541,0.003666864,-0.03844246,-0.02406836,1.631422e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.02248783,0.002643627,-0.02766934,-0.01730632,1.896491e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,29581,-0.02193971,0.002583558,-0.02700348,-0.01687593,2.12392e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.02832406,0.003336741,0.02178405,0.03486408,2.191688e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,29443,-0.02379891,0.002803769,-0.0292943,-0.01830352,2.196058e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,29820,-0.05377291,0.006337786,-0.06619497,-0.04135085,2.265404e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.02751565,0.003249956,0.02114574,0.03388557,2.667119e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,29478,-0.04159976,0.004923281,-0.0512494,-0.03195013,3.05564e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.07204235,0.008525403,-0.08875214,-0.05533256,3.062518e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,0.02411877,0.002856799,0.01851945,0.0297181,3.244307e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.04498523,0.005329914,-0.05543186,-0.0345386,3.3163e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,28774,0.04512004,0.005347576,0.03463879,0.05560129,3.39263e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,24966,-0.01632178,0.001934978,-0.02011434,-0.01252923,3.485166e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0549934,0.006520513,-0.06777361,-0.0422132,3.497738e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.04486393,0.005320667,-0.05529244,-0.03443543,3.579256e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.03686432,0.00437207,-0.04543357,-0.02829506,3.59059e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.03246228,0.003852017,-0.04001223,-0.02491233,3.6947e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,24776,-0.05756025,0.006829924,-0.07094691,-0.0441736,3.715759e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,29566,-0.03405994,0.004042354,-0.04198295,-0.02613692,3.744219e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,29349,-0.05001152,0.005938081,-0.06165016,-0.03837288,3.862099e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,28353,0.01914479,0.002273762,0.01468822,0.02360137,3.944296e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.03417327,0.004060221,-0.04213131,-0.02621524,4.089072e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,24867,0.02826851,0.003364085,0.0216749,0.03486211,4.580877e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.04618283,0.005501081,-0.05696495,-0.03540071,4.860455e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.02647033,0.003155246,-0.03265461,-0.02028604,5.153655e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.04469148,0.005328402,-0.05513515,-0.03424782,5.234879e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.04899139,0.005844767,-0.06044713,-0.03753564,5.478483e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.02875947,0.003437623,-0.03549721,-0.02202173,6.265113e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.0433944,0.005189665,-0.05356614,-0.03322266,6.501696e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.02764184,0.003307739,-0.034125,-0.02115867,6.7266e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,28277,-0.01389508,0.001663508,-0.01715556,-0.01063461,6.963127e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.01501464,0.001799292,-0.01854125,-0.01148803,7.440896e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,28931,-0.06835623,0.008202546,-0.08443322,-0.05227924,8.189443e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0509357,0.006115279,-0.06292164,-0.03894975,8.49239e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,24101,-0.03853601,0.004636836,-0.0476242,-0.02944781,9.998355e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,29545,-0.01398786,0.00168406,-0.01728862,-0.0106871,1.031353e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.02154447,0.002595717,-0.02663207,-0.01645686,1.095046e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.02030371,0.002447666,-0.02510114,-0.01550628,1.129873e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.03443594,0.004152513,0.02629702,0.04257487,1.152323e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.03638585,0.004389632,-0.04498952,-0.02778217,1.198541e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,29023,-0.04486849,0.005415803,-0.05548346,-0.03425351,1.234155e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0270134,0.003262767,0.02061838,0.03340843,1.290752e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0216202,0.002613857,-0.02674336,-0.01649704,1.379607e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,24587,-0.03206791,0.00387672,-0.03966628,-0.02446954,1.384312e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.01402078,0.001697518,-0.01734792,-0.01069365,1.521759e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.04077842,0.004955431,-0.05049107,-0.03106578,1.96543e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.03447496,0.004196009,-0.04269914,-0.02625079,2.187709e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,24805,-0.02011669,0.002448968,-0.02491667,-0.01531672,2.236105e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.04470412,0.005451785,-0.05538962,-0.03401863,2.503575e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,29518,-0.02241586,0.002736098,-0.02777861,-0.01705311,2.657941e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,28916,-0.02952526,0.003608629,-0.03659818,-0.02245235,2.908858e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.04043788,0.004946982,-0.05013397,-0.0307418,3.122218e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.04229602,0.005191605,-0.05247156,-0.03212047,3.879587e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.01764838,0.002167447,-0.02189658,-0.01340018,4.023156e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.01177135,0.001446908,-0.01460729,-0.008935411,4.291932e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,28797,-0.03407621,0.004189976,-0.04228857,-0.02586386,4.36222e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.03915556,0.004823722,-0.04861005,-0.02970106,4.951092e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,29218,-0.01938639,0.002390535,-0.02407183,-0.01470094,5.27395e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.01895558,0.002338375,-0.02353879,-0.01437236,5.45611e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.01758714,0.002178557,-0.02185711,-0.01331717,7.17606e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,24538,-0.01918271,0.002376863,-0.02384137,-0.01452406,7.313522e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.02682221,0.00332481,-0.03333883,-0.02030558,7.518183e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0396935,0.004930569,-0.04935741,-0.03002958,8.623146e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0276777,0.003441001,-0.03442207,-0.02093334,9.058868e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.03934045,0.004900129,-0.04894471,-0.0297362,1.03124e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.01131674,0.001410553,-0.01408142,-0.008552053,1.077855e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.04332028,0.005400929,-0.0539061,-0.03273446,1.0886e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.03042063,0.003794348,-0.03785755,-0.02298371,1.12893e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.02455249,0.003062988,-0.03055595,-0.01854904,1.133662e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.02225157,0.002775682,-0.02769191,-0.01681123,1.134522e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,29373,-0.03853096,0.004810076,-0.04795871,-0.02910321,1.184739e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.04119592,0.005148432,-0.05128684,-0.03110499,1.273574e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0306615,0.003832984,-0.03817415,-0.02314885,1.306053e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,29349,-0.04252439,0.005320893,-0.05295334,-0.03209544,1.376453e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.02825368,0.003535405,0.02132429,0.03518307,1.390331e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.02543681,0.003184936,-0.03167929,-0.01919434,1.437553e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,29786,-0.04457664,0.00559932,-0.05555131,-0.03360197,1.765727e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,24805,-0.03265842,0.004107883,-0.04070987,-0.02460697,1.941245e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.02074386,0.00261081,0.01562667,0.02586105,2.005277e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.03901251,0.004925667,-0.04866682,-0.0293582,2.468981e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.05067565,0.006402202,-0.06322397,-0.03812733,2.567757e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,24111,-0.02270411,0.002870369,-0.02833003,-0.01707819,2.687645e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.02492824,0.003155102,-0.03111223,-0.01874424,2.882729e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,29531,0.01599315,0.00202583,0.01202252,0.01996377,3.012575e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,24805,-0.01983735,0.002519404,-0.02477538,-0.01489931,3.579723e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.04418747,0.005627259,-0.0552169,-0.03315804,4.219808e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.02225075,0.002833631,-0.02780467,-0.01669683,4.22282e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,28774,-0.03478171,0.004431077,-0.04346662,-0.02609679,4.321787e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.03842884,0.004898989,-0.04803086,-0.02882683,4.50275e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.02672965,0.00340961,-0.03341249,-0.02004682,4.704352e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.02305652,0.002945285,-0.02882928,-0.01728376,5.147474e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,24381,0.01212925,0.001550001,0.009091253,0.01516726,5.268445e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.04274905,0.005466024,-0.05346246,-0.03203565,5.457195e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.03193537,0.004089542,-0.03995087,-0.02391987,5.995382e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.03798005,0.004868274,-0.04752187,-0.02843823,6.321769e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,24229,-0.02251844,0.002886537,-0.02817606,-0.01686083,6.378815e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.02909848,0.003732796,-0.03641476,-0.0217822,6.638691e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.03673594,0.004724879,-0.0459967,-0.02747518,7.835514e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,29443,-0.06765097,0.008737062,-0.08477562,-0.05052633,1.002148e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,29434,-0.01742512,0.002252677,-0.02184037,-0.01300988,1.064522e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.02308785,0.002988581,-0.02894547,-0.01723023,1.158775e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0555152,0.007193716,-0.06961488,-0.04141551,1.233917e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.06612341,0.008572945,-0.08292638,-0.04932044,1.276055e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.03551615,0.004610315,-0.04455237,-0.02647993,1.365021e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.05802002,0.007538976,-0.07279641,-0.04324362,1.448032e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.03943239,0.005126754,-0.04948083,-0.02938395,1.507963e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,24454,-0.01396911,0.001818137,-0.01753266,-0.01040556,1.609796e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,29541,0.01512717,0.001971404,0.01126322,0.01899112,1.727873e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,29169,0.01777242,0.002317792,0.01322955,0.02231529,1.803752e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.04514887,0.005890401,-0.05669405,-0.03360368,1.845873e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,29725,-0.01566938,0.002044956,-0.01967749,-0.01166126,1.879603e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.02578811,0.003367983,-0.03238936,-0.01918687,1.965296e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0656919,0.0086038,-0.08255535,-0.04882845,2.322402e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.05290059,0.006929503,-0.06648242,-0.03931877,2.355684e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.05238796,0.006863302,-0.06584003,-0.03893588,2.361912e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.03378079,0.0044265,-0.04245673,-0.02510485,2.406108e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.02269915,0.00297513,-0.02853041,-0.01686789,2.426674e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.02609976,0.003421888,-0.03280666,-0.01939286,2.483025e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,29313,-0.01352085,0.001777772,-0.01700528,-0.01003642,2.922963e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.04246087,0.005585846,-0.05340913,-0.03151261,3.032957e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.03175226,0.004179693,-0.03994445,-0.02356006,3.127725e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,24326,-0.06245566,0.008230683,-0.07858779,-0.04632352,3.361364e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.03392949,0.004472279,-0.04269516,-0.02516382,3.402171e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.04739907,0.006251295,-0.0596516,-0.03514653,3.517166e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.03649401,0.004817496,-0.0459363,-0.02705172,3.688168e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.01507904,0.001993738,-0.01898676,-0.01117131,4.046126e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.02298217,0.003039454,0.01702484,0.0289395,4.129172e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.0222891,0.002948621,0.01650981,0.0280684,4.175081e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.03847078,0.005102032,0.0284708,0.04847076,4.850079e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.03088247,0.0040963,-0.03891122,-0.02285372,4.870403e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.02177594,0.002890842,-0.02744199,-0.01610989,5.111475e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.03709079,0.004924985,0.02743782,0.04674376,5.200815e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0381294,0.005069225,-0.04806508,-0.02819372,5.560742e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.01098728,0.001461123,0.008123477,0.01385108,5.643535e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0262055,0.003489956,-0.03304581,-0.01936518,6.138426e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0385142,0.005131611,-0.04857216,-0.02845625,6.30711e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.02294192,0.003057534,-0.02893468,-0.01694915,6.431921e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.04742036,0.006321473,-0.05981044,-0.03503027,6.525982e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,29135,-0.01857615,0.002477909,-0.02343285,-0.01371945,6.730419e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.05154699,0.006877768,-0.06502741,-0.03806656,6.869769e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.06049293,0.00807346,-0.07631691,-0.04466895,6.935014e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.02301883,0.003072192,-0.02904032,-0.01699733,6.943087e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.02739062,0.003656659,-0.03455767,-0.02022357,7.047483e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,24240,-0.01619297,0.002161927,-0.02043035,-0.0119556,7.119046e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.06654917,0.008899882,-0.08399294,-0.0491054,7.831264e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.01936884,0.002592174,-0.02444951,-0.01428818,8.156656e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.01299495,0.001744038,-0.01641326,-0.009576634,9.512968e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.02638799,0.003546515,-0.03333916,-0.01943682,1.035298e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.04708377,0.006334881,-0.05950014,-0.03466741,1.094953e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.05072852,0.00683257,-0.06412035,-0.03733668,1.162554e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,28628,-0.0599068,0.008078605,-0.07574087,-0.04407274,1.245356e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.03326825,0.004486904,-0.04206258,-0.02447392,1.260744e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.03978119,0.005368695,-0.05030383,-0.02925855,1.305482e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.04986063,0.006737944,-0.063067,-0.03665426,1.398156e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0137256,0.001857114,0.01008565,0.01736554,1.497983e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.02544437,0.003443319,-0.03219328,-0.01869547,1.513088e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.04087784,0.005532163,-0.05172088,-0.0300348,1.52607e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.01926831,0.002608972,-0.02438189,-0.01415473,1.569444e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.03341838,0.004526125,-0.04228958,-0.02454717,1.592332e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.02232152,0.003024867,-0.02825026,-0.01639278,1.632984e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,29443,0.02605427,0.003535548,0.0191246,0.03298394,1.761238e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.02100478,0.002851955,-0.02659461,-0.01541495,1.825967e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.02273047,0.00309248,-0.02879174,-0.01666921,2.041145e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.01866985,0.00254035,-0.02364893,-0.01369076,2.043894e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,28774,-0.04346072,0.005930706,-0.0550849,-0.03183653,2.396062e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.02233163,0.003048775,-0.02830723,-0.01635603,2.465817e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.03745513,0.005115024,-0.04748058,-0.02742969,2.507867e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.01571543,0.002148036,-0.01992558,-0.01150528,2.615929e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.03188844,0.004358473,-0.04043104,-0.02334583,2.626274e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,24966,-0.02824196,0.003860262,-0.03580807,-0.02067584,2.630383e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0664896,0.009095691,-0.08431715,-0.04866204,2.753503e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.00979445,0.001340176,-0.01242119,-0.007167704,2.786086e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.01308597,0.00179427,-0.01660274,-0.009569204,3.103801e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,28931,-0.03702827,0.005081026,-0.04698708,-0.02706946,3.236966e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.04945048,0.006788023,-0.062755,-0.03614595,3.298679e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.02342162,0.003222573,-0.02973786,-0.01710537,3.74172e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.01246063,0.00171509,0.009099052,0.0158222,3.813581e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.01277603,0.001761224,-0.01622803,-0.00932403,4.144481e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,24195,-0.02362153,0.003256339,-0.03000395,-0.01723911,4.167767e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,24240,-0.02731464,0.003771081,-0.03470596,-0.01992332,4.513574e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.02922364,0.004038371,-0.03713885,-0.02130843,4.739848e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.03173677,0.004404857,-0.04037029,-0.02310325,5.944491e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.02755113,0.003829696,-0.03505734,-0.02004493,6.469704e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,29349,0.0152016,0.002114926,0.01105635,0.01934686,6.742974e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.03645775,0.005087646,-0.04642953,-0.02648596,7.948057e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0250644,0.003499783,-0.03192397,-0.01820482,8.191468e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.01872327,0.002616164,-0.02385095,-0.01359559,8.495669e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.05658226,0.007919403,-0.07210429,-0.04106023,9.229642e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.034174,0.004784543,-0.04355171,-0.0247963,9.377237e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.01979739,0.002775092,-0.02523657,-0.01435821,9.982947e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.03003257,0.004216427,-0.03829677,-0.02176838,1.086749e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.01754379,0.002465299,-0.02237578,-0.0127118,1.138848e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,29694,-0.01535191,0.002158011,-0.01958161,-0.01112221,1.153489e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,24966,-0.01185244,0.001666526,-0.01511883,-0.00858605,1.174016e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.03067888,0.004314034,-0.03913439,-0.02222338,1.175329e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.01110748,0.001561961,0.00804604,0.01416893,1.181773e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.01443608,0.002031867,0.01045362,0.01841854,1.232161e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.02094269,0.002949135,-0.026723,-0.01516239,1.264141e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.05101969,0.007202606,-0.0651368,-0.03690258,1.437119e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.01793477,0.002534014,-0.02290144,-0.01296811,1.506203e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.05225816,0.007401946,-0.06676597,-0.03775034,1.709254e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.05408698,0.007671727,-0.06912356,-0.0390504,1.833749e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.01961173,0.002782761,-0.02506594,-0.01415752,1.869573e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.02806466,0.003987583,-0.03588033,-0.020249,2.000775e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0188095,0.002674422,-0.02405137,-0.01356763,2.06498e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.01937445,0.002760095,-0.02478423,-0.01396466,2.285088e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.04758688,0.006780879,-0.0608774,-0.03429636,2.30258e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.01869265,0.002666186,-0.02391837,-0.01346692,2.426478e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.02522191,0.003602925,-0.03228364,-0.01816018,2.61762e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.01740671,0.002487311,0.01253158,0.02228184,2.660099e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.02118888,0.00302789,0.01525422,0.02712355,2.664828e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,28797,-0.03394273,0.004855216,-0.04345895,-0.0244265,2.7892e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,28916,-0.02372786,0.003395226,-0.0303825,-0.01707321,2.836755e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.03793645,0.00543418,-0.04858744,-0.02728546,3.004092e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.02071074,0.002967016,-0.02652609,-0.01489538,3.019306e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.03346012,0.004794763,-0.04285786,-0.02406239,3.058981e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0321167,0.004610904,0.02307932,0.04115407,3.343982e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.03857727,0.0055384,-0.04943254,-0.02772201,3.358479e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.01355523,0.001947042,-0.01737143,-0.009739026,3.426296e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.01169358,0.001680346,-0.01498706,-0.008400106,3.498423e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.02976043,0.004293767,-0.03817621,-0.02134465,4.278835e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.014215,0.002051424,-0.01823579,-0.01019421,4.33174e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.01978559,0.002856973,-0.02538526,-0.01418592,4.45465e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0246628,0.003562926,-0.03164613,-0.01767947,4.544453e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.04001213,0.005782595,0.02867824,0.05134601,4.628211e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.03273797,0.004732188,-0.04201306,-0.02346288,4.671173e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.06332949,0.009155339,-0.08127395,-0.04538502,4.71761e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.01454393,0.002103082,0.01042189,0.01866597,4.755484e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.02387548,0.003453524,-0.03064438,-0.01710657,4.847419e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.02921937,0.004228686,0.02093114,0.03750759,4.951294e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.02319367,0.003362451,-0.02978408,-0.01660327,5.406345e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.03059172,0.004450197,-0.0393141,-0.02186933,6.383444e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.03633773,0.005288781,-0.04670374,-0.02597172,6.513498e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.01926348,0.002805007,-0.02476129,-0.01376566,6.686572e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,29536,-0.01482772,0.002162399,-0.01906603,-0.01058942,7.16695e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,29434,-0.04643605,0.006778319,-0.05972155,-0.03315054,7.494986e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.01801943,0.002635315,-0.02318465,-0.01285422,8.209411e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.03611504,0.005290708,-0.04648483,-0.02574525,8.896952e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.02666231,0.003908503,-0.03432298,-0.01900165,9.176805e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.01351977,0.001983087,0.009632921,0.01740662,9.439386e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,29434,0.02101846,0.003083263,0.01497526,0.02706165,9.4787e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.03086835,0.004535578,-0.03975809,-0.02197862,1.023944e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.01748611,0.002571364,0.01244624,0.02252598,1.063746e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.01759892,0.002587821,-0.02267105,-0.01252679,1.064918e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.01629656,0.002396642,-0.02099398,-0.01159914,1.06806e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.02629322,0.003869449,-0.03387734,-0.0187091,1.103602e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.0138809,0.002042813,0.009876989,0.01788482,1.108133e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.035805,0.005270895,-0.04613595,-0.02547404,1.119629e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,24229,-0.02522021,0.003715304,-0.0325022,-0.01793821,1.161687e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.02376832,0.003502866,-0.03063394,-0.0169027,1.184453e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.01597999,0.002366572,-0.02061848,-0.01134151,1.481478e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.02377383,0.003524283,-0.03068142,-0.01686623,1.556226e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.04255259,0.006309371,-0.05491896,-0.03018623,1.565446e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.01891395,0.002807252,-0.02441616,-0.01341173,1.640789e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,28774,-0.03539643,0.005254441,-0.04569514,-0.02509773,1.653282e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.02189072,0.003252301,-0.02826523,-0.01551621,1.724725e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.04374119,0.006499278,0.03100261,0.05647977,1.726672e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.02518138,0.003752978,-0.03253721,-0.01782554,1.986175e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.03721817,0.005554639,-0.04810526,-0.02633108,2.116127e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.03656576,0.005461686,-0.04727067,-0.02586086,2.197067e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,24938,0.02416747,0.003610565,0.01709076,0.03124418,2.22455e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.01405057,0.00210047,-0.0181675,-0.009933653,2.282787e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.03307822,0.00494713,-0.04277459,-0.02338184,2.337992e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,28916,-0.02154424,0.003223368,-0.02786204,-0.01522644,2.371093e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.01711211,0.002567448,0.01207991,0.02214431,2.701423e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.03377391,0.00508207,-0.04373477,-0.02381306,3.080494e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.02530972,0.003815293,-0.0327877,-0.01783175,3.339578e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,28774,-0.0325213,0.004906379,-0.0421378,-0.0229048,3.45411e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.03855759,0.005818018,-0.0499609,-0.02715427,3.479798e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.03062002,0.004625598,-0.03968619,-0.02155384,3.674868e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.01479354,0.002239111,0.01040488,0.0191822,4.005886e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.02228573,0.003377925,0.015665,0.02890646,4.253481e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.03583941,0.005450787,-0.04652295,-0.02515587,4.945571e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.02044721,0.003109891,0.01435182,0.02654259,4.949224e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.02042104,0.003113222,-0.02652295,-0.01431912,5.491583e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,24647,-0.02082797,0.0031752,-0.02705136,-0.01460458,5.503036e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.009912272,0.001513789,-0.0128793,-0.006945246,5.928044e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.01427066,0.002179976,0.009997902,0.01854341,5.996738e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.05634091,0.008609132,-0.07321481,-0.03946702,6.074355e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.01607889,0.002458705,-0.02089795,-0.01125983,6.27194e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,29618,0.01953123,0.002987636,0.01367546,0.02538699,6.363548e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.04030647,0.006167446,-0.05239467,-0.02821828,6.44967e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0247786,0.003795129,-0.03221705,-0.01734014,6.728359e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,29349,-0.02056836,0.003152255,-0.02674678,-0.01438994,6.912373e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,28890,-0.02608712,0.0040056,-0.0339381,-0.01823615,7.504243e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.02615465,0.004016105,0.01828308,0.03402621,7.513227e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,24240,-0.01372404,0.002115168,-0.01786977,-0.009578312,8.843189e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,29395,-0.01883903,0.002904601,-0.02453205,-0.01314602,8.958766e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.03854116,0.005945594,-0.05019452,-0.02688779,9.176032e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.03827607,0.00593351,-0.04990575,-0.02664639,1.129954e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.01889406,0.002932952,-0.02464265,-0.01314548,1.201272e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.01221825,0.001898009,0.008498156,0.01593835,1.237416e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.01887576,0.0029326,0.01312786,0.02462366,1.241183e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0106624,0.001659496,-0.01391502,-0.007409791,1.338129e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,29443,0.01113777,0.00173614,0.007734933,0.0145406,1.427295e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,29434,-0.02968184,0.00464376,-0.03878361,-0.02058007,1.664317e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.04062563,0.006365172,-0.05310137,-0.02814989,1.768737e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.03538829,0.005545974,0.02451818,0.0462584,1.78678e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.02768843,0.004341273,0.01917954,0.03619733,1.826296e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0146533,0.00229891,0.01014744,0.01915916,1.868555e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.02991215,0.004696109,-0.03911652,-0.02070777,1.928903e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.01848078,0.002917671,-0.02419942,-0.01276215,2.422233e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,24240,0.02955371,0.004688226,0.02036479,0.03874264,2.954098e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.03928838,0.006241971,-0.05152264,-0.02705411,3.132827e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.02258784,0.003590436,-0.02962509,-0.01555058,3.205879e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.03989112,0.006344808,-0.05232694,-0.02745529,3.286166e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.01014213,0.001613927,-0.01330543,-0.006978836,3.351642e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.02640137,0.004211248,-0.03465542,-0.01814733,3.678582e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.01512162,0.0024123,0.01039352,0.01984973,3.703944e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.01942573,0.00310087,-0.02550343,-0.01334802,3.799143e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,28916,-0.03450457,0.005518227,-0.0453203,-0.02368885,4.08696e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,29296,-0.01389572,0.002224407,-0.01825556,-0.009535885,4.243404e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.01731806,0.002777604,-0.02276216,-0.01187396,4.593623e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.02313691,0.003713614,-0.03041559,-0.01585822,4.720076e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.01672442,0.002685574,-0.02198814,-0.01146069,4.816705e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.01348745,0.002166707,-0.01773419,-0.009240699,4.886372e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.06036452,0.009743792,-0.07946235,-0.04126669,5.899221e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.01522366,0.002457718,0.01040653,0.02004079,5.934592e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.01449501,0.00234158,-0.01908451,-0.009905516,6.102501e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,29566,-0.01333684,0.002156661,-0.0175639,-0.009109788,6.330576e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.02399992,0.003885287,-0.03161508,-0.01638476,6.631704e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.01645349,0.002677033,-0.02170047,-0.0112065,8.058623e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0226523,0.003689325,-0.02988337,-0.01542122,8.383325e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.02123292,0.003467112,0.01443738,0.02802846,9.236519e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.04330696,0.007107315,-0.0572373,-0.02937662,1.122404e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.02378132,0.003904099,-0.03143336,-0.01612929,1.133589e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.02221779,0.003647533,0.01506862,0.02936695,1.137293e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.03199521,0.005254285,-0.04229361,-0.02169681,1.148e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0160066,0.002631604,-0.02116454,-0.01084865,1.201426e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.01859068,0.003060771,-0.02458979,-0.01259157,1.264435e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.06570457,0.01082195,-0.08691559,-0.04449354,1.283386e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,29439,0.0258637,0.004259956,0.01751419,0.03421322,1.283868e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,24281,-0.01882878,0.003101397,-0.02490752,-0.01275005,1.289493e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.02605834,0.004295356,-0.03447724,-0.01763945,1.322411e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.02047472,0.003375353,-0.02709041,-0.01385903,1.33071e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.01834313,0.003024916,-0.02427197,-0.0124143,1.346741e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.04289702,0.007083409,-0.0567805,-0.02901354,1.415588e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.02376077,0.003927649,-0.03145896,-0.01606258,1.472718e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,24805,-0.01948614,0.003231126,-0.02581914,-0.01315313,1.655032e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,-0.005942037,0.000985455,-0.007873528,-0.004010545,1.665743e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.02035001,0.003388873,-0.0269922,-0.01370781,1.936861e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,24101,-0.01907739,0.003176771,-0.02530387,-0.01285092,1.937411e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.02554323,0.004256201,-0.03388539,-0.01720108,1.979414e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.02034812,0.003390963,-0.02699441,-0.01370183,1.988318e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.02254351,0.003757014,-0.02990726,-0.01517977,1.991547e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.01308107,0.002195714,-0.01738467,-0.008777468,2.589383e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.009924442,0.001670288,-0.01319821,-0.006650678,2.851156e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0516245,0.00869062,-0.06865811,-0.03459088,2.884658e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.02109215,0.003556807,-0.02806349,-0.01412081,3.061408e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.01054121,0.00177955,0.00705329,0.01402913,3.192441e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0225621,0.003816381,-0.03004221,-0.01508199,3.419752e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.01060361,0.001800011,-0.01413163,-0.00707559,3.891271e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.008996683,0.001527911,-0.01199139,-0.006001977,3.945602e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,-0.009487221,0.001613304,-0.0126493,-0.006325144,4.132221e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.01023419,0.001740559,-0.01364568,-0.006822695,4.160712e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.02553698,0.004345594,-0.03405434,-0.01701961,4.23509e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0476545,0.008122484,-0.06357457,-0.03173443,4.495235e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.01389714,0.002370192,-0.01854271,-0.009251562,4.594797e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.03706369,0.006332317,-0.04947503,-0.02465235,4.885713e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.02903454,0.004967762,-0.03877135,-0.01929772,5.142796e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.009721434,0.001669434,0.006449344,0.01299352,5.832836e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.02064673,0.003548572,-0.02760193,-0.01369153,6.007084e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.017295,0.002974802,-0.02312561,-0.01146439,6.17032e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.01017766,0.00175266,0.006742447,0.01361287,6.426029e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,24793,-0.03418366,0.0058879,-0.04572395,-0.02264338,6.486086e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.01918921,0.003312617,-0.02568194,-0.01269649,7.009745e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.01485931,0.002565693,-0.01988807,-0.009830549,7.045944e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,29121,-0.02390881,0.004130326,-0.03200425,-0.01581338,7.170247e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,24381,-0.01516878,0.002621947,-0.0203078,-0.01002977,7.326322e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0248084,0.004289349,0.01640128,0.03321552,7.381383e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.01667277,0.002890254,0.01100787,0.02233767,8.073861e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.02479285,0.004319486,-0.03325904,-0.01632666,9.593928e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.04125716,0.00720677,-0.05538243,-0.02713189,1.047985e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.02151731,0.003759393,-0.02888572,-0.0141489,1.054859e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0243185,0.004250186,-0.03264886,-0.01598814,1.064425e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.02378892,0.004158401,-0.03193938,-0.01563845,1.071493e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,29396,-0.01070802,0.00187208,-0.01437729,-0.007038739,1.076527e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.05002619,0.00874638,-0.06716909,-0.03288329,1.077803e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0109473,0.001913993,0.007195876,0.01469873,1.080231e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.02579608,0.004516828,0.0169431,0.03464906,1.133366e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.03379991,0.005934739,-0.045432,-0.02216782,1.243459e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.01476911,0.002598839,0.009675384,0.01986283,1.339072e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0240579,0.004234694,-0.0323579,-0.0157579,1.353361e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,28845,-0.01806485,0.003183693,-0.02430489,-0.01182481,1.406901e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.02861929,0.005046095,-0.03850963,-0.01872894,1.430911e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.04905798,0.008672393,-0.06605587,-0.03206009,1.556524e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0185126,0.003275659,-0.02493289,-0.01209231,1.604961e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.01283284,0.002272067,-0.01728609,-0.008379593,1.640118e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,29443,0.008002406,0.001418926,0.00522131,0.0107835,1.718466e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,28847,-0.03625307,0.006434577,-0.04886484,-0.0236413,1.776116e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.04630144,0.008232122,-0.0624364,-0.03016648,1.880671e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.01253235,0.002230095,0.008161363,0.01690333,1.933972e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.02172978,0.003886901,-0.0293481,-0.01411145,2.287799e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.01852598,0.003315788,-0.02502492,-0.01202703,2.327864e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.01717037,0.003074042,0.01114525,0.02319549,2.349394e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.01283442,0.002299842,-0.01734211,-0.008326733,2.418634e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.02117515,0.003794986,-0.02861332,-0.01373697,2.430024e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0246509,0.004425208,-0.03332431,-0.01597749,2.566145e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.03919828,0.007069715,-0.05305492,-0.02534164,2.972861e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.02142639,0.003864276,-0.02900037,-0.01385241,2.973847e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.02140081,0.003862708,-0.02897172,-0.0138299,3.044325e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.02411587,0.004359573,-0.03266063,-0.0155711,3.20337e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.02672421,0.004835544,-0.03620188,-0.01724654,3.29852e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,24229,-0.01306027,0.002368892,-0.0177033,-0.008417245,3.558773e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.03031914,0.00550358,-0.04110616,-0.01953212,3.63924e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,29434,-0.02217249,0.004026532,-0.0300645,-0.01428049,3.688888e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.02890663,0.005260039,-0.03921631,-0.01859696,3.933788e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.01027938,0.00187055,-0.01394566,-0.006613107,3.936999e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.02217783,0.004037383,-0.0300911,-0.01426456,3.988854e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.01461333,0.002662742,-0.01983231,-0.009394359,4.096667e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.01698757,0.003096642,-0.02305699,-0.01091816,4.149511e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.02495226,0.004548535,-0.03386739,-0.01603713,4.157686e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,28931,-0.03239014,0.005907244,-0.04396833,-0.02081194,4.213791e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,29349,-0.01651226,0.003020949,-0.02243333,-0.0105912,4.642625e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.02872559,0.005258928,-0.03903309,-0.01841809,4.739479e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.02374959,0.004356247,-0.03228784,-0.01521135,5.033831e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.03607431,0.006630412,-0.04906992,-0.0230787,5.357509e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.03049679,0.005616325,-0.04150478,-0.01948879,5.687394e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.01302887,0.002399874,-0.01773262,-0.008325117,5.712958e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.01229463,0.002265932,0.007853404,0.01673586,5.822986e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.02465139,0.004553137,-0.03357554,-0.01572724,6.216685e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.01430953,0.002644433,-0.01949262,-0.00912644,6.320657e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.02233383,0.004128838,-0.03042635,-0.01424131,6.388257e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.01563415,0.002895041,-0.02130843,-0.009959865,6.71343e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.007328048,0.001360201,0.004662053,0.009994042,7.210306e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.01227927,0.002285332,0.007800019,0.01675852,7.798357e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,28797,-0.02883767,0.005369605,-0.03936209,-0.01831324,7.910973e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.008845018,0.001648616,-0.01207631,-0.00561373,8.161826e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.02754712,0.005134807,-0.03761134,-0.0174829,8.165395e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,29117,0.02598302,0.004851803,0.01647348,0.03549255,8.604652e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0144579,0.002700682,-0.01975124,-0.009164564,8.707137e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.01953402,0.003652399,-0.02669272,-0.01237532,8.947495e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.0129479,0.002421111,0.008202521,0.01769328,8.963782e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,29725,0.01766569,0.003307379,0.01118322,0.02414815,9.296278e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.01688956,0.003162345,-0.02308776,-0.01069137,9.322031e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.0104985,0.00196659,0.006643989,0.01435302,9.458033e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,24938,0.02000812,0.003748838,0.0126604,0.02735584,9.524213e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.01532192,0.002874291,-0.02095553,-0.009688313,9.870136e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.01202562,0.002259102,-0.01645346,-0.007597784,1.027127e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,24229,-0.0242625,0.004561351,-0.03320275,-0.01532225,1.051799e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.02446551,0.004600672,-0.03348283,-0.01544819,1.059476e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.02358545,0.004462457,-0.03233187,-0.01483904,1.264046e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.01265785,0.002396283,-0.01735457,-0.007961139,1.28676e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,24966,0.008654052,0.001638665,0.005442267,0.01186584,1.294445e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,29349,0.005778458,0.001094381,0.003633473,0.007923444,1.300191e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.04164466,0.007894924,-0.05711871,-0.02617061,1.337934e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.01149753,0.002181514,-0.0157733,-0.007221766,1.372343e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,28751,-0.03298868,0.006272003,-0.0452818,-0.02069555,1.453454e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.01100101,0.002094023,-0.01510529,-0.00689672,1.502707e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,29208,-0.01724732,0.003284319,-0.02368458,-0.01081005,1.519917e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.01453163,0.002769769,-0.01996037,-0.009102881,1.56067e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.02128734,0.004066863,-0.02925839,-0.01331628,1.66958e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,29725,0.01684943,0.003220078,0.01053808,0.02316078,1.682623e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.0139675,0.002685481,-0.01923105,-0.008703961,1.99667e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.01115203,0.002151847,-0.01536965,-0.006934408,2.205978e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.01084858,0.002095829,-0.0149564,-0.006740751,2.281727e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,24381,0.0350283,0.006771824,0.02175552,0.04830107,2.326185e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.02627118,0.0050796,-0.0362272,-0.01631517,2.335238e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,29694,-0.02440511,0.004720487,-0.03365726,-0.01515295,2.355612e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0230492,0.004467022,-0.03180456,-0.01429384,2.490586e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.02161386,0.004193845,-0.0298338,-0.01339393,2.570288e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.01176517,0.002289818,0.007277126,0.01625321,2.79788e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.01581815,0.00309924,-0.02189266,-0.009743641,3.348152e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,29478,-0.01055392,0.002068327,-0.01460785,-0.006500004,3.370283e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.02195711,0.004314318,0.01350104,0.03041317,3.614657e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.03209801,0.006309463,-0.04446456,-0.01973146,3.659215e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.009416901,0.001851765,0.005787441,0.01304636,3.696377e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,24793,-0.02488088,0.004899714,-0.03448432,-0.01527745,3.841347e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.02447612,0.004829793,-0.03394251,-0.01500972,4.05053e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.03261994,0.006448327,-0.04525866,-0.01998122,4.2526e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.01679756,0.003321065,-0.02330685,-0.01028828,4.270007e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.0128336,0.002539209,-0.01781045,-0.00785675,4.348947e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.02805287,0.005553966,-0.03893864,-0.0171671,4.428105e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,29786,-0.0152347,0.003016483,-0.021147,-0.009322391,4.432923e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.02290074,0.004535105,-0.03178955,-0.01401194,4.458206e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0117932,0.002335588,-0.01637095,-0.007215446,4.465125e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.01799267,0.003566159,0.011003,0.02498234,4.552851e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.01029401,0.00204551,-0.01430321,-0.006284812,4.869911e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.01787578,0.003557225,0.01090362,0.02484794,5.058336e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.02266996,0.004514602,-0.03151858,-0.01382134,5.162975e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.007437786,0.001481957,0.00453315,0.01034242,5.233994e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.01634827,0.00325849,-0.02273491,-0.00996163,5.281142e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.02157043,0.004322112,-0.03004177,-0.01309909,6.056212e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0154164,0.003091307,-0.02147536,-0.009357433,6.167608e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.03305617,0.006629298,-0.04604959,-0.02006274,6.193665e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.01803496,0.003627432,-0.02514473,-0.01092519,6.676788e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.01753654,0.003536872,-0.02446881,-0.01060427,7.154217e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.01928545,0.003898992,-0.02692747,-0.01164342,7.615809e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.02149355,0.004352003,-0.03002348,-0.01296363,7.904203e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.02583178,0.005247518,-0.03611691,-0.01554664,8.592947e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.05141909,0.01046547,0.03090676,0.07193142,9.016419e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,28452,-0.02133987,0.004349267,-0.02986444,-0.01281531,9.320692e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,24195,-0.01667246,0.003401203,-0.02333881,-0.0100061,9.55148e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,29274,0.01014919,0.002074071,0.006084011,0.01421437,9.965211e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.01006357,0.002056638,0.006032558,0.01409458,9.97262e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,29497,0.01174197,0.002402134,0.007033783,0.01645015,1.023284e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.016193,0.003318935,-0.02269811,-0.009687886,1.071977e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.01908755,0.003913759,-0.02675852,-0.01141658,1.082651e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.0108876,0.002232643,-0.01526358,-0.006511624,1.08639e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.01020504,0.002097667,0.006093616,0.01431647,1.152093e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.00964971,0.00198898,-0.01354811,-0.005751309,1.232189e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.01121717,0.002315332,-0.01575522,-0.006679116,1.274266e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.02356673,0.004874223,-0.0331202,-0.01401325,1.338355e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0182001,0.003777685,-0.02560436,-0.01079584,1.458704e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,29333,-0.0118836,0.002470306,-0.0167254,-0.007041797,1.512425e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.01095713,0.002283051,-0.01543191,-0.006482345,1.599879e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,24867,0.01233714,0.0025721,0.007295824,0.01737846,1.623774e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,24329,0.01064566,0.002219453,0.006295536,0.01499579,1.623975e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.01552199,0.003243697,-0.02187964,-0.009164344,1.715811e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.01055143,0.002210542,0.006218765,0.01488409,1.821837e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.005818869,0.001220088,0.003427497,0.008210242,1.859837e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.01200171,0.002516861,-0.01693476,-0.007068665,1.864709e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.03737082,0.007839963,-0.05273715,-0.02200449,1.881571e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.008968279,0.001882908,0.005277778,0.01265878,1.916395e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.01749829,0.003681999,-0.024715,-0.01028157,2.021836e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.02111817,0.004447084,-0.02983445,-0.01240188,2.05842e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.009751724,0.002055463,-0.01378043,-0.005723016,2.102189e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.008290929,0.001752313,0.004856396,0.01172546,2.239886e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.02191253,0.00465992,-0.03104597,-0.01277908,2.58361e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.1000162,0.02131727,-0.141798,-0.05823432,2.720397e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,-0.006867406,0.001466423,-0.009741594,-0.003993218,2.838312e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.02490337,0.005318735,-0.03532809,-0.01447865,2.850815e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0193969,0.004149156,-0.02752924,-0.01126455,2.953979e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.01250133,0.002676213,-0.01774671,-0.007255957,3.009287e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.01611691,0.003462531,-0.02290347,-0.009330348,3.259628e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.007302391,0.001570782,-0.01038112,-0.004223658,3.351794e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.03217952,0.00693477,-0.04577167,-0.01858737,3.496996e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.02313104,0.004987208,-0.03290597,-0.01335611,3.53462e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,28879,-0.01428994,0.003084918,-0.02033637,-0.008243498,3.633887e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.03483453,0.007534618,-0.04960238,-0.02006668,3.793699e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.02831834,0.006134586,-0.04034213,-0.01629455,3.925227e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.02210054,0.004801258,-0.03151101,-0.01269008,4.180476e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.03215434,0.00700448,-0.04588312,-0.01842556,4.442685e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,24845,0.01238718,0.002704489,0.007086387,0.01768798,4.667163e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.01096858,0.002409848,0.006245275,0.01569188,5.350875e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,28580,0.02196656,0.004826774,0.01250609,0.03142704,5.361589e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.02032046,0.004471844,-0.02908528,-0.01155565,5.543353e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0787317,0.01733248,-0.1127034,-0.04476004,5.586902e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.01155624,0.002549851,-0.01655395,-0.006558537,5.862688e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.02285301,0.005044569,0.01296566,0.03274037,5.915997e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.01046798,0.00231196,0.005936536,0.01499942,5.989925e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.009002005,0.001989086,0.005103395,0.01290061,6.04309e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,29566,-0.01043045,0.002306516,-0.01495122,-0.00590968,6.144736e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,28443,-0.01172101,0.002592473,-0.01680226,-0.006639767,6.174649e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.01442448,0.003195252,-0.02068718,-0.008161791,6.381198e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.008791583,0.001957177,-0.01262765,-0.004955516,7.088506e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.01165117,0.00259443,-0.01673626,-0.00656609,7.121824e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,24938,0.01018747,0.002272706,0.005732971,0.01464198,7.409146e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,-0.02963938,0.0066134,-0.04260165,-0.01667712,7.432421e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0181893,0.00407375,-0.02617385,-0.01020475,8.037123e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,24845,-0.01237759,0.00277839,-0.01782324,-0.006931948,8.427851e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.01973139,0.004438444,-0.02843074,-0.01103204,8.803987e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.01362792,0.003065962,-0.01963721,-0.007618634,8.82563e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,29632,-0.01969662,0.004438943,-0.02839695,-0.01099629,9.145125e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.01516349,0.003419508,-0.02186573,-0.008461258,9.266223e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.02204601,0.004980567,-0.03180792,-0.0122841,9.622448e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0130313,0.002948427,-0.01881022,-0.007252384,9.92454e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.01376201,0.003118892,-0.01987504,-0.00764898,1.026425e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.01731862,0.003939929,-0.02504088,-0.00959636,1.108889e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.02790621,0.006360655,-0.04037309,-0.01543933,1.15247e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.009084167,0.002073177,-0.01314759,-0.00502074,1.182071e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.01480154,0.003379146,0.008178414,0.02142467,1.190222e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.02431586,0.005558643,-0.0352108,-0.01342092,1.222587e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,28916,0.007225344,0.001653299,0.003984877,0.01046581,1.245324e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.02308438,0.005287035,-0.03344697,-0.01272179,1.268395e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.00901462,0.002065112,0.004967001,0.01306224,1.274357e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,29820,0.005421561,0.001242602,0.002986062,0.007857061,1.286793e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.0142748,0.003278888,-0.02070143,-0.007848184,1.344015e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,-0.02128276,0.004894,-0.030875,-0.01169052,1.373734e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,29694,-0.00840885,0.001942412,-0.01221598,-0.004601723,1.502258e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.007273447,0.001681655,-0.01056949,-0.003977404,1.529094e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.02010809,0.0046534,-0.02922876,-0.01098743,1.558186e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.01482217,0.003438549,-0.02156173,-0.008082614,1.633615e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.01286667,0.002995364,0.006995759,0.01873759,1.749596e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.01261293,0.002940538,-0.01837638,-0.006849475,1.797876e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,29478,-0.01243735,0.002902851,-0.01812694,-0.006747766,1.837057e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.01186988,0.002772636,-0.01730425,-0.006435516,1.865779e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.01096471,0.002561764,-0.01598577,-0.005943656,1.873747e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.01803192,0.004224313,-0.02631157,-0.009752266,1.974411e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0108643,0.002545442,0.005875238,0.01585337,1.977253e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.02624053,0.006149163,-0.03829289,-0.01418817,1.985784e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,24966,-0.0079967,0.001874086,-0.01166991,-0.004323492,1.988605e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.008669561,0.002037278,0.004676495,0.01266263,2.093861e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,21656,-0.03231552,0.007635049,-0.04728022,-0.01735082,2.32036e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.01296803,0.003064506,-0.01897446,-0.006961595,2.328073e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.01347593,0.003184755,-0.01971805,-0.007233814,2.331e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.008966226,0.002120523,-0.01312245,-0.004810002,2.363092e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.006568909,0.001553649,-0.009614062,-0.003523757,2.365677e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.01366375,0.003243455,-0.02002092,-0.00730658,2.532104e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.008281104,0.001965875,0.004427989,0.01213422,2.533842e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.01300814,0.003091362,-0.01906721,-0.006949069,2.585226e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,29434,-0.01978712,0.004706263,-0.02901139,-0.01056284,2.625224e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.007605485,0.001818344,-0.01116944,-0.004041531,2.891453e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.006571507,0.001575971,-0.00966041,-0.003482603,3.05717e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0296744,0.007126298,-0.04364194,-0.01570685,3.13714e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.01341129,0.003226208,-0.01973465,-0.007087919,3.235598e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.01441582,0.00346942,0.007615754,0.02121588,3.262539e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.01161131,0.002795352,-0.0170902,-0.006132424,3.281291e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.008304616,0.002000058,0.004384503,0.01222473,3.304433e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.01030916,0.002486309,0.005435997,0.01518233,3.387263e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,24914,-0.006782017,0.00163586,-0.009988302,-0.003575731,3.396875e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-0.008982942,0.002168395,-0.013233,-0.004732888,3.442554e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.009515274,0.002298528,-0.01402039,-0.005010159,3.486774e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.01960418,0.004735481,-0.02888572,-0.01032263,3.487117e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,-0.01323992,0.003207338,-0.0195263,-0.006953538,3.67117e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.01210014,0.002934879,-0.01785251,-0.00634778,3.754232e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,29594,-0.01384829,0.003363956,-0.02044164,-0.007254933,3.854322e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.02355836,0.005729792,-0.03478875,-0.01232797,3.940913e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.01250417,0.0030424,0.006541072,0.01846728,3.970172e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,29443,0.00999492,0.002434847,0.00522262,0.01476722,4.054952e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.01587385,0.003883137,-0.0234848,-0.0082629,4.364892e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.009902022,0.002423341,-0.01465177,-0.005152274,4.398671e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,28745,-0.01656612,0.004064873,-0.02453327,-0.00859897,4.605202e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.00824536,0.002029627,-0.01222343,-0.00426729,4.867504e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.007634499,0.001881669,-0.01132257,-0.003946429,4.979376e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.01280252,0.003163699,-0.01900337,-0.006601666,5.208202e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.03171878,0.007848174,-0.0471012,-0.01633636,5.326734e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,24966,-0.006105043,0.001514063,-0.009072606,-0.003137479,5.541548e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,29478,0.0111653,0.002770503,0.005735109,0.01659548,5.590245e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.008024547,0.001991401,0.004121401,0.01192769,5.601138e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,24966,0.009242555,0.002299109,0.004736303,0.01374881,5.83541e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,29820,-0.0151988,0.003787893,-0.02262307,-0.007774529,6.023382e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.008155106,0.002038842,-0.01215124,-0.004158975,6.356508e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.01240387,0.003102016,-0.01848382,-0.006323915,6.389022e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.01110971,0.002782263,-0.01656294,-0.005656476,6.542004e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.01237004,0.003112634,0.006269281,0.01847081,7.083869e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.008781744,0.002217102,0.004436224,0.01312726,7.487995e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.01836054,0.004671644,0.009204115,0.02751696,8.506541e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.01092526,0.002781765,-0.01637752,-0.005473002,8.608133e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0227927,0.005811297,-0.03418284,-0.01140256,8.800349e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0157471,0.004022705,0.007862598,0.0236316,9.082026e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,29199,0.03600224,0.009198184,0.0179738,0.05403068,9.096313e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,28671,-0.01338749,0.003425086,-0.02010066,-0.00667432,9.302367e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,28916,-0.03286201,0.008422662,-0.04937043,-0.0163536,9.576791e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,29466,-0.01123225,0.002883405,-0.01688373,-0.00558078,9.821983e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.01640972,0.004214693,0.008148922,0.02467052,9.904309e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.01637208,0.004205166,-0.02461421,-0.008129959,9.910084e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-0.007345756,0.00189088,-0.01105188,-0.003639632,0.0001026637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.01053992,0.002714166,-0.01585969,-0.005220156,0.0001033219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.01057662,0.002731445,0.005222986,0.01593025,0.0001081556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,29349,-0.00793241,0.002050296,-0.01195099,-0.003913829,0.0001095595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.009640687,0.002492044,0.004756281,0.01452509,0.0001097563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,24793,0.03124707,0.00809145,0.01538783,0.04710631,0.0001128684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.00800465,0.002076545,-0.01207468,-0.003934622,0.0001161248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.01672892,0.004341156,0.008220252,0.02523758,0.000116656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.007887918,0.00204947,0.003870957,0.01190488,0.0001190192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.009281783,0.002412122,-0.01400954,-0.004554025,0.0001193485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.04012616,0.01048766,-0.06068198,-0.01957034,0.000130499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.01463135,0.003824814,-0.02212799,-0.007134718,0.0001308924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.01333859,0.003487106,-0.02017331,-0.006503858,0.0001310381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.01832339,0.004799681,-0.02773076,-0.008916016,0.0001350786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.01115606,0.002923668,0.005425673,0.01688645,0.0001360945
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.0091802,0.002406989,-0.0138979,-0.004462502,0.0001370791
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.005636623,0.001478295,-0.008534081,-0.002739165,0.000137674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.01038628,0.002730634,0.005034239,0.01573832,0.0001428992
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.008352097,0.002199579,-0.01266327,-0.004040924,0.0001467258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.01826878,0.004818156,-0.02771237,-0.008825199,0.0001499431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.007694941,0.002033033,0.003710196,0.01167969,0.0001540436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.009713252,0.00256716,-0.01474489,-0.004681617,0.0001548543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.01098914,0.002906171,-0.01668523,-0.005293042,0.0001563683
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.01953641,0.005169328,-0.02966829,-0.009404523,0.0001576414
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.007722123,0.002043346,0.003717165,0.01172708,0.0001577401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.007586959,0.002013722,0.003640064,0.01153385,0.0001651248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.01007348,0.002674773,0.004830922,0.01531603,0.0001662026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.01718168,0.004573737,0.00821716,0.02614621,0.0001726438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,28916,-0.01044149,0.002784147,-0.01589842,-0.004984564,0.0001769411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,28872,-0.01523097,0.004062674,-0.02319381,-0.007268124,0.0001778876
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,29341,-0.01947855,0.005198264,-0.02966715,-0.009289954,0.0001792148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.01020814,0.002727934,0.004861389,0.01555489,0.00018286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.01042306,0.002788265,-0.01588806,-0.004958061,0.0001857791
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,29218,-0.03545353,0.009504006,-0.05408138,-0.01682568,0.000191555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,24111,0.009752271,0.00261545,0.004625989,0.01487855,0.0001928984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,28931,-0.01279927,0.003439603,-0.01954089,-0.00605765,0.0001986945
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.009836532,0.002644782,-0.01502031,-0.004652759,0.0002002842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.006449051,0.001739595,-0.009858658,-0.003039444,0.0002099362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.01377359,0.003725859,-0.02107627,-0.006470905,0.0002188432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.007870238,0.002142982,0.003669992,0.01207048,0.0002406467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,28650,-0.008073987,0.002202598,-0.01239108,-0.003756895,0.0002471419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.01366203,0.003729905,-0.02097264,-0.006351415,0.000249958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.01482778,0.004055109,-0.02277579,-0.006879765,0.0002561431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.01582042,0.004332225,-0.02431158,-0.007329263,0.000260854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,24016,0.009276223,0.002543361,0.004291235,0.01426121,0.0002656433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.008279524,0.002270601,0.003829145,0.0127299,0.0002663927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.01233869,0.003385594,-0.01897446,-0.005702929,0.0002684886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,29293,-0.01474096,0.004045201,-0.02266956,-0.006812367,0.0002688331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.008490455,0.002331729,-0.01306064,-0.003920265,0.000271848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00744779,0.002047982,0.003433744,0.01146183,0.0002766801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.006814115,0.001877959,0.003133316,0.01049491,0.0002856958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.01553686,0.004298334,-0.02396159,-0.007112121,0.000301296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.005867768,0.001623769,0.002685181,0.009050355,0.0003023969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.01491033,0.004154102,-0.02305237,-0.006768292,0.0003321114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00818417,0.002286849,0.003701946,0.01266639,0.0003458561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,29434,-0.01583987,0.004431381,-0.02452538,-0.007154363,0.00035149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.01028671,0.002878455,-0.01592848,-0.004644941,0.0003525574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,28931,-0.01292925,0.003620849,-0.02002611,-0.005832383,0.0003565001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.007100973,0.001997862,-0.01101678,-0.003185164,0.0003796132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.006202092,0.001745623,-0.009623513,-0.002780671,0.0003815509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.02481294,0.006997752,-0.03852854,-0.01109735,0.0003919632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,24240,-0.01811625,0.005122793,-0.02815693,-0.008075576,0.0004063759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.01512436,0.004278474,-0.02351017,-0.006738548,0.0004084209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,24381,-0.009885077,0.002811403,-0.01539543,-0.004374728,0.0004387877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0149547,0.004254126,0.006616614,0.02329279,0.0004399968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.01544653,0.004398054,-0.02406672,-0.006826343,0.0004452048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.007201167,0.002054252,-0.0112275,-0.003174833,0.0004565614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.03001208,0.008571159,-0.04681155,-0.01321261,0.0004632978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.01328038,0.003797989,-0.02072444,-0.005836325,0.0004718962
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,-0.006973344,0.001994423,-0.01088241,-0.003064274,0.0004723641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,24914,-0.003736258,0.001070378,-0.005834199,-0.001638317,0.0004827785
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,-0.01532166,0.004396568,-0.02393894,-0.006704389,0.0004930167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,28722,-0.009076842,0.002613142,-0.0141986,-0.003955084,0.0005144056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.007604106,0.002193903,0.003304056,0.01190416,0.0005291524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.0214816,0.006205794,-0.03364496,-0.009318248,0.0005380251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.006468746,0.001874813,0.002794112,0.01014338,0.0005608036
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.01534907,0.004459108,0.006609214,0.02408892,0.0005780197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.009940952,0.002890044,-0.01560544,-0.004276466,0.0005831229
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.02255568,0.006561062,0.009695995,0.03541536,0.0005874326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.008515248,0.002480324,0.003653813,0.01337668,0.0005975039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.01562839,0.004563156,0.0066846,0.02457217,0.000616034
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.006977179,0.002037576,-0.01097083,-0.00298353,0.0006173248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.01717328,0.00503908,0.007296682,0.02704988,0.0006552472
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.00655796,0.001927993,-0.01033683,-0.002779094,0.000671197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.008468899,0.002494783,0.003579124,0.01335867,0.0006882737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.007138787,0.002107541,-0.01126957,-0.003008006,0.000706886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,24445,0.008341183,0.002464163,0.003511423,0.01317094,0.0007129126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,24805,-0.0074984,0.002231671,-0.01187248,-0.003124325,0.0007806189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,24867,-0.01516047,0.004516572,-0.02401295,-0.006307993,0.0007901598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.0133348,0.003975681,-0.02112713,-0.005542463,0.0007974517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,29820,0.009902212,0.002956247,0.004107967,0.01569646,0.0008103209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.008943068,0.002679587,0.003691077,0.01419506,0.0008466938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.01687983,0.005060648,-0.0267987,-0.006960964,0.0008526793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.01226373,0.003685964,0.005039237,0.01948822,0.0008787287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,28931,-0.01187756,0.003570356,-0.01887546,-0.004879662,0.0008798542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.0110898,0.003333876,-0.0176242,-0.004555406,0.0008808587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.007516681,0.002262088,-0.01195037,-0.003082989,0.0008922033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,28722,-0.01476819,0.004448931,-0.0234881,-0.006048289,0.0009029348
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,24111,0.00964372,0.00291002,0.003940082,0.01534736,0.000921167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.01171714,0.003537032,-0.01864972,-0.004784556,0.0009253438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,24867,-0.01642286,0.004994261,-0.02621161,-0.00663411,0.001009177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.01162367,0.003538377,-0.01855889,-0.004688449,0.001021133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.01545228,0.004706952,-0.02467791,-0.006226657,0.001029026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.01253877,0.003826792,-0.02003929,-0.00503826,0.001052178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.008732133,0.002669515,-0.01396438,-0.003499884,0.00107293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,24101,0.02269888,0.006940691,0.009095128,0.03630264,0.001075438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,-0.009931426,0.003045416,-0.01590044,-0.003962411,0.001111282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.01013912,0.003111749,0.00404009,0.01623815,0.001122237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.007482533,0.002297139,0.002980141,0.01198492,0.001125962
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,29536,0.01187561,0.003646541,0.004728387,0.01902283,0.001128516
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.009190699,0.00282925,-0.01473603,-0.003645369,0.001161904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.009333182,0.002873787,0.003700559,0.01496581,0.001164981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.009566415,0.002951102,-0.01535057,-0.003782256,0.001189784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.01389531,0.004296994,0.005473206,0.02231742,0.001223498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,24805,-0.01430694,0.004429722,-0.0229892,-0.005624685,0.001240554
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.007883953,0.002446713,0.003088395,0.01267951,0.001273208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.006381681,0.001983062,0.002494881,0.01026848,0.001291828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.009856041,0.003063185,0.003852198,0.01585988,0.001294429
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,24867,-0.005947948,0.001852357,-0.009578568,-0.002317327,0.001324352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.00916582,0.002857978,-0.01476746,-0.003564182,0.001342559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.01218292,0.00379943,-0.0196298,-0.004736033,0.001345017
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.006515816,0.002032355,-0.01049923,-0.0025324,0.001347439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.01432011,0.004470615,-0.02308251,-0.005557701,0.0013607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.01057087,0.0033236,-0.01708512,-0.004056611,0.001471832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.008739111,0.002760701,-0.01415008,-0.003328137,0.001549872
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00783507,0.002475617,0.002982861,0.01268728,0.001553315
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.01015373,0.003232189,-0.01648882,-0.003818638,0.001683216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.01005008,0.003201342,0.00377545,0.01632471,0.00169537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.01680322,0.005353326,-0.02729574,-0.006310703,0.001698172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,29311,-0.007884794,0.00251638,-0.0128169,-0.002952688,0.001729718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.01904262,0.00608662,-0.0309724,-0.007112848,0.001758143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.01065686,0.003426974,-0.01737373,-0.003939995,0.001874596
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.007060387,0.002270968,-0.01151148,-0.00260929,0.001879543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,29820,-0.005909857,0.001901359,-0.009636521,-0.002183193,0.001883901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.00670499,0.002157203,-0.01093311,-0.002476872,0.001884571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.007562769,0.00243346,-0.01233235,-0.002793186,0.001886882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,29216,-0.01160628,0.003734862,-0.01892661,-0.004285952,0.001888241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0170683,0.00550498,-0.02785806,-0.006278536,0.001933682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.009882847,0.003187771,-0.01613088,-0.003634816,0.001935872
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.01719391,0.005568758,-0.02810868,-0.006279144,0.002020308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.009495723,0.003088578,-0.01554934,-0.003442111,0.002111126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.01976446,0.006430431,-0.0323681,-0.007160812,0.002116991
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.009931721,0.003241659,-0.01628537,-0.003578069,0.002187645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,24938,-0.01938249,0.006354918,-0.03183813,-0.006926854,0.002290823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,29713,-0.004666558,0.001531206,-0.007667722,-0.001665394,0.00230852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,24111,0.01031692,0.003388172,0.003676101,0.01695773,0.002329465
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.003871394,0.001272818,0.001376671,0.006366117,0.002355369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,24111,0.01017733,0.003349234,0.003612835,0.01674183,0.002378519
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.01053086,0.003472903,0.003723966,0.01733775,0.002429158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.001785628,0.0005889115,0.0006313619,0.002939895,0.002431261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.008094796,0.002671608,-0.01333115,-0.002858445,0.00244866
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.009261582,0.003063676,0.003256776,0.01526639,0.002505201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00951953,0.0031491,0.003347295,0.01569177,0.002505961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.01383088,0.004597472,-0.02284192,-0.00481983,0.002628778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.007535825,0.00250999,0.002616244,0.01245541,0.002681416
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.006189697,0.002061986,0.002148204,0.01023119,0.002686039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.01169407,0.003898261,-0.01933466,-0.004053478,0.002703732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.005598001,0.001868307,0.00193612,0.009259883,0.002735062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.005649923,0.001900207,0.001925518,0.009374327,0.002948895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.005645266,0.001900184,-0.009369627,-0.001920905,0.002972067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.009744344,0.003284641,-0.01618224,-0.003306449,0.003013137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.01560219,0.005290724,-0.02597201,-0.005232375,0.003191408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,24445,0.008888245,0.003020146,0.002968759,0.01480773,0.003253694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.005795931,0.001970607,-0.009658322,-0.00193354,0.003272131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,28774,0.006923532,0.002367839,0.002282567,0.0115645,0.003458484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,29218,-0.008998501,0.003096171,-0.015067,-0.002930005,0.003659685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.007415315,0.002552153,0.002413095,0.01241753,0.003669848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.01131958,0.003908383,-0.01898001,-0.003659145,0.003779584
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,28797,0.01706372,0.005899637,0.005500427,0.028627,0.003826786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.009929,0.003437027,-0.01666557,-0.003192427,0.003870081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,24111,0.01504654,0.005236143,0.004783695,0.02530938,0.004061883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00800299,0.002789567,0.002535439,0.01347054,0.004122591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.009810761,0.003423833,-0.01652147,-0.003100048,0.004167425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.009712687,0.003396338,0.003055864,0.01636951,0.004243373
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.005392817,0.001887794,0.00169274,0.009092894,0.004284699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.008922144,0.003123698,-0.01504459,-0.002799696,0.004289457
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,29349,-0.0389816,0.01365092,-0.06573739,-0.0122258,0.004298531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,24343,-0.01194436,0.004184265,-0.02014552,-0.003743195,0.004312907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,24445,0.005884043,0.00207504,0.001816965,0.009951121,0.00457731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,29566,0.007694261,0.002719897,0.002363263,0.01302526,0.004674271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.006836295,0.002417172,-0.01157395,-0.002098638,0.004684601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.006922209,0.002447801,-0.0117199,-0.002124518,0.004688189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,24101,0.009734774,0.003452677,0.002967528,0.01650202,0.004813987
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,-0.004622537,0.001642981,-0.007842781,-0.001402294,0.004904301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,29523,-0.01122089,0.00399222,-0.01904564,-0.003396141,0.004946799
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.005081702,0.00180869,0.001536669,0.008626735,0.004964233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.01204114,0.004288713,0.003635263,0.02044702,0.004994687
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.005766505,0.002062869,0.001723281,0.009809728,0.005187209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.005679741,0.002036785,-0.009671841,-0.001687642,0.005297972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,24016,0.006287876,0.002256721,0.001864703,0.01071105,0.005335722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.01557251,0.005590206,-0.02652932,-0.004615711,0.00534508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.004866539,0.001747564,0.001441313,0.008291764,0.005360853
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,29426,0.01323966,0.004790518,0.003850246,0.02262908,0.005718169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,24966,-0.003912697,0.001416943,-0.006689905,-0.001135488,0.00576024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.01117018,0.004061144,-0.01913003,-0.003210342,0.005954865
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,24229,0.007960598,0.002896256,0.002283936,0.01363726,0.005989795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,24845,0.005280675,0.001921685,0.001514173,0.009047177,0.006001423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.006894046,0.002511158,0.001972176,0.01181592,0.00604869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.006364017,0.002321178,0.001814507,0.01091353,0.00611639
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.01038538,0.003792631,-0.01781894,-0.002951825,0.006180187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,24195,-0.007918225,0.002897373,-0.01359708,-0.002239374,0.006282541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.005907086,0.002162817,-0.01014621,-0.001667965,0.006314141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.007861404,0.002887295,-0.0135205,-0.002202305,0.00647862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.008509921,0.003128689,0.002377692,0.01464215,0.006533561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.02017883,0.007440021,-0.03476127,-0.005596386,0.00668843
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.00904414,0.003336754,0.002504102,0.01558418,0.006722918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.01376062,0.005078902,0.003805968,0.02371526,0.006746016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,29478,-0.01572451,0.005827606,-0.02714662,-0.004302405,0.006973851
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.01162554,0.004319309,-0.02009139,-0.003159696,0.007117436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.01024735,0.003809878,0.002779987,0.01771471,0.007157007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,24966,-0.002942114,0.001097833,-0.005093867,-0.0007903609,0.007368632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.007585555,0.002831753,0.00203532,0.01313579,0.007394721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.009339438,0.003488423,-0.01617675,-0.002502129,0.007426673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.009356762,0.003495559,-0.01620806,-0.002505466,0.007438046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.007141516,0.002675798,0.001896951,0.01238608,0.007614422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.007186351,0.002694288,0.001905547,0.01246715,0.007652486
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,24101,0.009541283,0.003578569,0.002527288,0.01655528,0.007675871
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.007698314,0.002889379,-0.0133615,-0.002035131,0.007718881
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.005663227,0.00212729,-0.009832714,-0.001493739,0.00776882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,24229,-0.007883509,0.002962084,-0.01368919,-0.002077824,0.007785074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.007057581,0.002652117,-0.01225573,-0.001859431,0.007793439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.01285393,0.004844128,-0.02234842,-0.00335944,0.00797108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,28774,-0.007430874,0.002801279,-0.01292138,-0.001940367,0.007990134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.01633884,0.006184877,0.004216486,0.0284612,0.008252611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,29242,0.009460136,0.003582263,0.002438901,0.01648137,0.008274796
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,28774,-0.01285077,0.004876513,-0.02240874,-0.003292808,0.008412334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.01389643,0.00529531,-0.02427524,-0.003517626,0.008687535
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.01225652,0.004671391,-0.02141244,-0.003100592,0.00870245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.006619862,0.002525103,-0.01156906,-0.001670659,0.008755741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.01335533,0.005114031,-0.02337883,-0.00333183,0.009019906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.00757247,0.002900495,-0.01325744,-0.0018875,0.009039807
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.009326597,0.003576927,-0.01633737,-0.002315819,0.009127868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.006268965,0.00240473,-0.01098224,-0.001555694,0.009141373
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.007258045,0.002827855,-0.01280064,-0.00171545,0.0102753
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,29478,-0.00857592,0.003342858,-0.01512792,-0.002023919,0.01030924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.009380216,0.003663649,0.002199465,0.01656097,0.01046172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.00529468,0.002069734,0.001238001,0.009351358,0.0105283
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.004236482,0.001656635,-0.007483487,-0.0009894777,0.01055541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,29218,0.002244829,0.0008778817,0.0005241814,0.003965478,0.01055996
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.006926239,0.002714885,-0.01224741,-0.001605064,0.01074002
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.005771605,0.002262911,0.001336299,0.01020691,0.01076129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00858684,0.003370373,0.001980909,0.01519277,0.01084845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.01023762,0.004021084,-0.01811895,-0.002356298,0.01090213
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.008919054,0.003503903,-0.0157867,-0.002051405,0.01091947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.009694819,0.003841269,-0.01722371,-0.002165932,0.01161377
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,28931,0.005536952,0.002194547,0.00123564,0.009838264,0.0116395
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,24101,-0.020262,0.008052314,-0.03604454,-0.004479467,0.01186601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.005742801,0.002290874,-0.01023291,-0.001252688,0.01218773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,24938,-0.007891116,0.003148069,-0.01406133,-0.001720901,0.01219434
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.01518487,0.00608573,-0.0271129,-0.003256842,0.01259555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,24195,-0.01361922,0.00546977,-0.02433997,-0.002898471,0.01278431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00284431,0.001144294,0.0006014936,0.005087126,0.01293709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.004689012,0.001886972,-0.008387478,-0.0009905464,0.01296389
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,-0.01515817,0.006101355,-0.02711683,-0.003199515,0.01298387
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00895417,0.003606796,-0.01602349,-0.001884849,0.01304993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.005314958,0.002150684,-0.009530299,-0.001099618,0.01346941
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,0.01860887,0.007536909,0.003836526,0.03338121,0.01355355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.01488627,0.006082652,-0.02680826,-0.00296427,0.01439885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.008670509,0.003546842,-0.01562232,-0.0017187,0.01450823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.007772703,0.003185555,0.001529014,0.01401639,0.01469505
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,29693,-0.005659802,0.002323671,-0.0102142,-0.001105407,0.01486819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.004845467,0.00199412,-0.008753942,-0.0009369927,0.01511093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.01050694,0.004328022,-0.01898986,-0.002024016,0.0152029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.007259493,0.002996353,0.001386641,0.01313234,0.01540974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,24657,-0.005219031,0.002164803,-0.009462045,-0.0009760175,0.01592234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.004600186,0.001913654,-0.008350949,-0.0008494235,0.01622978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.01094526,0.004555177,-0.01987341,-0.002017116,0.01627553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.007623604,0.003179902,-0.01385621,-0.001390996,0.01651657
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.008055653,0.003375456,0.001439759,0.01467155,0.01701532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.008729626,0.003658807,0.001558364,0.01590089,0.01704407
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.01887869,0.007928877,0.003338096,0.03441929,0.01727295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.009982063,0.004194378,0.001761083,0.01820304,0.01732638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.005531927,0.002333896,-0.01010636,-0.0009574903,0.01778369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.01480651,0.006272973,-0.02710154,-0.002511483,0.01826488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,24445,-0.007484018,0.003173199,-0.01370349,-0.001264549,0.01835634
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.01763081,0.007514427,-0.03235908,-0.002902529,0.01897086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.008850808,0.003773845,0.001454072,0.01624754,0.01901948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.01308872,0.005584269,-0.02403388,-0.00214355,0.01909364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.006952416,0.002972463,0.001126389,0.01277844,0.01934651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,24229,0.01751375,0.007494516,0.002824501,0.032203,0.01945375
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.005032482,0.002153971,-0.009254264,-0.0008106998,0.01947961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.009104245,0.003922705,0.001415744,0.01679275,0.02029999
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.003268308,0.001408542,0.0005075655,0.00602905,0.02033007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.007797796,0.003361491,0.001209275,0.01438632,0.02036302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,29218,-0.009402025,0.004053726,-0.01734733,-0.001456721,0.02038273
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,24016,0.007932229,0.003426263,0.001216754,0.0146477,0.02061445
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.008652353,0.003752715,0.001297031,0.01600768,0.0211398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.01018016,0.004425042,-0.01885324,-0.001507079,0.02142368
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.007595577,0.003302536,-0.01406855,-0.001122606,0.02146101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,24903,0.005992541,0.00260658,0.0008836447,0.01110144,0.02151287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,0.005671104,0.002477116,0.0008159565,0.01052625,0.02206343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,28830,-0.008053334,0.003524752,-0.01496185,-0.00114482,0.02233211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.003473081,0.001520305,0.0004932824,0.006452879,0.02235146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.01122762,0.004933198,-0.02089668,-0.001558547,0.0228589
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,29725,0.01027659,0.004541305,0.001375632,0.01917755,0.02364808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.006187942,0.002735177,0.0008269939,0.01154889,0.02368433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,29820,-0.005173884,0.002294516,-0.009671135,-0.0006766322,0.0241474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.006195215,0.002754097,0.000797184,0.01159325,0.02449263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.004230139,0.001891523,-0.007937525,-0.0005227538,0.02533683
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,24229,0.009231576,0.004128984,0.001138768,0.01732438,0.02537404
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00486421,0.00218388,-0.009144615,-0.0005838046,0.02593331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.008695038,0.003912312,-0.01636317,-0.001026907,0.02626005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.009388179,0.004224647,0.001107871,0.01766849,0.0262763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,24195,-0.00973169,0.004386871,-0.01832996,-0.001133423,0.02653907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,24016,0.006571236,0.002980965,0.0007285455,0.01241393,0.02750573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.004693129,0.002129359,0.0005195859,0.008866672,0.02753298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.004694686,0.00213408,-0.008877482,-0.0005118899,0.02782425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,24240,-0.01370478,0.006232784,-0.02592103,-0.001488518,0.02790009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.006034639,0.002748743,-0.01142218,-0.0006471024,0.02814146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.005431721,0.002479141,0.0005726044,0.01029084,0.02846359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.02716362,0.0124006,0.002858432,0.0514688,0.02849538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.006371041,0.002912761,0.0006620287,0.01208005,0.02873126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.006380149,0.002920082,0.0006567893,0.01210351,0.02890415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,24951,0.003564958,0.001632857,0.0003645584,0.006765357,0.02902565
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.009335016,0.004282656,0.0009410098,0.01772902,0.02928745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.005344623,0.002452161,0.0005383875,0.01015086,0.02930001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.008908641,0.004090887,-0.01692678,-0.000890503,0.02943956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,29519,-0.004805599,0.002209374,-0.009135973,-0.0004752259,0.02963089
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,24867,-0.005889154,0.002712969,-0.01120657,-0.0005717353,0.02996015
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.01365038,0.006305171,-0.02600852,-0.001292249,0.0304012
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.009770327,0.004513157,-0.01861611,-0.0009245396,0.03040867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.003987239,0.001844772,0.0003714858,0.007602992,0.03067646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.01412919,0.006553459,-0.02697397,-0.001284411,0.03109433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.01763751,0.008209357,-0.03372785,-0.00154717,0.03168655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.004945782,0.002302805,0.0004322835,0.00945928,0.03174588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.005181248,0.002420474,0.0004371185,0.009925377,0.03231691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.008821882,0.004121444,0.0007438514,0.01689991,0.03232578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.007855682,0.003671515,0.0006595138,0.01505185,0.0323947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,24374,0.005031314,0.002354217,0.0004170485,0.00964558,0.03259576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,24111,0.008025381,0.003757731,0.0006602293,0.01539053,0.03271401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.007485146,0.003506751,0.0006119134,0.01435838,0.03281223
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.004961048,0.002324519,0.0004049915,0.009517105,0.03283272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,24966,-0.01122952,0.005264119,-0.02154719,-0.000911848,0.03291645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,24445,-0.01111672,0.005213387,-0.02133495,-0.0008984766,0.03298883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.004528955,0.002127781,-0.008699405,-0.0003585044,0.03330506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,24111,-0.01134796,0.005358531,-0.02185068,-0.0008452354,0.03420761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00793436,0.003750481,-0.0152853,-0.0005834186,0.03439258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,24845,-0.007864007,0.003733356,-0.01518139,-0.0005466283,0.03517812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,24845,0.006019742,0.0028627,0.0004088505,0.01163063,0.03549155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.01190217,0.005676584,-0.02302828,-0.0007760657,0.03602766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.004992521,0.002381513,0.0003247557,0.009660286,0.0360602
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.005008543,0.002390829,0.0003225181,0.009694569,0.03618874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.006326811,0.003021362,0.0004049419,0.01224868,0.03626801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,24805,-0.0172546,0.008281032,-0.03348542,-0.001023779,0.03720411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.009355905,0.004492016,-0.01816026,-0.0005515531,0.03728128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.006515666,0.003130866,0.0003791693,0.01265216,0.0374343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,24966,-0.002906679,0.001405213,-0.005660898,-0.0001524609,0.03860362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.004870505,0.002355017,-0.009486338,-0.000254672,0.03863559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.006091325,0.00295991,0.0002899002,0.01189275,0.03960647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.004102763,0.001994984,0.0001925935,0.008012933,0.03973936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.01086244,0.00528845,0.0004970743,0.0212278,0.03998719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.007504141,0.0036536,-0.0146652,-0.0003430855,0.0399958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.01146471,0.005643588,0.0004032729,0.02252614,0.04221959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,24016,-0.01060497,0.005241845,-0.02087898,-0.0003309501,0.04307017
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,28114,-0.004106072,0.002031759,-0.00808832,-0.0001238239,0.04329501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.006746786,0.003351811,0.0001772364,0.01331634,0.04413859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.004280525,0.002133534,-0.008462251,-9.879921e-05,0.04483452
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.003149713,0.001573287,-0.006233356,-6.607052e-05,0.04529638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.01065619,0.005326393,0.0002164599,0.02109592,0.0454425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.003920835,0.001959797,7.963148e-05,0.007762038,0.04544287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,24938,0.01287309,0.006438076,0.0002544608,0.02549172,0.04556248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,28931,0.004104958,0.002064913,5.772869e-05,0.008152188,0.04682586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,28797,-0.004467494,0.002249849,-0.008877198,-5.779033e-05,0.04707764
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.008567286,0.00431735,-0.01702929,-0.0001052799,0.04722423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.007045238,0.003552414,-0.01400797,-8.250718e-05,0.04735148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.007824197,0.003951113,-0.01556838,-8.001501e-05,0.04768662
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.00639557,0.003232711,5.945596e-05,0.01273168,0.04789587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,24101,0.007692258,0.003902484,4.338941e-05,0.01534113,0.04872176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.004319355,0.002191828,-0.008615337,-2.337249e-05,0.04877162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.007542255,0.003853545,-0.0150952,1.069345e-05,0.05033239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,-0.006705529,0.003435156,-0.01343843,2.737692e-05,0.05094617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,29443,-0.007313237,0.003765638,-0.01469389,6.741289e-05,0.05213478
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,-0.01229075,0.006332017,-0.02470151,0.0001199999,0.05226193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,24229,0.003763467,0.001939856,-3.865124e-05,0.007565585,0.05238215
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.005726447,0.002969458,-9.369129e-05,0.01154658,0.05380887
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,28916,-0.00677139,0.00351679,-0.0136643,0.0001215174,0.05418332
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,28797,0.007675736,0.003999401,-0.0001630911,0.01551456,0.05496623
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,29434,0.008339195,0.004358124,-0.0002027286,0.01688112,0.05569599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,24229,0.003915625,0.002056558,-0.0001152297,0.007946479,0.05692598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.005109278,0.002683832,-0.0001510332,0.01036959,0.05695798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.004000995,0.002102,-0.0001189245,0.008120914,0.05699721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.006358758,0.00334853,-0.0002043601,0.01292188,0.05758032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.009525776,0.005034215,-0.0003412849,0.01939284,0.05847539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.005170385,0.002733787,-0.0001878383,0.01052861,0.05859757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.009524032,0.005037612,-0.01939775,0.0003496884,0.05869178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.006261996,0.003315204,-0.0127598,0.0002358037,0.05892092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,28774,-0.005200912,0.002762128,-0.01061468,0.0002128596,0.05971907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,24938,-0.01205584,0.006411089,-0.02462157,0.0005098937,0.06005612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.004667048,0.002486005,-0.009539618,0.0002055226,0.06048295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.005902725,0.003146192,-0.0002638114,0.01206926,0.0606469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.007796498,0.004164219,-0.0003653715,0.01595837,0.06118285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,29820,-0.002641844,0.001412573,-0.005410487,0.0001267987,0.0614609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.004518084,0.002426497,-0.0002378509,0.009274019,0.06261629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,24229,-0.004743904,0.002548608,-0.009739176,0.0002513684,0.06270401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.004459952,0.002397746,-0.009159535,0.0002396299,0.06288718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.01075733,0.005786802,-0.02209946,0.0005848012,0.06304756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.01047058,0.005635979,-0.0215171,0.0005759356,0.06320802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,24845,0.01015397,0.005466935,-0.0005612258,0.02086916,0.06327437
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.005963169,0.003218073,-0.000344254,0.01227059,0.06389096
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,29454,0.004808068,0.002596777,-0.0002816155,0.009897752,0.0641002
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.007103102,0.003839887,-0.0004230767,0.01462928,0.06435151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.007666683,0.004157365,-0.01581512,0.0004817523,0.06517786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.003950511,0.002144105,-0.008152957,0.000251934,0.06541438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.007137099,0.003877764,-0.01473752,0.0004633193,0.0657042
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,24445,0.004730754,0.002571077,-0.0003085558,0.009770064,0.06578188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,28931,0.006508056,0.003537996,-0.0004264162,0.01344253,0.06585557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.005787377,0.003148239,-0.01195792,0.0003831709,0.06602988
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,24111,0.00458684,0.002495662,-0.0003046574,0.009478337,0.06608573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.005464024,0.002988182,-0.0003928136,0.01132086,0.06747802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.002978153,0.001638024,-0.006188681,0.0002323745,0.06905324
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.003915965,0.002157834,-0.0003133905,0.00814532,0.06957186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.006886354,0.003799222,-0.0005601208,0.01433283,0.06991074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,24016,0.007272632,0.004023405,-0.000613241,0.01515851,0.07068416
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.00296882,0.001644923,-0.000255229,0.006192868,0.07111019
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.004907283,0.002722725,-0.0004292578,0.01024382,0.07150402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,29725,-0.004128563,0.002291218,-0.00861935,0.0003622243,0.07157009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00721047,0.004017858,-0.0006645317,0.01508547,0.07272876
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,24195,0.007707124,0.004298838,-0.0007185974,0.01613285,0.07301114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.006065983,0.003384965,-0.0005685485,0.01270052,0.07313729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.01001583,0.005597873,-0.0009560038,0.02098766,0.07359192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.005364761,0.003013111,-0.0005409366,0.01127046,0.07501133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.004992503,0.00281606,-0.0005269743,0.01051198,0.07626088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.007912766,0.004485242,-0.01670384,0.000878308,0.07771465
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.01079311,0.006125604,-0.02279929,0.001213074,0.07808756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.01474945,0.00837655,-0.03116749,0.001668592,0.07828422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,24922,0.003772572,0.002146558,-0.0004346806,0.007979825,0.07884512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,24203,0.008891292,0.005062851,-0.001031896,0.01881448,0.07906986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.004035087,0.002306792,-0.008556399,0.0004862249,0.08026562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00376926,0.00215756,-0.007998078,0.0004595579,0.08064984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.008241266,0.004722805,-0.001015432,0.01749796,0.08099867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.01159442,0.006662639,-0.02465319,0.00146435,0.08183403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.003195806,0.001837477,-0.006797262,0.0004056493,0.08200364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.003798136,0.002185679,-0.0004857943,0.008082066,0.08226985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.006001913,0.003460577,-0.0007808187,0.01278464,0.08286573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.01181985,0.006843786,-0.001593976,0.02523367,0.08416405
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,24229,0.004265287,0.002470094,-0.0005760978,0.009106672,0.08422156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.008778231,0.005096389,-0.001210692,0.01876715,0.08500244
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.009642898,0.005598887,-0.02061672,0.001330921,0.08503006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,28931,-0.004840397,0.002814768,-0.01035734,0.0006765484,0.085508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.005470071,0.003184678,-0.0007718983,0.01171204,0.08587862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.006277008,0.003661056,-0.0008986616,0.01345268,0.08644325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,28774,-0.007390836,0.004311453,-0.01584128,0.001059613,0.0864967
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.01204218,0.007041408,-0.02584334,0.001758979,0.08724233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.004885078,0.002856489,-0.0007136401,0.0104838,0.08724712
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.005193064,0.003040603,-0.0007665179,0.01115265,0.08766628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,24229,0.00674251,0.003948713,-0.0009969672,0.01448199,0.08773808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,24016,0.005489873,0.003218036,-0.0008174778,0.01179722,0.0880266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,24195,0.004278196,0.002510795,-0.000642963,0.009199355,0.08840877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.007812686,0.004591833,-0.001187307,0.01681268,0.0888751
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.006998734,0.004136053,-0.0151054,0.00110793,0.090632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.005630173,0.003327702,-0.01215247,0.0008921223,0.09067599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.004103537,0.0024433,-0.0006853307,0.008892405,0.09306641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.007135816,0.004254415,-0.01547447,0.001202837,0.09349978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,24016,0.003729663,0.00223295,-0.0006469186,0.008106244,0.09487599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.0079857,0.004781208,-0.001385468,0.01735687,0.09488761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,-0.003096371,0.001856798,-0.006735695,0.0005429537,0.09541056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.004313713,0.002593618,-0.009397204,0.0007697788,0.09628251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,29725,-0.003533298,0.002125682,-0.007699635,0.0006330382,0.09648419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.007443513,0.004478586,-0.001334517,0.01622154,0.09652122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.005276626,0.003185922,-0.0009677817,0.01152103,0.09768772
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.007210086,0.0043715,-0.01577822,0.001358054,0.09908904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.006121791,0.003716955,-0.001163441,0.01340702,0.09957302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.005979684,0.003632601,-0.001140214,0.01309958,0.09975286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.004217626,0.002562259,-0.0008044011,0.009239653,0.0997649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.004110973,0.002497543,-0.0007842121,0.009006157,0.09977547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.006511645,0.003972415,-0.01429758,0.001274289,0.101181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.007056079,0.004304578,-0.01549305,0.001380893,0.101184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.007067293,0.004319666,-0.01553384,0.001399253,0.1018372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.002597597,0.001588403,-0.0005156724,0.005710867,0.1019884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,29400,0.00835727,0.005116287,-0.001670653,0.01838519,0.1023822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.005184048,0.003185634,-0.01142789,0.001059795,0.1036821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.008140563,0.005011551,-0.0179632,0.001682077,0.1043117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,24793,-0.004108749,0.002530249,-0.009068038,0.0008505396,0.1044202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.005344735,0.003300868,-0.01181444,0.001124966,0.1054168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.007990321,0.004945017,-0.01768255,0.001701912,0.1061431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,24101,0.006189793,0.003836508,-0.001329763,0.01370935,0.1066724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,24381,-0.00400706,0.002488821,-0.00888515,0.0008710294,0.1074057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.004628891,0.002880731,-0.001017342,0.01027512,0.1081012
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.01292251,0.008056187,-0.02871263,0.002867621,0.1087167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.004274967,0.002665995,-0.0009503842,0.009500318,0.1088337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.008221547,0.00513048,-0.001834195,0.01827729,0.1090603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,29313,-0.007975373,0.005021172,-0.01781687,0.001866124,0.1122183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,0.007343197,0.004625966,-0.001723696,0.01641009,0.1124377
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.008021281,0.005061623,-0.01794206,0.001899499,0.1130418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,24229,-0.005671606,0.003582658,-0.01269362,0.001350403,0.1134181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,28797,-0.00450555,0.002851928,-0.01009533,0.001084229,0.1141577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.005794892,0.003676838,-0.01300149,0.00141171,0.1150266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,24195,-0.00401957,0.002561546,-0.009040201,0.001001061,0.1166152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.007678916,0.004924115,-0.01733018,0.001972351,0.1189007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.002574903,0.001657641,-0.005823879,0.0006740732,0.1203494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.003661198,0.002369482,-0.0009829864,0.008305383,0.1223238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,24101,0.01020544,0.006614477,-0.002758934,0.02316982,0.1228695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.008975081,0.005821157,-0.002434388,0.02038455,0.1231345
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,28931,-0.004961248,0.003233148,-0.01129822,0.001375722,0.124919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.002514154,0.001641854,-0.0007038793,0.005732187,0.1257084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.005280494,0.003471764,-0.01208515,0.001524164,0.1282772
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.004983956,0.003291994,-0.01143626,0.001468351,0.1300483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,24229,-0.001862147,0.001230594,-0.00427411,0.0005498168,0.1302393
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.004923985,0.003255243,-0.01130426,0.001456292,0.130386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.01285444,0.008521898,-0.02955736,0.003848479,0.1314628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.007817607,0.005191806,-0.002358332,0.01799355,0.132142
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.003827509,0.002547493,-0.008820596,0.001165578,0.1329909
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,29478,-0.01258675,0.008436029,-0.02912136,0.00394787,0.1357039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.006710002,0.004498862,-0.01552777,0.002107767,0.1358463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.008520741,0.005744426,-0.01977982,0.002738334,0.1380059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.003204292,0.002162861,-0.0074435,0.001034916,0.1384827
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,24101,0.008272916,0.005608325,-0.002719401,0.01926523,0.1401951
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.006314542,0.004298817,-0.002111139,0.01474022,0.14187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,24195,-0.006403318,0.004372577,-0.01497357,0.002166934,0.1430905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.003473216,0.002373681,-0.001179199,0.008125631,0.143418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.004778453,0.003272091,-0.01119175,0.001634846,0.1442002
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.007355797,0.005056024,-0.0172656,0.00255401,0.1457214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,24111,0.005381733,0.003701241,-0.001872699,0.01263617,0.1459497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,29757,-0.003132509,0.002166075,-0.007378015,0.001112998,0.1481405
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.004599388,0.003186396,-0.01084472,0.001645947,0.1489081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.006311892,0.004405387,-0.002322666,0.01494645,0.1519374
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.003896879,0.00272029,-0.001434889,0.009228646,0.1520049
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.008818135,0.006157814,-0.02088745,0.00325118,0.1521479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.002502628,0.001754734,-0.005941906,0.0009366497,0.1538168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.004773125,0.003350813,-0.01134072,0.001794469,0.154322
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,24195,-0.00235655,0.001660016,-0.005610182,0.0008970811,0.1557385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.003825278,0.002698031,-0.009113419,0.001462863,0.1562608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.003617967,0.00256099,-0.001401574,0.008637507,0.1577483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,29434,-0.003926582,0.002804352,-0.009423111,0.001569947,0.1614716
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,29349,-0.001923685,0.001379919,-0.004628326,0.000780956,0.1633111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,24111,0.006138837,0.004403659,-0.002492335,0.01477001,0.1633211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.006340898,0.004566474,-0.01529119,0.00260939,0.1649744
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.004320798,0.003123728,-0.001801708,0.0104433,0.1666107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.005615906,0.004076905,-0.002374827,0.01360664,0.1683728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,29676,0.00429396,0.003131861,-0.001844488,0.01043241,0.1703676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,29132,0.006725866,0.004905937,-0.00288977,0.0163415,0.1703965
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.007336821,0.005383004,-0.003213867,0.01788751,0.1729078
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.004971756,0.003648173,-0.01212217,0.002178663,0.172956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.002982548,0.002190013,-0.007274974,0.001309878,0.1732466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.01402416,0.01041822,-0.03444387,0.006395539,0.1782767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,29518,0.004386982,0.003267211,-0.002016752,0.01079072,0.1793698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.005901072,0.004400578,-0.0145262,0.002724061,0.1799386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.01296067,0.009675738,-0.03192512,0.006003772,0.1804177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.004295738,0.003211089,-0.01058947,0.001997996,0.1809799
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.004695063,0.003527443,-0.01160885,0.002218724,0.1831961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,24546,0.00329793,0.002481476,-0.001565763,0.008161624,0.1838539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.007976172,0.006003629,-0.01974328,0.003790942,0.1840063
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.004566907,0.003439446,-0.01130822,0.002174408,0.1842558
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,-0.003476618,0.00262986,-0.008631143,0.001677907,0.1861857
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.003257377,0.002468461,-0.001580807,0.008095561,0.1869818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.005838354,0.004426657,-0.002837893,0.0145146,0.1872123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.002110378,0.001609006,-0.001043274,0.005264029,0.1896642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.002578508,0.001973604,-0.006446771,0.001289756,0.1913938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.003567,0.00273167,-0.001787072,0.008921072,0.1916346
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.007551998,0.00578748,-0.003791463,0.01889546,0.1919444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.006413236,0.004920216,-0.01605686,0.003230387,0.1924329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.008173026,0.00627509,-0.0204722,0.00412615,0.192773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.003833565,0.002959058,-0.001966189,0.009633318,0.195148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.004621764,0.003568632,-0.002372755,0.01161628,0.1952954
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.004665336,0.003620121,-0.002430101,0.01176077,0.1975065
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.004605768,0.003585557,-0.002421923,0.01163346,0.1989677
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,-0.008250958,0.006433388,-0.0208604,0.004358483,0.1996699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.00472853,0.003688756,-0.002501432,0.01195849,0.1998983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,29599,-0.01034137,0.008100399,-0.02621815,0.005535413,0.2017361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.003988601,0.003146926,-0.01015658,0.002179374,0.2050013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,24016,0.005559922,0.004393892,-0.003052107,0.01417195,0.2057492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.003849837,0.003049809,-0.002127788,0.009827462,0.2068457
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.009924531,0.007862455,-0.02533494,0.00548588,0.2068643
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.004378027,0.003474806,-0.002432593,0.01118865,0.2077053
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.005204377,0.004159128,-0.01335627,0.002947514,0.21083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.004666581,0.0037357,-0.00265539,0.01198855,0.2116075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.003199269,0.002564207,-0.001826576,0.008225114,0.2121661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,28931,-0.003073165,0.002465569,-0.00790568,0.00175935,0.2126158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,-0.006378137,0.005134843,-0.01644243,0.003686156,0.2141988
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.004009962,0.00323448,-0.002329618,0.01034954,0.2150778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.005623591,0.0045423,-0.003279316,0.0145265,0.2157098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.008303115,0.006711774,-0.02145819,0.004851962,0.2160632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.004879666,0.003948555,-0.002859502,0.01261883,0.216541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.004757139,0.003854875,-0.01231269,0.002798416,0.2171939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.003653871,0.002992892,-0.009519939,0.002212197,0.2221528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,24445,0.005033781,0.004123485,-0.00304825,0.01311581,0.2221891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00580639,0.004759536,-0.01513508,0.0035223,0.2224961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.01330596,0.01099898,-0.03486396,0.008252029,0.2263862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,24195,-0.005028429,0.004193869,-0.01324841,0.003191554,0.2305415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,24951,0.00516475,0.004354709,-0.00337048,0.01369998,0.2356277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.002281362,0.001924052,-0.006052504,0.001489781,0.2357499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,29434,-0.002955995,0.002505949,-0.007867655,0.001955664,0.2381724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.005569518,0.004732833,-0.003706834,0.01484587,0.2392918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.007783311,0.006632585,-0.005216556,0.02078318,0.2406086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,29322,0.003061728,0.002609484,-0.00205286,0.008176317,0.2406818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.002579272,0.002200816,-0.006892872,0.001734329,0.2412238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.003099902,0.002651109,-0.002096272,0.008296077,0.2422982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00313548,0.002689429,-0.008406761,0.002135802,0.2436835
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,24240,0.001522186,0.001305954,-0.001037483,0.004081856,0.2437981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.002282718,0.001973459,-0.001585262,0.006150698,0.2474007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.003031159,0.002633029,-0.002129577,0.008191895,0.2496588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.003982005,0.003475593,-0.01079417,0.002830156,0.2519266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.007018253,0.006165255,-0.01910215,0.005065646,0.2549832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-0.002833107,0.002495231,-0.00772376,0.002057545,0.2562132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,29478,0.006306133,0.005555091,-0.004581846,0.01719411,0.2563013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.005191743,0.00457352,-0.003772356,0.01415584,0.2563134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.001959802,0.001727933,-0.005346551,0.001426948,0.2567266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,24229,-0.002660523,0.002346533,-0.007259727,0.001938681,0.2568854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.006532207,0.005761366,-0.00476007,0.01782448,0.2568919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.005680319,0.00502797,-0.004174503,0.01553514,0.2585953
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,24016,-0.006004726,0.005321247,-0.01643437,0.004424919,0.259144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,24016,0.005639588,0.005018919,-0.004197493,0.01547667,0.261166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,29590,-0.003328858,0.00296935,-0.009148785,0.002491069,0.2622659
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.005615211,0.005036414,-0.00425616,0.01548658,0.2648947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,24867,-0.002881962,0.002591997,-0.007962276,0.002198352,0.2662051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.005448671,0.004903792,-0.004162761,0.0150601,0.2665305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,24966,-0.001191328,0.00107251,-0.003293447,0.0009107908,0.2666714
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.002997536,0.002706126,-0.00230647,0.008301542,0.2680087
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,28774,-0.003580861,0.003235057,-0.009921572,0.00275985,0.2683495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,0.002456518,0.00222743,-0.001909244,0.00682228,0.2701038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.002586943,0.002353004,-0.00719883,0.002024944,0.2715933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.003951463,0.003603712,-0.003111812,0.01101474,0.2728718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.003105403,0.002835977,-0.008663918,0.002453111,0.2735259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.003624666,0.003310771,-0.01011378,0.002864446,0.2736108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.003244192,0.002967284,-0.002571685,0.009060068,0.2742641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.008369227,0.007692053,-0.02344565,0.006707198,0.2765903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.004545021,0.004184993,-0.01274761,0.003657566,0.2774774
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.003636335,0.003355936,-0.0029413,0.01021397,0.2785717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.004987434,0.00462416,-0.01405079,0.00407592,0.2807931
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.004313731,0.004016253,-0.01218559,0.003558126,0.2828011
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.004152072,0.003870566,-0.003434237,0.01173838,0.2834031
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.002727384,0.002550568,-0.002271729,0.007726497,0.2849325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.003762239,0.003540047,-0.003176254,0.01070073,0.2878973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.001817125,0.001729091,-0.001571894,0.005206144,0.2933086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,24101,-0.003618528,0.003466384,-0.01041264,0.003175584,0.2965461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.003589462,0.003461429,-0.003194939,0.01037386,0.2997501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,24793,-0.008253543,0.007967144,-0.02386915,0.007362059,0.3002367
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.003924229,0.003795408,-0.01136323,0.003514772,0.3011739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.002450568,0.002393807,-0.002241294,0.007142431,0.3059818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,24706,0.005301262,0.00522091,-0.004931722,0.01553425,0.3099297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.007591853,0.007488468,-0.02226925,0.007085544,0.3106855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,24016,0.006857192,0.006771106,-0.006414177,0.02012856,0.3112072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,28931,0.003439878,0.003406073,-0.003236025,0.01011578,0.3125397
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,24445,0.01229465,0.01222541,-0.01166715,0.03625645,0.3145874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,24101,-0.003214598,0.003197609,-0.009481912,0.003052716,0.3147563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,24195,0.00499286,0.00496861,-0.004745615,0.01473133,0.3149644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.003651225,0.003652925,-0.003508509,0.01081096,0.3175455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.003415201,0.003445141,-0.003337276,0.01016768,0.3215444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,29497,-0.002127727,0.002147779,-0.006337374,0.002081921,0.3218581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.003676202,0.003722694,-0.003620278,0.01097268,0.323402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.003390791,0.003437016,-0.00334576,0.01012734,0.3238727
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.005596935,0.005722265,-0.01681258,0.005618704,0.3280339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.002420058,0.002480627,-0.007282087,0.002441971,0.3292806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,28626,0.004711165,0.004850471,-0.004795759,0.01421809,0.3314171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,29413,-0.008917731,0.009242942,-0.0270339,0.009198435,0.3346453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.0054454,0.005644308,-0.01650824,0.005617444,0.3346733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,24606,0.002164572,0.002247118,-0.002239779,0.006568923,0.3354236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.005467585,0.005692925,-0.01662572,0.005690549,0.3368548
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,29392,-0.005450972,0.005692129,-0.01660754,0.0057056,0.3382555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.004737496,0.00499398,-0.005050706,0.0145257,0.3428125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,24101,-0.005060805,0.005338373,-0.01552402,0.005402406,0.3431363
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.00725792,0.007675586,-0.007786229,0.02230207,0.3443694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.001905482,0.002026567,-0.002066589,0.005877553,0.3470982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.002286779,0.002434952,-0.002485727,0.007059285,0.3476645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.006328609,0.006785882,-0.00697172,0.01962894,0.3510287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.006125097,0.0065816,-0.006774839,0.01902503,0.3520493
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.004386559,0.004716626,-0.004858028,0.01363115,0.3523682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.004784974,0.005145885,-0.005300961,0.01487091,0.3524507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.003228862,0.003474594,-0.01003907,0.003581341,0.3527545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,27585,0.003273288,0.003539919,-0.003664953,0.01021153,0.3551411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.001999142,0.002164342,-0.002242969,0.006241253,0.3556649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.003760308,0.004089409,-0.004254934,0.01177555,0.357831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.005744187,0.006264552,-0.006534335,0.01802271,0.3591859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.003646315,0.003978299,-0.004151151,0.01144378,0.3593855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.001993519,0.002178178,-0.002275711,0.006262749,0.3600837
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.002564371,0.002815877,-0.008083489,0.002954748,0.3624715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.003636222,0.00399305,-0.004190155,0.0114626,0.3624953
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.001787961,0.001981265,-0.00209532,0.005671241,0.3668338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.002690279,0.002987625,-0.003165465,0.008546023,0.3678768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.002078741,0.002311752,-0.006609775,0.002452293,0.3685505
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,29536,0.002038229,0.002275468,-0.002421688,0.006498146,0.3703986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,24240,-0.004740959,0.005303139,-0.01513511,0.005653194,0.3713356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,28931,0.009161762,0.01026802,-0.01096357,0.02928709,0.3722603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,24016,0.002188731,0.002458743,-0.002630405,0.007007866,0.3733766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.001986126,0.002231789,-0.006360433,0.00238818,0.373513
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.004973497,0.005613821,-0.006029592,0.01597659,0.3756598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,24016,0.002629094,0.002972929,-0.003197846,0.008456035,0.3765189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,24445,-0.005484853,0.006215308,-0.01766686,0.006697151,0.3775288
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.003258979,0.00369326,-0.003979811,0.01049777,0.3775612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.002546654,0.002899245,-0.008229175,0.003135866,0.3797434
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.003547293,0.004041477,-0.004374001,0.01146859,0.3801033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.005329113,0.006095418,-0.01727613,0.006617906,0.3819734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,24101,0.0030539,0.003495743,-0.003797756,0.009905556,0.3823419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.002314225,0.002660259,-0.002899882,0.007528332,0.3843502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.002348167,0.002743858,-0.007726128,0.003029794,0.392122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.002314615,0.002710168,-0.007626545,0.002997315,0.3930863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,0.005601858,0.006575435,-0.007285995,0.01848971,0.3942574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,24195,-0.002574035,0.0030227,-0.008498528,0.003350458,0.3944623
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,29589,-0.002090142,0.002468227,-0.006927867,0.002747582,0.3971027
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.002683569,0.003169241,-0.008895282,0.003528144,0.3971403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.004575397,0.005418045,-0.01519477,0.006043971,0.3984131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.002906208,0.003453,-0.009674087,0.003861671,0.3999937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.003043087,0.00363783,-0.00408706,0.01017323,0.4028757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.007170527,0.008602053,-0.02403055,0.009689496,0.4045241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.002181126,0.002623722,-0.002961368,0.007323621,0.4058065
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.002482955,0.003009616,-0.003415892,0.008381803,0.4093756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.001993345,0.002429074,-0.00675433,0.002767639,0.4118711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.005088341,0.006298072,-0.01743256,0.007255879,0.4191441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,29454,-0.001351407,0.001680141,-0.004644483,0.001941669,0.4212062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,0.002792331,0.003472537,-0.004013842,0.009598504,0.4213365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.003293225,0.004116269,-0.004774662,0.01136111,0.4236892
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,24229,0.005881086,0.007386624,-0.008596697,0.02035887,0.425935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.00330564,0.004155061,-0.01144956,0.00483828,0.4262886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.002421616,0.003066062,-0.008431098,0.003587865,0.4296433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.003064432,0.003946425,-0.004670562,0.01079942,0.4374565
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.002517021,0.003244493,-0.003842186,0.008876227,0.437885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,24867,-0.001836384,0.002371507,-0.006484537,0.00281177,0.4387294
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.003508535,0.004545852,-0.005401335,0.01241841,0.4402344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.001451813,0.001885427,-0.00514725,0.002243625,0.4412955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,-0.002852996,0.003705879,-0.01011652,0.004410527,0.4413924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00269435,0.003557203,-0.004277768,0.009666467,0.4487968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.001601193,0.002114149,-0.005744925,0.002542539,0.4488356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,-0.00102335,0.001353368,-0.003675951,0.001629252,0.4495664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,28719,-0.001896653,0.002510866,-0.00681795,0.003024643,0.4500283
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.004090496,0.005465969,-0.0148038,0.006622804,0.4542522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.003220541,0.004327882,-0.01170319,0.005262108,0.4568003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.005399842,0.007290968,-0.01969014,0.008890456,0.4589306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,0.003271106,0.004448794,-0.00544853,0.01199074,0.4621754
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.005434493,0.007478453,-0.02009226,0.009223274,0.4674237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.003291483,0.004533489,-0.01217712,0.005594155,0.4678228
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.002650904,0.003658917,-0.00982238,0.004520573,0.4687616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.001355538,0.001873091,-0.00231572,0.005026795,0.469263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.003285382,0.004546914,-0.005626569,0.01219733,0.4699621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.004370519,0.006054928,-0.007497139,0.01623818,0.470417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.002776077,0.003850151,-0.004770218,0.01032237,0.4708964
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00300906,0.004191441,-0.005206164,0.01122428,0.4728223
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.004055679,0.005677471,-0.007072164,0.01518352,0.4750201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.001364617,0.00191592,-0.005119821,0.002390586,0.4763155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,28797,0.008515635,0.01196146,-0.01492883,0.0319601,0.4765185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.001448185,0.002037228,-0.005441153,0.002544782,0.4771774
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,28797,0.004425877,0.006283668,-0.007890112,0.01674187,0.481223
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,28797,0.004647997,0.006603891,-0.00829563,0.01759162,0.4815462
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00180944,0.002574709,-0.00685587,0.003236989,0.4822029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.002480385,0.003535299,-0.004448802,0.009409572,0.4829321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.002943641,0.00422983,-0.01123411,0.005346825,0.4864818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.002802883,0.004039171,-0.01071966,0.005113892,0.4877355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,-0.002511248,0.003621977,-0.009610324,0.004587828,0.4881042
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,24445,-0.002053768,0.003004676,-0.007942933,0.003835397,0.4942823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.001923574,0.002818571,-0.007447972,0.003600825,0.4949508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.003489945,0.005176677,-0.01363623,0.006656342,0.5002116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,24938,0.002138246,0.003184136,-0.00410266,0.008379152,0.5018886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,28931,-0.002439372,0.003643185,-0.009580014,0.00470127,0.5031364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.003013079,0.004519558,-0.01187141,0.005845255,0.5049856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.002535907,0.00384933,-0.01008059,0.00500878,0.5100358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.00120089,0.00183999,-0.00240549,0.004807269,0.5139808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,24229,0.00271712,0.004178394,-0.005472533,0.01090677,0.5155185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,-0.002619936,0.00404741,-0.01055286,0.005312987,0.5174362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.00107998,0.001671124,-0.004355382,0.002195422,0.5181172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.001874718,0.002936705,-0.003881225,0.007630661,0.523236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.001734924,0.002743701,-0.003642729,0.007112578,0.5271772
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,23801,-0.00179162,0.002843293,-0.007364474,0.003781234,0.5286211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.002775404,0.004413655,-0.01142617,0.005875359,0.5294704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.003052327,0.004866398,-0.006485812,0.01259047,0.5305175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.002722203,0.004367458,-0.01128242,0.005838015,0.5330982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00287319,0.004648687,-0.01198462,0.006238237,0.5365384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.001544505,0.002521519,-0.003397673,0.006486683,0.5401933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,24111,0.003709592,0.006073529,-0.008194524,0.01561371,0.5413508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,28916,0.004724908,0.007755565,-0.010476,0.01992581,0.5423781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.004319659,0.007123535,-0.01828179,0.00964247,0.5442598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.001671532,0.002759356,-0.007079869,0.003736806,0.544674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,0.00116675,0.001926467,-0.002609126,0.004942626,0.5447578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.002634431,0.004361478,-0.005914066,0.01118293,0.5458343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.002349265,0.003921754,-0.0100359,0.005337373,0.5491556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,29694,0.001265657,0.002113019,-0.002875861,0.005407175,0.5491907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.001137165,0.001900284,-0.004861722,0.002587392,0.5495655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.002852808,0.00477817,-0.01221802,0.006512405,0.5504794
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.006371839,0.0106765,-0.01455411,0.02729779,0.5506401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.003658572,0.006180483,-0.01577232,0.008455174,0.5538857
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.002033268,0.003435197,-0.008766254,0.004699718,0.553927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,24938,-0.003903293,0.006624256,-0.01688683,0.009080248,0.555704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.003261469,0.005556503,-0.007629278,0.01415222,0.5572331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.001629626,0.002793199,-0.003845043,0.007104295,0.5596117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.00187855,0.003249067,-0.008246722,0.004489622,0.5631461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,-0.001699465,0.002959355,-0.007499801,0.004100871,0.5657912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.004806174,0.008465208,-0.01178563,0.02139798,0.5702059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.00236755,0.004200927,-0.01060137,0.005866267,0.5730467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.002721386,0.004853085,-0.00679066,0.01223343,0.5749705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.002555487,0.004598957,-0.01156944,0.006458468,0.5784439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,29497,-0.00130141,0.002372052,-0.005950632,0.003347812,0.5832545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.00248584,0.004567728,-0.006466907,0.01143859,0.5862956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.002885927,0.005334835,-0.00757035,0.0133422,0.5885408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.002538696,0.004711145,-0.006695148,0.01177254,0.5899814
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.001557128,0.00289064,-0.007222782,0.004108526,0.5901122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.002592448,0.004831976,-0.006878225,0.01206312,0.5916047
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.001719916,0.003210868,-0.004573386,0.008013217,0.5922024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.002541595,0.00475072,-0.006769815,0.01185301,0.5926606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.002305677,0.004311355,-0.006144578,0.01075593,0.5927987
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.006121681,0.01149367,-0.02864928,0.01640592,0.5943061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.001563613,0.002939027,-0.00419688,0.007324106,0.594718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.001338508,0.002556725,-0.003672673,0.006349689,0.600614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,29725,0.0009355091,0.001798879,-0.002590293,0.004461311,0.6030317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.001261764,0.002426913,-0.003494985,0.006018514,0.6031345
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.001335417,0.002572899,-0.003707464,0.006378299,0.6037429
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.003180285,0.006154646,-0.00888282,0.01524339,0.6053499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,24845,0.000833971,0.001635214,-0.002371049,0.004038991,0.6100509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.001367203,0.002680838,-0.006621645,0.003887239,0.6100626
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.002875063,0.005777467,-0.008448772,0.0141989,0.6187466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,28931,-0.003265741,0.006631823,-0.01626411,0.009732632,0.6224157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,-0.001444984,0.002951282,-0.007229496,0.004339528,0.6244119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,24938,-0.001680446,0.003433364,-0.00840984,0.005048948,0.6245303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.001928171,0.003945548,-0.009661446,0.005805104,0.6250619
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.001377159,0.002843243,-0.006949914,0.004195597,0.6281334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,28931,-0.001685947,0.003520883,-0.008586878,0.005214985,0.6320547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.001699843,0.003581251,-0.00531941,0.008719096,0.6350403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,24111,0.001683927,0.003548379,-0.005270895,0.008638749,0.6351033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,24922,0.0009118455,0.001925328,-0.002861797,0.004685488,0.6357855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.002626316,0.005548875,-0.01350211,0.008249479,0.635999
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,-0.003355104,0.007098875,-0.0172689,0.01055869,0.6364844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.001224714,0.002594744,-0.003860985,0.006310413,0.6369318
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,24381,0.001773356,0.003763414,-0.005602935,0.009149648,0.6374954
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.001652607,0.003549834,-0.008610283,0.005305069,0.6415456
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,24111,-0.001273137,0.002751458,-0.006665995,0.004119722,0.6435739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.0008540464,0.001861734,-0.002794951,0.004503044,0.6464269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,29461,0.006153319,0.01353863,-0.02038239,0.03268903,0.6494717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,24845,0.003115284,0.006864176,-0.0103385,0.01656907,0.6499431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.001542209,0.003400846,-0.008207867,0.005123449,0.6502086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,0.001829738,0.004052778,-0.006113706,0.009773182,0.6516487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.001172429,0.002632899,-0.006332911,0.003988053,0.6561073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.00177829,0.004025428,-0.009668129,0.006111549,0.6586637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,0.00272863,0.006205846,-0.009434828,0.01489209,0.660167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.002937868,0.006711339,-0.01609209,0.01021636,0.6615736
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.001323335,0.003029671,-0.00726149,0.00461482,0.6622664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.001791776,0.004157135,-0.006356208,0.009939761,0.6664633
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.002324202,0.005444473,-0.01299537,0.008346964,0.6694618
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.001313446,0.003080806,-0.004724933,0.007351825,0.6698696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.0007706586,0.001820305,-0.004338456,0.002797139,0.67203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.001216199,0.002879164,-0.006859361,0.004426963,0.6727267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.000937195,0.002226415,-0.005300968,0.003426578,0.6737994
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.001499676,0.003571041,-0.008498915,0.005499564,0.6745222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.003001674,0.007150274,-0.01101286,0.01701621,0.6746364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.001218558,0.002914999,-0.004494841,0.006931957,0.6759286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.002200407,0.005321493,-0.01263053,0.008229719,0.6792482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.00123308,0.003024831,-0.007161749,0.004695589,0.6835325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.0009446278,0.002332456,-0.005516241,0.003626985,0.6854863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,29218,0.001023228,0.002530164,-0.003935894,0.00598235,0.685913
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.001472414,0.003654949,-0.005691287,0.008636115,0.6870586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.002029963,0.005047576,-0.007863286,0.01192321,0.6875655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,0.0007626749,0.001896642,-0.002954744,0.004480094,0.6876004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.0008183348,0.002084232,-0.004903429,0.00326676,0.6945947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.0009606391,0.002454038,-0.005770553,0.003849275,0.6954662
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,24111,-0.001868315,0.004873568,-0.01142051,0.007683879,0.7014587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.001145029,0.002989903,-0.004715181,0.007005239,0.7017489
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.0009262323,0.002419953,-0.00566934,0.003816875,0.7019093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,24922,-0.001042297,0.002727784,-0.006388753,0.004304158,0.7023874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,24229,0.001175166,0.003119021,-0.004938116,0.007288448,0.7063449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,24016,-0.001707476,0.004611391,-0.0107458,0.007330851,0.711182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,28931,-0.001662586,0.004508839,-0.01049991,0.007174737,0.7123247
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.001448395,0.003950389,-0.006294367,0.009191157,0.7138861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,23913,-0.0009178331,0.002509472,-0.005836399,0.004000733,0.7145568
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.001354754,0.003724665,-0.005945589,0.008655097,0.7160665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,0.00105069,0.002909243,-0.004651426,0.006752805,0.7179861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.001733106,0.004822245,-0.01118471,0.007718493,0.7193003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.0007010522,0.001975873,-0.004573764,0.00317166,0.7227379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.001617058,0.004597471,-0.007393985,0.0106281,0.7250455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.001348169,0.003884102,-0.006264671,0.00896101,0.7285197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,28931,-0.001367994,0.004019852,-0.009246905,0.006510917,0.7336259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.001381368,0.004104776,-0.006663994,0.00942673,0.736476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.0008684674,0.002590107,-0.004208142,0.005945077,0.7374004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,24867,-0.000531683,0.001590104,-0.003648287,0.002584921,0.7381033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.001183786,0.003543291,-0.005761064,0.008128636,0.7383129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.001039026,0.003142195,-0.007197727,0.005119676,0.7408975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.001463175,0.004425978,-0.007211742,0.01013809,0.7409586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.001347103,0.004185811,-0.009551293,0.006857088,0.7475874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.002004292,0.006332492,-0.01441598,0.01040739,0.7516188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,24793,0.0006217183,0.001967474,-0.003234532,0.004477968,0.7520066
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.0009100728,0.002918053,-0.004809312,0.006629458,0.7551369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.001576104,0.005056144,-0.008333939,0.01148615,0.7552551
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.0009467787,0.003045357,-0.006915678,0.005022121,0.755885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.001249541,0.004039134,-0.009166243,0.006667161,0.7570514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,24805,-0.005723057,0.01880268,-0.0425763,0.03113019,0.7608451
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,28931,0.00105383,0.003480032,-0.005767033,0.007874693,0.7620278
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,-0.0005077072,0.001692756,-0.003825509,0.002810095,0.7642336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,0.0004552912,0.001519182,-0.002522306,0.003432888,0.764412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.001844667,0.006282127,-0.01415764,0.0104683,0.7690371
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.0009714826,0.003392933,-0.005678666,0.007621631,0.7746309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.001168731,0.004104117,-0.006875338,0.0092128,0.7758225
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,24101,-0.00130699,0.004602494,-0.01032788,0.007713898,0.7764325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.005405002,0.01914961,-0.04293823,0.03212823,0.7777532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.0008386001,0.002972912,-0.004988307,0.006665507,0.7778839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,-0.002466383,0.008915763,-0.01994128,0.01500851,0.7820649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.001301478,0.004709475,-0.01053205,0.007929093,0.7822788
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.001305015,0.004809512,-0.008121628,0.01073166,0.7861314
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.001598153,0.005978068,-0.01331517,0.01011886,0.7892123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,24754,-0.0009918095,0.003750789,-0.008343357,0.006359738,0.7914532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,24101,0.0009405444,0.003586988,-0.006089951,0.00797104,0.7931617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,28931,-0.0009895295,0.003779343,-0.008397042,0.006417983,0.7934576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.001395667,0.005354771,-0.009099684,0.01189102,0.7943724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.0005729526,0.002210272,-0.004905085,0.00375918,0.7954656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,-0.003407577,0.01339114,-0.0296542,0.02283905,0.799138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.0007467881,0.003013741,-0.006653721,0.005160145,0.8042956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.001202111,0.004863269,-0.01073412,0.008329898,0.8047698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.0009839322,0.00399389,-0.008811956,0.006844092,0.8054061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.0008619184,0.00357788,-0.006150727,0.007874564,0.8096331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,-0.0009206033,0.003923172,-0.008610021,0.006768814,0.8144763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.001062814,0.004686859,-0.01024906,0.00812343,0.8206087
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,28797,0.002262395,0.01001727,-0.01737145,0.02189624,0.8213201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,24756,-0.0009573149,0.004260737,-0.00930836,0.00739373,0.8222278
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,-0.0004385423,0.001954366,-0.0042691,0.003392015,0.8224549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.002019016,0.009039976,-0.01973737,0.01569934,0.8232701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.000722286,0.003292792,-0.007176157,0.005731585,0.8263764
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,28916,-0.0005151808,0.002368577,-0.005157591,0.00412723,0.8278152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.002155368,0.009984707,-0.02172539,0.01741466,0.8290932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.0005891288,0.002744143,-0.004789391,0.005967649,0.830014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,29820,0.001122771,0.005237651,-0.009143025,0.01138857,0.8302637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.0009635324,0.004580654,-0.009941614,0.008014549,0.8333976
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,24016,0.0009222825,0.004385242,-0.007672792,0.009517357,0.8334235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,24101,0.000573624,0.002730592,-0.004778336,0.005925585,0.8336124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.001330238,0.006340895,-0.01375839,0.01109792,0.8338356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.0007382143,0.003527815,-0.007652732,0.006176304,0.8342507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,-0.0008454341,0.004043271,-0.008770244,0.007079376,0.8343743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.0005536356,0.002649963,-0.004640291,0.005747563,0.8345108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,-0.0009189242,0.004404989,-0.009552703,0.007714854,0.8347542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00144417,0.007023722,-0.01521067,0.01232233,0.8370948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,0.001228269,0.006101175,-0.01073003,0.01318657,0.8404525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,28931,0.0004440462,0.002280945,-0.004026606,0.004914699,0.8456476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,-0.00177262,0.009262311,-0.01992675,0.01638151,0.8482293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.0006456914,0.003420592,-0.007350051,0.006058668,0.8502778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,-0.0004590913,0.002444674,-0.005250652,0.004332469,0.8510409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,24229,0.0006368467,0.003396317,-0.006019935,0.007293628,0.8512616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0004868855,0.002658623,-0.004724015,0.005697786,0.854694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,28774,-0.0006213435,0.003426364,-0.007337016,0.006094329,0.8561005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.0008559942,0.004777074,-0.01021906,0.008507072,0.8577916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.000720186,0.004174647,-0.008902494,0.007462122,0.8630345
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,28916,0.0008862506,0.005158119,-0.009223663,0.01099616,0.8635829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,24421,-0.001207772,0.007157253,-0.01523599,0.01282044,0.8659963
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0004810787,0.002960873,-0.00628439,0.005322233,0.8709303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,0.002029327,0.01250318,-0.02247691,0.02653556,0.8710671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.0003820687,0.002362293,-0.004248026,0.005012163,0.8715148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,24195,0.0005666104,0.003508588,-0.006310222,0.007443443,0.8717069
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,0.0003390444,0.002110153,-0.003796856,0.004474945,0.8723522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,0.0009747592,0.006088766,-0.01095922,0.01290874,0.8728104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.0008628696,0.005413028,-0.009746666,0.0114724,0.8733503
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.0004770509,0.003036888,-0.006429351,0.005475249,0.8751788
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.0005855261,0.003879525,-0.008189395,0.007018343,0.8800342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.0005154553,0.003567745,-0.007508235,0.006477324,0.8851254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.0006602775,0.004629818,-0.00973472,0.008414165,0.8865961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,24445,-0.0005368813,0.003827696,-0.008039165,0.006965403,0.8884539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,0.0007606937,0.005558435,-0.01013384,0.01165523,0.8911474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,24111,-0.0003960449,0.002906098,-0.006091997,0.005299907,0.8916006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,0.0005525741,0.004362225,-0.007997387,0.009102535,0.8992007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000456924,0.00364476,-0.007600654,0.006686806,0.9002359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,24229,0.0006597146,0.005444265,-0.01001104,0.01133047,0.9035526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.0002772873,0.002305047,-0.004795179,0.004240604,0.9042497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.0003844307,0.003278033,-0.006809376,0.006040514,0.9066432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,24793,0.0003188852,0.002750403,-0.005071904,0.005709674,0.9077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.0003337536,0.00292509,-0.006066931,0.005399424,0.9091592
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,28931,0.0006241888,0.005536688,-0.01022772,0.0114761,0.91024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.0004497847,0.004164855,-0.007713331,0.0086129,0.9140003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,29694,0.0005825204,0.005468438,-0.01013562,0.01130066,0.9151673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0003012516,0.002834326,-0.005254027,0.00585653,0.9153555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.0003654195,0.003557127,-0.007337388,0.006606549,0.918179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,-0.0002380978,0.002601298,-0.005336643,0.004860447,0.9270719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,0.0002071538,0.002313768,-0.004327832,0.00474214,0.9286607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.0001990416,0.002294959,-0.004697162,0.004299079,0.9308868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,0.000488882,0.005673155,-0.0106305,0.01160827,0.9313283
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,-0.0001909544,0.002412699,-0.004919844,0.004537936,0.9369174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.0006379359,0.008225443,-0.01548393,0.0167598,0.9381816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.0001272171,0.001857511,-0.003513504,0.003767938,0.9453977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,24111,-0.0003053526,0.004735464,-0.009586862,0.008976157,0.9485869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,24195,0.0002758374,0.004369631,-0.008288639,0.008840313,0.9496667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,24229,-0.0002154384,0.003457237,-0.006991622,0.006560745,0.9503123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,0.0001166145,0.001882487,-0.003573059,0.003806288,0.9506054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,28774,-0.0002233177,0.003826769,-0.007723784,0.007277149,0.9534649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.000165857,0.002980968,-0.00567684,0.006008554,0.9556301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,24793,0.0001930639,0.003479003,-0.006625781,0.007011909,0.9557453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.000323752,0.006185516,-0.01179986,0.01244736,0.958258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0001854672,0.003729241,-0.007123846,0.00749478,0.9603354
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,24111,0.0001485392,0.003109937,-0.005946938,0.006244016,0.9619057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,29565,0.000133086,0.002787595,-0.005330601,0.005596773,0.961922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,24195,-0.0001291299,0.00303603,-0.006079748,0.005821488,0.9660746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.0001055956,0.002495544,-0.004996862,0.004785671,0.966249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,24229,7.151182e-05,0.001899918,-0.003652327,0.00379535,0.9699755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0001051322,0.002865956,-0.005512141,0.005722406,0.970738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,24793,-0.0001165278,0.003219317,-0.00642639,0.006193334,0.971126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,-0.0001237592,0.003649001,-0.007275802,0.007028284,0.9729445
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,28490,5.545652e-05,0.001900566,-0.003669653,0.003780566,0.9767221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,24195,-5.0667e-05,0.001982846,-0.003937045,0.003835711,0.9796144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,-8.354921e-05,0.004021504,-0.007965697,0.007798598,0.9834248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-3.752214e-05,0.002109722,-0.004172578,0.004097533,0.9858102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,24445,-5.356736e-05,0.003888339,-0.007674711,0.007567577,0.9890085
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-6.507233e-05,0.005492192,-0.01082977,0.01069962,0.9905469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,24229,5.205515e-05,0.004450892,-0.008671693,0.008775804,0.9906687
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,3.25083e-05,0.003158146,-0.006157457,0.006222474,0.9917872
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,28916,-2.008481e-05,0.001983683,-0.003908103,0.003867933,0.9919216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-3.069994e-05,0.003514771,-0.006919651,0.006858252,0.993031
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,24833,1.618583e-05,0.003425974,-0.006698724,0.006731096,0.9962305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-3.78909e-07,0.002961861,-0.005805626,0.005804868,0.9998979
